University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Doctoral Dissertations

Graduate School

12-2009

Small Windows of Hope: Understanding the Meaning of Fatigue
Experienced by Cancer Patients
Lois Starnes Doane
University of Tennessee - Knoxville

Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss
Part of the Nursing Commons

Recommended Citation
Doane, Lois Starnes, "Small Windows of Hope: Understanding the Meaning of Fatigue Experienced by
Cancer Patients. " PhD diss., University of Tennessee, 2009.
https://trace.tennessee.edu/utk_graddiss/586

This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee
Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized
administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact
trace@utk.edu.

To the Graduate Council:
I am submitting herewith a dissertation written by Lois Starnes Doane entitled "Small Windows
of Hope: Understanding the Meaning of Fatigue Experienced by Cancer Patients." I have
examined the final electronic copy of this dissertation for form and content and recommend
that it be accepted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy, with a major in Nursing.
Sandra P. Thomas, Major Professor
We have read this dissertation and recommend its acceptance:
Mary Gunther, Susan Speraw, Ralph Brockett
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

To the Graduate Council:
I am submitting herewith a dissertation written by Lois Starnes Doane entitled “Small
Windows of Hope: Understanding the Meaning of Fatigue Experienced by Cancer
Patients.” I have examined the final electronic copy of this dissertation for form and
content and recommend that it be accepted in partial fulfillment of the requirements for
the degree of Doctor of Philosophy, with a major in Nursing.
Sandra P. Thomas
Major Professor

We have read this dissertation
and recommend its acceptance:

Mary Gunther
Susan Speraw
Ralph Brockett

Accepted for the Council:
Carolyn R. Hodges
Vice Provost and
Dean of the Graduate School

(Original signatures are on file with official student records.)

Small Windows of Hope: Understanding the Meaning
of Fatigue Experienced by Cancer Patients

A Dissertation
Presented for the
Doctor of Philosophy Degree
The University of Tennessee, Knoxville

Lois Starnes Doane
December 2009

Copyright © 2009 by Lois Starnes Doane
All rights reserved.

ii

Dedication

This dissertation is dedicated to my sons, William Landon Starnes Doane and
Tyler Starnes Doane, who encouraged me to pursue my doctorate. To Landon, thanks for
your love, support and for being so proud of me, and to Tyler, who is smiling down from
Heaven and is saying, “Mom, I knew you would do it; please be happy.”
Also, a special acknowledgment to my mother, Mabel Starnes Gilliam, who
taught me the love of God and the importance of caring for other people. A special
thanks to my sister, Linda Starnes Lumpkins, who supported me in this professional
endeavor, and who has always walked with me throughout my life‟s journey. A special
recognition to my late father, Elmer Lee Starnes, who always encouraged me to utilize
my God-given gifts and talents.

iii

Acknowledgements

In recognition of all oncology patients and families who have touched my life
over the past 34 years, you have changed my life forever. Especially, I convey a most
sincere gratitude to the participants in the study who shared their courageous stories with
me. I shall always be indebted for you allowing me to peer “through your window” as
you valiantly shared your experience of fatigue and how you courageously fought to
always have “small windows of hope” as you dealt with your pervasive tiredness. I also
thank the cancer survivors who attend CancerNet, an ongoing cancer support group that
has met since 1985. Each month you inspire me to live each day to its fullest potential.
I am most grateful to Dr. Sandra Thomas, committee chair, who also serves as
director of the doctoral program. Not only is Dr. Thomas exemplary of a dedicated
educator and mentor, but she also exudes a genuine interest in each doctoral student
during their tenure in the nursing program. She encourages each student to develop
academically and professionally, and she also conveys a sincere concern about her
students as they face adversities during their academic years. During the tragic loss of
my 19-year-old son, Tyler, Dr. Thomas provided tremendous support. With her
encouragement I returned to school for completion of my dissertation. I shall always be
indebted to Dr. Thomas because without her commitment to my personal and
professional development, I would have been unable to achieve this important goal.
I also thank Dr. Ralph Brockett, Dr. Mary Gunther and Dr. Susan Speraw,
committee members, for their guidance, wisdom and support. They provided valuable
iv

insight and they, along with the phenomenology research group, spent hours reading and
interpreting interview transcripts.
A special appreciation and acknowledgement are given to my sister, Linda
Starnes Lumpkins, who has always supported me in every endeavor in my life. I owe a
great deal of my professional success, including the completion of my dissertation, to her
as God blessed me with the greatest sister imaginable. I also thank my friends Sandra,
Bob and Duane for helping with the manuscript. A special thanks for Bob‟s
encouragement to complete my dissertation and his unending support and unwavering
concern for my happiness. I am most grateful to his assistance, guidance and devotion
given freely in helping me complete this significant goal.
I also want to acknowledge my manager, Donna Vaughn, MBA, RN, who
provided ongoing support for my completing studies over the past three years. She, being
a well respected author, offered many suggestions in helping me complete the
dissertation. I also thank Susan Schultz, Regional Director, for her enduring support of
me completing my educational studies. Both of these wonderful friends and colleagues
have provided tremendous support to me, both personally and professionally.
A special acknowledgement to Frank, my many friends, and oncology nursing
and medical colleagues. Your support through the years, both personally and
professionally, has enabled me to complete this important milestone in my professional
life.
I also thank my former nursing students who have always made me so proud that
many of you became oncology nurses; this is the greatest professional gift you could ever
v

bestow upon me. I also am grateful you make such a unique and distinct difference in the
lives of oncology patients and families each day.
Above all, I thank God for the many blessings He has always bestowed upon me;
whether being on the mountaintop or in the valley….His footsteps are always beside me.

vi

Abstract

The purpose of the study was to describe the experience of early stage breast
cancer women who were living with cancer-related fatigue. Using a phenomenological
approach based on the work of Merleau-Ponty, the researcher completed six interviews in
which women described the experience of being tired each day.
Interviews were transcribed verbatim and analyzed using a hermeneutical
approach developed by Pollio and applied to nursing research by Thomas. Each interview
was examined within the context of all the interviews to identify themes noted in all
transcriptions. Dealing with the prevailing and profound fatigue that entrenched these
women‟s lives was overwhelming. There was an overarching sense of living in the
“Shadow of Death,” which served as the contextual ground. This sense of looming in the
“Shadow of Death” reflected that these women survived cancer and cancer therapies;
however, fatigue rendered their bodies, minds and lives changed…..an irreversible
change.
Living with fatigue was described by the women as “part of weaving the fabric of
my life,” yet the tapestry was never complete and had many imperfections. These flawed
threads in the tapestry emerged as four figural themes: “Being Alone in my Cave,”
“Coming Out of the Cocoon,” “It‟s a Lost Fight” and “Who am I Now?”
They described living in two worlds: one being hard and demanding, regardless of
how hard they worked to overcome their fatigue; the second world served as a safe
vii

refuge, a cave, that allowed them to “peer through the window of hope” into the outside
world. As fatigue improved they initiated “coming out of the cocoon,” but realized their
bodies were entrapped with many losses.
Losses were described as “permanent visitors” which led to feelings of loneliness
and despair with their life being relegated to a non-participative role with family, friends
and work. Regardless of effort, their recalcitrant body was unable to overcome the
fatigue. With fortitude, they confronted a search for the “old me” to realize every fabric
of their life had changed, never to return to the “old self” which left them to peer into the
outside world while searching for small “windows of hope.”
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CHAPTER I
INTRODUCTION
Early treatment of patients with cancer clearly has resulted in increased cure and
survival rates; however, therapy frequently results in short- and long-term consequences
that affect patients‟ physical and emotional well-being. Fatigue is one such side effect
that is profound and pervasive. According to a Fatigue Coalition survey, patients with
cancer rated fatigue ahead of pain, nausea, and depression as the cancer-related condition
being the most common and troublesome, the longest lasting, and having the greatest
impact on their day-to-day functioning and economic well-being (Vogelsang, Breitbart,
& Cella, 1997). Fatigue is the most common and distressing symptom resulting from
cancer therapies: 60-100% of patients receiving chemotherapy report experiencing
fatigue, which has been termed the “common denominator” of symptom distress
(Winningham et al., 1994). The impact of cancer-related fatigue on the patient‟s quality
of life and ability to carry out activities of daily living has significant implications for
patients who experience a notable decline in functional ability during and after cancer
treatment (Nail & Winningham, 1995). The fatigue is associated with considerable
psychological distress and can impose a significant financial burden by limiting a
patient‟s ability to work. Approximately 28% of cancer patients experiencing fatigue
terminate their work indefinitely and 23% accept disability. Approximately 11% of
family members take family medical leave to care for their loved ones experiencing
fatigue (Breithart, Cella, & Curt, 2000). Not only does fatigue impact the patient and
families‟ quality of life but may also impact survival. Mormont, Watermont, and
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Bluezen (2000) reported a five-fold lower survival, poorer quality of life and more
fatigue when rest and activity are interrupted.
In fact, cancer survivors consider management of their cancer-related fatigue as
their highest priority in cancer care as their fatigue remains a chronic health problem long
after the treatments are completed (Bower & Ganz, 2007). A recent review of the
literature reported by Stone (2008), and De Jong, Courtens, Abu-Saad, and Schouten
(2002) concluded that post-treatment fatigue persists up to five years after completion of
breast cancer treatments. Bower et al. (2006) reported that 34% of long-term breast
carcinoma survivors reported significant fatigue at 5-10 years after diagnosis.
While this extreme exhaustion has been recognized as an almost universal side
effect of cancer and cancer treatment, the phenomenon is multifaceted, is subjectively
measured, and has only been studied minimally to understand the meaning of the fatigue
from the patient‟s perspective. The complex nature and etiologies of the symptom have
challenged researchers, and the knowledge regarding fatigue and its relationship with
other factors are limited. Despite the widespread recognition of the tiredness as a
symptom of disease or as a result of treatment, the concept is not clearly defined nor
clearly understood from either the patient‟s or researcher‟s perspective. There is no
understanding of how a cancer patient defines fatigue, how it impacts on his/her quality
of life, and what long-term effects it has on the patient.
There are minimal qualitative or quantitative studies delineating how fatigue
impacts the various domains of quality of life, including physical, social, emotional,
psychosocial and spiritual dimensions. Neither is there information about the patient
2

experiencing difficulty in being employed while dealing with cancer-related fatigue.
Therefore, the phenomenological approach to studying cancer-related fatigue provides an
opportunity to gain an understanding of the essence of this unrelenting symptom. The
outcome of the study may equip the healthcare professional to better understand what it is
like for the patient to experience this extreme exhaustion. With this understanding,
strategies can be implemented to improve the cancer patient‟s quality of life.

Purpose of Study
The purpose of the study is to describe the breast cancer patient‟s lived experience
of fatigue. By using an existential phenomenological approach, a rich description of the
patient‟s perception of living with being tired will be obtained.

Philosophical Lens: Phenomenology
The qualitative approach selected to develop an understanding of the phenomenon
of cancer-related fatigue is existential phenomenology, which is derived from the
perspective of Merleau-Ponty. He proposes that an experience consists of “the essence
that is identified through a perception” or through “being in the world” or “being-withothers.” A phenomenological report strives to “give direct description of our
experience.” His premise is further elucidated by realizing that to understand an
individual‟s experience; one must view the meaning of that experience for the person
holistically. The understanding of the meaning, or perception, evolves from the
interaction of the individual with his/her environment. The term “figural” refers to
awareness of certain aspects in the environment over others. “Intentionality” refers to the
3

direction of the human experience, including perception, and also includes events, objects
and the “phenomena in the world” (Merleau-Ponty, 1962). The objects that capture us or
that we seek after reveal what is significant to us, really telling us who we are.
Furthermore, perception provides a direct experience of events, objects and the
phenomena of the world. According to Merleau-Ponty (1962), our existence is always
experienced as a way of “standing out” while the things experienced as further away and
more indefinite are termed as “ground”. In other words, when looking at a figure and the
world, we can only focus on one at a time (Thomas & Pollio, 2002, pp. 14-15).
The existential phenomenological approach enables us to describe who we are
and how we live in life as well as it enables the human being to appreciate both our
freedom and responsibility in shaping the situation we are facing. It thus allows people
with cancer-related fatigue to describe their experience of fatigue from their own and
unique perspective, including those changes in freedoms and responsibilities that have
evolved secondary to the development of fatigue. This approach is selected because there
first must be an understanding of what the cancer patient experiences with their fatigue
before a conceptual framework or practice guideline can be developed to treat and
manage these patients. It is important to go into the world of the cancer patient and hear
what is happening to those who are experiencing the symptom in order to really
understand the experience of cancer-related fatigue.
In addition, the approach is selected because it deeply connects with cancer
patients and helps to understand them more holistically as they deal with the cancer
trajectory. The nurse‟s caring becomes important for cancer survivors as cancer-related
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fatigue may persist for an extended time, despite completion of treatment and a good
prognosis. This becomes even more important as more than half of cancer patients will
be treated and never acquire a remission of their potentially terminal disease. Having the
presence of a caring oncology nurse who is genuinely interested in the world of the
patient becomes extremely important in helping the patient live each day to its fullest and
ultimately improve their quality of life, regardless of the time remaining.

Summary of Research
In summary, the paucity of phenomenological studies about cancer-related fatigue
provides a rationale to study the phenomena from the inception of the clinical symptom
throughout the trajectory of the cancer experience. Without an understanding of the
patient‟s experience, the healthcare provider has no basis knowing how to approach the
patient about managing their fatigue. Therefore, an in-depth understanding of the
experience of cancer-related fatigue is pivotal to identifying strategies to assist the patient
in dealing with their fatigue. By understanding the experience of the patient‟s fatigue, the
healthcare provider assists the patient to identify management strategies for their fatigue,
thus ultimately improving the patient‟s quality of life.

Significance of the Problem
While fatigue has been recognized as an almost universal side effect of cancer and
cancer treatment and has been included in many studies for the past 25 years, effective
treatments for fatigue have not yet been developed. In addition, researchers agree that
fatigue related to cancer therapy is a multifaceted, subjectively measured phenomenon,
5

but no physiologic measurement that quantifies fatigue has been accepted (Winningham
et al., 1994). Minimal research has been conducted to understand its mechanisms.
Although the exhausting symptom impacts greatly on the patient‟s quality of life, very
little is known about the clinical epidemiology of the fatigue and what interventions are
most likely to be effective. Most studies of fatigue related to cancer treatment have
focused on patients‟ subjective self-reported experiences, with a few studies measuring
changes in fatigue over a course of repeated treatments (Jacobsen, et al., 1999). The
complex nature and etiologies of fatigue have challenged researchers, and knowledge
regarding fatigue and its relationship with other factors is limited. In addition, despite the
prevalence of fatigue, surprisingly little is known about cancer-related fatigue that can
guide nursing assessments and interventions.
Selecting cancer-related fatigue as a concept for study is of paramount importance
to nursing as the knowledge of fatigue reported in the nursing literature is derived from
other disciplines that have investigated fatigue. The nursing perspective is unique among
health disciplines. It is concerned not only with the health status of the whole person and
the family subsystem, but it also is concerned with people‟s subjective perceptions and
objective responses to their health status. This is a broader view of the person‟s response
to fatigue than the focus found in other disciplines. Therefore, the concept of cancerrelated fatigue needs to be further elucidated so that from a nursing perspective, cancerrelated fatigue can be described, explained, and predicted with a plan to prescribe
appropriate nursing care. In addition, there is a paucity of studies that reflect how a
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cancer patient would define his/her fatigue, how it impacts on his/her quality of life, and
how to manage the symptom.
The terms associated with the phenomenon of cancer-related fatigue have not
been well defined. However, Ream, & Richardson, (1996) have observed that “the
saliency of the definition derived from a concept analysis for clinical populations has
been determined through minimal phenomenological inquiry” (p. 45). Further
phenomenological, empirical and theoretical work is therefore needed to clarify and test
the definitions and models of fatigue.
Efforts to develop research-based treatment guidelines for cancer-related fatigue
have been challenged by the lack of phenomenological studies, disagreement about an
acceptable definition, and the absence of formal diagnostic criteria. Any proposed
definition of cancer-related fatigue must recognize that it can occur as a warning sign of
an impending health crisis, such as the diagnosis or recurrence of cancer; a potential side
effect of cancer treatment, such as surgery, chemotherapy, radiotherapy, bone marrow
transplant or biotherapy; or a possible complication of post-treatment recovery. Multiple
definitions and discipline-specific perspectives on cancer-related fatigue exist that make
it difficult to synthesize the literature and determine cumulative findings that are useful to
nursing practice. In addition, an urgent need exists for a consistent, research-based
definition of fatigue. This definition should include consideration of etiologies and
mechanisms of fatigue that may distinguish true fatigue from expressions such as
tiredness, lack of energy, and other common terms (Winningham, et al., 1994).
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Aside from the aforementioned reasons that research is warranted, it is of
paramount importance to understand the patient‟s experience of their fatigue. Cancerrelated fatigue cannot be explained by physiologic mechanisms alone. It must be
understood from the patient‟s perspective as he/she describes the meaning of fatigue
which may include physical, psychological, social and spiritual aspects which potentially
may impact the patient “quality of life.” Additionally, an understanding of these most
common symptoms experienced by cancer patients is needed before treatment strategies
can be pursued. Despite the current knowledge about cancer-related fatigue, healthcare
professionals have little understanding about the meaning of fatigue from the patient‟s
perspective. Therefore, appreciating the patient‟s perception of their fatigue will enable
the healthcare professional not only define fatigue but identify various strategies to help
deal with cancer patients‟ experience.
Historical Perspective
In order to gain a perspective on the cancer-related fatigue syndrome, it is
necessary to retrace the paths of discovery and to examine fatigue as part of historical and
universal phenomenon. Fatigue is best understood from the point of view of energetics.
Energetics is the study of energy in its many forms and how it is used in organisms,
specifically the cells of the human body. As such, it is the underlying principle of how
organisms live and function, specifically: metabolism, anabolism and catabolism. There
is also a phenomenon, entropy, which works against all life, from conception to death.
From an energetic perspective, this phenomenon of entropy serves as the foundation of
fatigue (Winningham & Burke, 2000).
8

Investigating the nature of fatigue-related issues goes back at least two millennia
to Hippocrates. Vitalism, which considered life to be activated and maintained by some
intrinsic, inestimable, and immeasurable factor, was an outgrowth of Aristotle‟s
philosophy. The most powerful challenge to vitalism, as a scientific theory, came in the
early 1600s when Descartes presented his philosophy of mechanics. Descartes made
many and varied contributions to science that are still having an influence today,
including the influence of the mind on the body and psychoneuroimmunology
(Winningham & Burke, 2000).
Although vitalism generally fell into disrepute among scientists, vestiges
remained. As late as the nineteenth century, invalids or sick individuals, including cancer
patients showing fatigability, weakness or cachexia, were identified as lacking in “vital
powers” or “vital force” (Winningham & Burke, 2000, p. 15).
On a more basic level, the idea of another source of energy was central to the
development of Han Selye‟s general adaptation syndrome (stress) theory, which was
called adaptive energy. Although this energy was not derived from nutrient utilization in
metabolism, he acknowledged he had no idea what it was, just that it existed. Selye
proposed that adaptive energy held the key to understanding fatigue and aging
(Winningham & Burke, 2000).
The use of the word “fatigue” has come mainly from science, physiology, and
engineering. During wartime, in particular, a large amount of funding went into fatigue
research focused on alertness and performance in pilots flying bombers, in workers
manufacturing, and in technicians monitoring instruments. During peacetimes,
9

industrialists focused on similar issues, but for a different reason, as they sought ways to
analyze and optimize efficiency of workers‟ performance. Subsequent foci on fatigue
centered on neuromuscular and endocrine aspects as well as cognitive factors. Since
World War II, NASA has picked up the trail of fatigue-related research because of its
relationship to performance and well being in astronauts, with a focus on harmful effects
of bed rest. More recent work has focused on elucidating the influence of neurohumoral
immunologic factors, such as cytokines. All this work has significance for understanding
and defining fatigue in cancer (Winningham & Burke, 2000).
There is no consensus on what the word “fatigue” means, especially for cancer
patients. To conceptualize a sense of the term “cancer-related fatigue,” there must be an
understanding that there are approximately 22 words associated with the etymology of
fatigue including asthenia, cachexia, exhaustion, fatigue, sleepiness, tired to weariness
(Winningham & Burke, 2000). It is doubtful whether most patients tested by current
cancer fatigue scales could give an adequate or accurate description or definition of many
of the words in the scale. A concise definition of fatigue has escaped elucidation because
the mechanisms appear to be so complex and multidimensional. It is noteworthy;
however, that many of the words used in fatigue scales measure quality of life issues,
which will be taken into consideration when asking the cancer patient to describe their
fatigue experience.

10

Nursing Historical Perspective
The inception of the concept of fatigue as it applies to nursing is relegated to
Florence Nightingale who wrote about a deficit of vital force or vital powers. She
observed what we today term fatigue in a variety of patients (Winningham & Burke,
2000). Nursing-oriented theories explaining the onset and experience of fatigue have
evolved in the absence of pathophysiologic theories of fatigue. Preliminary
pathophysiologic hypotheses linking fatigue with changes in muscles and nerves and
alternations in neural activity remain unsubstantiated. Nursing-oriented fatigue theories
depict factors that can act independently or concurrently to influence the manifestation of
fatigue. These practice-oriented theories are relatively unsophisticated and, therefore,
limited in their predictive capacity, but they offer tentative guidelines for clinical practice
and indicate directions for research. These theories focus predominantly on energy
utilization and conservation. The five most frequently cited and relevant theories for the
development of fatigue initiatives are Ryden‟s Conceptual Framework of Energy
Expenditure (Ryden, 1977); Aistairs Organizing Framework (Aistairs, 1987); Irvine,
Vincent, Graydon, Bubela, & Thompson‟s Energy Analysis Model (1994); Piper,
Lindsey, & Dodd‟s Integrated Fatigue Model (1987) and Winningham‟s
Psychobiological-Entropy Model (1994).
Ryden‟s Conceptual Framework of Energy Expenditure (1977) is the least
sophisticated of these fatigue theories. It provides some understanding of fatigue and the
factors that can lead to it as well as a limited explanation of how the process evolves.
With this theory, the human body is depicted as an open system that obtains energy from
11

the environment to sustain life. When the energy obtained exceeds essential lifesupporting demands, Ryden proposes that an excess becomes available for nonessential
activities, including work, socializing, and hobbies. During periods of illness, energy
demands escalate to allow healing and rehabilitation, leaving little in reserve for other
often rewarding activities. Patients with cancer commonly need energy to cope with the
demands of the disease and its treatment. Ryden perceives the stress associated with
adapting to cancer as a wasteful demand on limited energy resources that, if unremitting,
can deplete reserves and cause fatigue. The simplicity of Ryden‟s model is attractive
because it provides a basic and concise explanation of fatigue that can be applied widely.
The framework explains little about the fatigue process beyond asserting that it arises
from the interplay of energy supply and demand and proposing strategies, including
energy conservation and the management of stress, for combating energy deficits (Ryden,
1977).
In another one of the earliest theoretical articles on fatigue in cancer, Aistairs
(1987) built upon Selye‟s stress and general adaptation syndrome concepts. Aistairs also
perceives fatigue as an energy deficit. However, the Organizing Framework is more
detailed than Ryden‟s (1977) framework and explains how periods of under stimulation
in addition to periods of stress and stimulation act through feedback systems to lead to
fatigue (Aistairs, 1987). These details make this theory more useful, as they provide an
explanation for the association patients frequently make between inactivity, boredom, and
fatigue. This theory identifies stress as the principal cause of fatigue in patients with
cancer and incorporates physical stressors in the framework, including pain, infection,
12

and anemia, as well as emotional stressors. Assessment of the impact of stress-relieving
strategies on perceptions of fatigue can empirically test the link between stress and
fatigue. Aistairs‟ framework advocates meditation, exercise, progressive muscle
relaxation, time management, and patient education as strategies for relieving stress.
Although the framework is relatively unsophisticated, it provides a clear and concise
explanation of fatigue and the processes that lead to it (Aistairs, 1987).
Irvine, Vincent, Grayden, Babela, and Thompson‟s Energy Analysis Model
(1994) is similar to Ryden‟s Theory. The theoretical framework also conceptualizes the
human body as an open system dependent on energy sources from external and internal
environments for the production of energy. It proposes that fatigue arises when external
supplies are reduced, internal supplies are interrupted, and energy demands are high.
However, the major difference between the Energy Analysis Model, which was devised
specifically for patients with cancer, and those described previously lies in the inclusion
of another variable. This variable incorporates a variety of factors unique to cancer that
affects energy metabolism and expenditure. These include factors related to the disease,
treatment responses, and symptoms associated with cancer and its treatment.
Unfortunately, the model does not explain the action of these energy-response modifiers
on fatigue (Irvine, Vincent, Graydon, Bubela, & Thompson, 1994).
A fourth model, Piper Integrated Fatigue Model, was derived deductively from a
review of the fatigue literature (Piper et al., 1987). It is a comprehensive framework that
describes thirteen biological and psychosocial factors that influence the signs and
symptoms of fatigue in clinical populations. This widely applicable model delineates the
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multiple factors that can interrelate and lead to the chronic fatigue that patients with
cancer frequently report. Furthermore, it alludes to the multiple ways in which fatigue
can be manifested and provides a useful basis for nursing assessment. It fails, however,
to indicate the relationships among the variables and their weighting or hierarchy. It
provides insight into the phenomenon and supports the notion seen in clinical practice
that fatigue becomes more complex to manage as it becomes a chronic symptom, at
which point a combination of strategies may be required for relief of the fatigue (Piper,
Lindsey, & Dodd, 1987). The Winningham et al. (1994) Psychobiological-Entropy
Model currently provides the most sophisticated explanation of fatigue and its
implications for patients‟ functional status. The model defines fatigue as an energy
deficit that arises from preexisting conditions and disease, related symptoms, treatment,
environmental influences, and inactivity. According to this model, fatigue fulfills a
unique and substantial role in the origin of disability that sets it apart from other
symptoms. Although fatigue can be one of a myriad of primary symptoms that can lead
to decreased activity, the secondary fatigue that arises from reduced physical activity is
critical. This leads to a cycle of decreased activity, fatigue, and reduced functional status
that result in a vicious cycle of decreased mobility and subsequent disability. It is
suggested that interventions for fatigue should occur at two levels. First, interventions
should aim to manage the symptoms and factors that contribute to primary fatigue.
Second, they should aim to prevent secondary fatigue by achieving an optimal balance
between restorative rest and restorative activity (Winningham et al., 1994). Therefore, it
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seems appropriate that it is important to understand the patient‟s experience of fatigue to
better understand how it impacts on their daily activities.
Several attributes related to cancer-related fatigue have been identified. Although
the literature is relatively unsophisticated and the discussion varies in scope, there are a
number of common features identified, in particular, a change in energy, which is
connoted by terms such as energy input, energy consumption, and energy output or
expenditure. All of these terms focus on energetics, which has both physiologic and
psychosocial components that are attributable to fatigue. The physiologic attributes
include weakness, exhaustion, malaise, tiredness, decreased functioning, immobility,
sleep disturbances, adaptation and lack of learning, remembering and performing tasks
every day. The psychosocial attributes include stress, anxiety, depression and a
diminished will to live.
The phenomenon of cancer-related fatigue reflects approximately six patterns that
warrant identification and discussion. First, in the cancer patient, whether they are
receiving treatment or not, there is the potential of changes in their energy and energy
substrate patterns. There also is an accumulation of metabolites. Both of these result in a
decrease in the synthesis of protein and muscle contraction with a resultant muscle loss
and extreme weakness. Second, there is a potential change in disease state, symptom
patterns, sleep/wake patterns and activity/rest patterns which may result in muscles
wasting and further disability. Third, each treatment modality can impact greatly on the
degree of cancer-related fatigue. From a surgical standpoint, there appears to be a central
mechanism that is triggered from various insults to the body, including the surgical
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procedure, anesthesia, pain, narcotic analgesics and psychoactive drugs. Fatigue is the
end result of these interventions. In addition, both radiotherapy and chemotherapy affect
the patient in several ways. From a psychological perspective, the patient may
experience stress, mood variation, and sleep pattern disruptions. These treatments also
may affect the patient physiologically in several ways including nausea, vomiting, pain,
cachexia, and anemia and drug interactions. Biotherapy impacts the patient‟s energy
level greatly because of the exposure to both exogenous and endogenous cytokines with a
resultant fatigue, including mental effects, malaise, cognitive deficits, mental and motor
slowing, and somnolence, lack of initiative, slurred speech, sensory deficits and changes
in expression such as changes in handwriting. The fourth area focuses on changes in
regulation and transmission patterns as well as social and psychological factors. It
appears that there are underlying changes in neural mechanisms which block competing
and distracting stimuli. Consequently, there is impairment in cognitive functioning
which results in decreased concentration, difficulty in thinking and diminished attention
and impaired perceptions and forgetfulness. The fifth pattern reflects changes in life
events with counterproductive health belief practices, such as prior trauma and anxiety.
The sixth factor is innate host factors such as blood count, nadir count and the immune
system (Piper et al., 1987). As the result of the physiological, behavioral and
biochemical changes in these symptom patterns, there is a possible manifestation of
fatigue. It can impact quality of life greatly, including physical well-being, psychological
well-being, social well-being and spiritual well-being (Ferrell, 2008).
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Cancer-related fatigue is a multifaceted problem. The common threads identified
are subjective feelings of weariness, weakness, exhaustion and lack of energy and
causation from exertion and/or stress. It leads to increased discomfort and decreased
efficiency, and deterioration of both mental and physical activities (Ferrell, Grant, Dean,
Funk, & Ly, 1996). This, however, needs to be substantiated from a phenomenological
perspective.
Most researchers are concerned about causes of fatigue, such as physiologic,
psychological and situational factors, rather than the quality of the resulting experience of
fatigue per se. Furthermore, they have not interviewed patients who are experiencing the
fatigue in order to elucidate the meaning of the fatigue. Therefore, their definition of
cancer-related fatigue often does not reflect the quality of life issues surrounding this
most prevalent patient complaint. The immediate effects of fatigue, such as the inability
to function or maintain normal activities lead to issues surrounding the patient‟s quality
of life. Including an understanding of the patient‟s experience and quality of life issues
are essential components in a study of cancer-related fatigue. This extends the current
view of fatigue beyond the physical symptoms. Not only is the physical well-being
important, but also psychological, social and spiritual concern.
Analysis of data from Ferrell‟s Quality of Life Model (Ferrell, 2008) reveals that
fatigue is a symptom that affects all dimensions of quality of life. From the physical
well-being domain, attributes such as energy, functional ability, pain, sleep, rest and
strength are considered. Included in the psychological well-being domain are anxiety,
frustration, feeling useless, and fear of the meaning of fatigue, coping, and loss of
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independence, cognition and depression. The third domain, social well-being, includes:
impact on work/financial impact, leisure activities, family roles/relationships and
affection and sexual function. The fourth domain, spiritual well-being, includes changes
in spirituality, hopelessness, meaning of fatigue and changes in priorities in order to deal
with the energy deficit (Ferrell et al., 1996). Therefore, to be more encompassing and to
better understand the term, cancer-related fatigue and its consequences, quality of life
issues should be explored in the study of cancer-related fatigue. A phenomenological
study would illuminate how the patient‟s quality of life is impacted secondary to the
experienced fatigue.
Cancer-related fatigue continues to be a major debilitating symptom for
individuals with cancer, affecting activities of daily living, impacting treatment choices,
and decreasing quality of life. As patients with cancer become too tired to participate
fully in the roles and activities that make life meaningful, the most important impact of
fatigue may be in the realm of quality of life. A qualitative research perspective using a
phenomenological approach to determine the experience of the patient dealing with
cancer-related fatigue is noticeably absent. Because of that, there is a lack of practice
theories to guide clinical interventions based on understanding the experience of the
patient confronting and dealing with fatigue. Therefore, interviewing patients to
understand their experience of dealing with their fatigue seems appropriate as the
challenge is to acquire knowledge about the experience of cancer-related fatigue so
management strategies can be identified to assist the patients in dealing with this most
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unrelenting symptomology. Moreover, by identifying resources it will better equip the
patient to deal with their fatigue.
As alluded to, defining cancer-related fatigue is rather difficult as it is a complex
syndrome. For the past twenty-five years, oncology healthcare professionals have
attempted to define the term. At present, all would agree on one aspect: there is no
precise definition as it continues to be an explorative endeavor. Therefore, it is
incumbent on nurses to study the number one complaint that cancer patients experience
from a phenomenological perspective so that we can better understand their experience.
Now is the time to define the term from a patient‟s perspective.

Research Question
Despite the prevalence of fatigue, surprisingly little is known about the main
complaint that cancer patients experience that can guide nursing assessments and
interventions. The etiology of cancer-related fatigue is unknown. Clearly, there is
further need to develop nursing theories about cancer-related fatigue. Theories, however,
cannot be developed until the human experience of cancer-related fatigue is described
because the people who live the experience of the fatigue are the experts. It is incumbent
to understand the phenomenon of cancer-related fatigue before there can be an
understanding of the functional descriptions of fatigue that are often described in the
literature, such as malaise, weakness, exhaustion, asthenia, and cognitive dysfunction.
Therefore, the issue in question is: What is the meaning of the fatigue that cancer patients
experience? What is it is like to experience cancer-related fatigue? What does the cancerrelated fatigue feel like? To answer these questions, the participants will be asked what it
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has been like to live with being tired each day. The answers to this question become
important because despite the widespread recognition of fatigue as a symptom of disease
or as a result of treatment, the phenomenon is neither clearly defined nor clearly
understood.

Theoretical Definitions
Cancer-Related Fatigue:
Cancer-related fatigue is a self-recognized, multidimensional syndrome, resulting
in physical, mental, social and psychological deficits that profoundly affect
quality of life and may occur at any time during the cancer diagnosis/treatment
continuum.

Quality of Life:
Quality of life is a person‟s sense of well-being that stems from satisfaction or
dissatisfaction with the areas of life that are important to him/her and includes
physical, psychological, social and spiritual domains.

Activities of Daily Living:
Activities of daily living are self-care activities that the patient must accomplish
each day to meet personal needs, such personal hygiene/bathing, dressing/
grooming, feeding, and toileting.
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Assumptions
1. Oncology patients who receive cancer treatment(s) experience some degree of
fatigue.
2. Oncology patients will be forthright in sharing their experience about their
fatigue.
3. Cancer-related fatigue impacts the patient‟s quality of life and affects the
physical, emotional, psychosocial and spiritual domains.
4. Cancer-related fatigue affects the patient‟s ability to remain employed and
impacts their financial status.
5. Cancer-related fatigue may affect the patient‟s will to live more so than
having received the diagnosis of cancer.
6. Oncology patients will feel comfortable in sharing their experience with an
oncology nurse.
7. Cancer-related fatigue may vary depending on the treatment modality.
8. The level of cancer-related fatigue may vary throughout the course of the
therapy.
9. Cancer-related fatigue may persist indefinitely after the treatment is
completed.

Delimitations
The study will be confined to patients with early stage breast cancer who have
received radiotherapy and chemotherapy; age 65 years or younger; able to read and write;
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and not suffering from diseases previously shown to be associated with fatigue, such as
rheumatoid arthritis, lupus erythematosis, diabetes and heart disease.

Limitations
The study will not be generalized to all types of cancer patients receiving all
treatment modalities. However, findings of qualitative studies may be transferable to
clients in other settings, if clinicians judge that the themes are relevant to these clients.
Ray (1994) purports that clinicians use findings of a study in the context of their practice
when validity and relevance are present. The richness of the story determines how well
the results can be utilized in the clinical setting.
While fatigue has been recognized as an almost universal side effect of cancer and
cancer treatment and has been included in many studies for the past twenty-five years,
understanding the patient‟s experience with cancer-related fatigue has not yet been
illuminated. A phenomenological study will provide insight and understanding about
cancer-related fatigue. The narrative approach to qualitative research enables the patient
to share their story which in itself may be therapeutic and thus may help the patient to
cope with the diagnosis of cancer. In addition, by sharing their story, patients may be
enabled to “make sense” about their catastrophic illness. There is a paucity of studies
focusing on the patients‟ subjective self-reported experiences of fatigue, with a few
studies measuring changes in fatigue over a course of repeated treatments (Jacobsen et al,
1999). The complex nature and etiologies of fatigue have challenged researchers, and
knowledge regarding fatigue and its relationship with other factors is limited. Therefore,
conducting a phenomenological study will serve as the basis to better understand the
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phenomena of fatigue and thus enable the healthcare provider to strategize in providing
management strategies to reduce or ameliorate the devastating symptom.

Summary
Fatigue has been described as a universal symptom among cancer patients by the
National Comprehensive Cancer Network Cancer-Related Fatigue Panel (NCCN, 2007).
Despite an increasing number of surveys that have focused on cancer-related fatigue,
little is known about the experience of cancer-related fatigue for the patient. In addition,
the current management strategies are largely based on anecdotal reports. Nonetheless,
the growing recognition that fatigue is a major quality of life concern among cancer
patients is motivating an effort to recognize strategies to help reduce and ameliorate the
unrelenting symptomology. To address this concern, studying the experience of the
patient serves as the basis for understanding. Although cancer-related fatigue is a
complex symptom that is variably described and related to a large number of diverse
processes, understanding fatigue and identifying appropriate management strategies
cannot evolve until the patient‟s experience is understood.
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CHAPTER II
REVIEW OF LITERATURE
Cancer-related fatigue is a difficult subject to discuss as minimal research has
been conducted to investigate the mechanisms of this devastating cancer symptom.
Fatigue has a dramatic effect on the lives of cancer patients and can be induced by the
disease, the treatments, and the physiologic and psychologic stresses associated with
cancer. Most of the work on fatigue has been incidental to studies performed to evaluate
other symptoms or disease mechanisms, rather than the primary focus of the symptom.
Many of the substances proposed to mediate fatigue also have multiple physiologic
effects, making it difficult to determine the direct contribution to fatigue.
The “state of cancer-related fatigue” will be discussed in the following ways:
First, a framework for addressing the problem will be developed, focusing on what is
currently known from the patient experiencing the fatigue as well as the mechanisms of
cancer-related fatigue including both physiologic and psychologic factors. Correlates
associated with cancer-related fatigue also will be discussed. Subsequently, the effect of
these factors on quality of life will be reviewed. Assessment of cancer-related fatigue
also will be considered. General treatment recommendations based on current scientific
knowledge of the field will then be put forth. The summary of the framework is based on
a Medline and CINAHL database search primarily from 1996-2009. A few studies are
cited prior to this period as they serve as pivotal studies for the topic of cancer-related
fatigue.
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The diagram in Figure 1. provides an overview of the literature search on cancerrelated fatigue. The search includes four major components related to cancer-related
fatigue: mechanism, quality of life, assessments and interventions. Within each category
are listed components and associated correlates. Derived from the literature review, three
themes emerged as areas of further research, including mechanisms underlying fatigue
needed to prevent and treat the fatigue, issues surrounding quality of life, and the need for
qualitative studies from the patient‟s perception. The following pages will provide the
studies that have been conducted in each aforementioned category.

Figure 1: Diagram of Literature Review
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Introduction
Early treatment of patients with cancer clearly has demonstrated increased cure
and survival rates; however, therapy frequently results in short- and long-term
consequences that affect patients‟ physical and emotional well-being. Fatigue is one such
side effect. Cancer-related fatigue is a pervasive and distressing phenomenon that
presents a unique challenge to cancer survivors and those who care for them. According
to a Fatigue Coalition survey, patients with cancer rated fatigue ahead of pain, nausea,
and depression as the cancer-related condition being the most common and troublesome,
the longest lasting, and having the greatest impact on their day-to-day functioning and
economic well-being (Vogelzang, Breibart, & Cella, 1997). Fatigue is the most common
and distressing symptom resulting from cancer therapies; 60-100% of patients receiving
chemotherapy report experiencing fatigue, which has been termed the “common
denominator” of symptom distress (Winningham et al., 1994).
The impact of cancer-related fatigue on quality of life and ability to carry out
activities of daily living has significant implications for patients who experience a notable
decline in functional ability during and after cancer treatment (Nail & Winningham,
1995). Fatigue may be present even before treatment begins; it can increase during the
course of cancer treatment; and it can persist at a higher-than-baseline rate.
Unfortunately, fatigue is not limited to the period of active disease and treatment; it may
last for years after treatment is completed when the individual is considered to be in
remission (Blesch, Paice, & Wickham, 1991).
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Since fatigue may have a detrimental effect on the ability to direct one‟s attention
or to concentrate, it may adversely affect patients‟ ability to comprehend and retain
important information related to the disease and its treatment options (Cimprich, 1995).
Fatigue may also affect patients‟ compliance with the treatment regimen, or lead to
interruptions in, or premature withdrawal from, treatment. Failure to complete
recommended treatment on the optimal schedule reduces the chance of remission or cure
(Nail, Jones, Greene, Schipper, & Jensen, 1991). The prevalence, onset and persistence
of the symptom are insurmountable challenges, both for the patient and the healthcare
professional, because there are minimal interventions to help the underlying symptom
mechanisms which are not understood.
Fatigue is more common in cancer patients than in any other medical populations.
At least nine epidemiological studies of fatigue in the general population and patients
presenting to primary care practitioners indicate that fatigue is up to seven times more
prevalent in cancer patients as in the general population (Morrow, Andrews, Hickok,
Roscoe, & Matteson, 2002). Though cancer-related fatigue is highly prevalent, it seems
the symptom is an inappropriate response to cancer therapy, especially since it occurs in
the absence of physical activity.

Experiencing Cancer-Related Fatigue
While there is minimal evidence in the literature about cancer-related fatigue
being studied from a phenomenological perspective, a few studies have been conducted
on the phenomenon. An overview of the conducted research follows. A study conducted
by Pearse and Richardson (1996) describes cancer-related fatigue from a
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phenomenological perspective. Six patients were interviewed and the emerged themes
from the interviews reflected both a shared and individual experience of fatigue. These
themes included the causes and consequences of the fatigue as well as the nature of the
fatigue. Unfortunately, the experiences of the patients are not discussed well; neither is
there a discussion of how the fatigue impacts the patient‟s quality of life. It appears the
authors ask more specific questions than one would typically expect in a
phenomenological study. The authors state there was an attempt to evaluate reliability
and validity; however, there is no delineation of how that was achieved.
A second study conducted by Lindqvist, Widmark, and Rasmussen (2004)
reflected the researchers‟ intent to illuminate the meaning of cancer-related fatigue as
experienced by four cancer patients in a palliative care program. The interviews were
interpreted using a phenomenological-hermeneutic approach inspired by the philosophy
of Ricoeur. The findings reflect that the world of fatigue for the cancer patient is
connected with incurable cancer. Paradoxes that represent struggles between body, mind
and intellectual understanding are identified. These representations have important
implications for healthcare professionals who are communicating with patients about
fatigue. Unfortunately, the suggestions for care providers are not delineated in the paper.
A phenomenological inquiry about fatigue in patients with cancer and chronic
obstructive airways disease was reported by Ream and Richardson (2004). Nine patients
with cancer receiving chemotherapy and six participants with chronic obstructive airway
disease were interviewed. The experience of fatigue was similar in both groups. Fatigue
was described as distressing because it precludes the patient‟s normal work and
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recreational roles causing frustration, depression, and grief. Reliability and validity of
the findings were established. However, further studies are needed in order to study the
phenomenon across additional types of patients.
In summary, very few phenomenological studies have been conducted. From the
aforementioned studies, it is obvious that few authors have contributed to the literature in
understanding what fatigue means to the patient. Despite advances in symptom
management in oncology, this persistent and late side effect remains a major source of
distress for the cancer survivor. Therefore, it is a professional responsibility for us to go
to the patient and hear their words so we can begin to articulate the meaning of fatigue,
how it impacts the patient and family, and how can we better serve the patient in helping
them deal with their pervasive fatigue.

Antecedents to Fatigue: Physiologic and Psychologic Mechanism
The etiology of cancer-related fatigue is multifactorial and is proposed to involve
dysregulation of several interrelated biochemical, physiological and psychological
systems. Additionally, the fatigue generally differs with each individual and the phase of
their illness as well as the treatment modality they‟re receiving. Subsequent discussion
will include physiologic mechanisms: psychoneuroimmunology, various cancer treatment
modalities, muscle function, anemia and weight correlates. Psychologic mechanisms will
include depression, distress and cognition. Quality of life issues and assessment of
fatigue also will be addressed.
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Antecedents to Fatigue: Physiologic
Psychoneuroimmunology
The bi-directional pathways between the immune system and the brain may be at
the heart of some of the side effects of cancer and its treatment. The immune-to-brain
communication and the pro-inflammatory cytokines in the periphery and brain could be
important mediators of these symptoms the patient experiences, including fatigue. Inn as
study by Ahles and Saykin (2002), they found that many of the cognitive disturbances
observed in cancer patients seem more readily associated with the frontal cortex more so
than hippocampal dysfunction, but it may be that activation of the immune-to-brain
circuitry that leads to cytokine-induced disturbances in the frontal cortex as well as the
hippocampus. Ahles proposes that a number of the “quality of life” issues, including
cancer-related fatigue, may be due to the aforementioned immune-to-central nervous
system communication. Ahles & Saykin (2002) contends that in related fashion, fatigue
is a “debilitating concomitant of chemotherapy, and fatigue is not unlike the behavioral
changes that are a part of the sickness pattern” (Ahles & Saykin, 2002, p. 486). While
the study is considered a landmark study in psychoneuroimmunology, the study is small
and employs a correlational design.
There is a suggestion that the immune to brain communication with the
consequent induction of cytokines within the brain might produce cognitive disturbances,
especially memory disturbance. This becomes extremely relevant in reference to cancerrelated fatigue as memory and cognition are affected greatly in cancer-related fatigue. A
study by Dean and Ferrell (1995) includes patients receiving interferon alpha for
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malignant melanoma. Fatigue persists throughout the therapy with the affect domain
being the most affected; as a result, the patient‟s memory and cognition are greatly
impaired. In consideration of the areas that are known about the immune to brain
communication, it seems reasonable that cancer-related fatigue may be precipitated by
the sickness syndrome that evolves as a result of these communications (Dantzer &
Bluthe, 1993). The study includes a small number of patients and is descriptive in nature.
As alluded to, regardless of the underlying cause, cytokines are crucial
contributors to the sickness behavior, including the fatigue that patients experience.
These cytokines have a wide spectrum of central and peripheral effects that contribute to
the host defense, including effects on energy. When laboratory animals are injected with
IL-1 Beta and TNF-alpha, they show fatigue as well as decreased activity, anorexia,
increased somnolence, and social withdrawal (Dantzer, 2001).
In addition, tumor development is a very complex process. Cancer is not one
disease; rather it consists of more than a 100 different types of disease entities that often
behave differently. Some of the tumors are more likely to be associated with stressrelated alterations. Van der Pompe and Antoni (1996) studied metastatic breast cancer
patients who have elevated cortisol levels but attenuated ACTH and cortisol regression to
a behavior challenge. They propose that the elevated cortisol is due to the increased
metabolic clearance of cortisol secondary to increased utilization of metabolic substrates
in the presence of tumor. While the results are noteworthy, the patients were not
stratified. Some of the patients were not receiving therapy and another cohort was preterminal.
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To further elucidate the picture, some malignancies actually have high levels of
cytokines, which may further precipitate fatigue in cancer patients. Lymphoma patients
have high levels of IL-6 and IL-10. There is a correlation between the level of IL-6 and
IL-10 and the presence of B-symptoms; both cytokines have been found to be a
prognostic factor in chronic lymphocytic leukemia (Wetzler et al., 1994). Hodgkin‟s
disease patients also have a high level of Il-6 and IL-10 (Seymour, Talpz, Hagemeister,
Cabanillas & Kurzrock, 1997). Interleukin-6 is the most important independent
prognostic factor for predicting the complete remission rate and disease-free survival of
patients with diffuse large cell lymphoma (Preti, et al., 1997). IL-6 levels are also
elevated in renal cell carcinoma and serve as a prognostic factor for this malignancy The
IL-6 serves as an autocrine growth factor for renal malignant cell lines. To further
complicate the picture, in some malignancies, such as chronic myelogenous leukemia, not
only is IL-1 elevated as the disease progresses, but also there is increased level of the
endogenous antagonist to IL-1 receptor antagonist (Dean, 1999).
A more recent study by Collado-Hidalgo et al. (2006) studied the inflammatory
biomarkers for persistent fatigue in breast cancer survivors. The experimental design
included 50 fatigued and non-fatigued breast cancer survivors with immunologic
biomarkers completed on both groups. The researchers concluded that there was a link
between fatigue and inflammatory markers showing a functional alteration in
proinflammatory cytokine response to liposaccharide, which may define a prognostic
biomarker of behavioral fatigue. The researchers proposed that cancer-related fatigue
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might stem from an aberrant process that precipitates an aging process that is precipitated
by cancer therapy (p. 2765).
A longitudinal pilot study examining fatigue, the related correlates of sleep and
depression and select biomarkers were studied over time in females with early stage
breast cancer receiving chemotherapy. A prospective repeated measures pilot study was
conducted over 12 months. Findings suggested that fatigue, sleep and depression were
more prevalent in the breast cancer group compared to the cancer-free group. The
researchers suggested that the biomarkers, serum cortisol, melatonin, serotonin, cytokines
and other endocrine-based chemicals, may help explain the fatigue in cancer patients
(Payne, Piper, Rabinowitz, & Zimmerman, 2006).
Orre, Murison, and Dahl (2009) investigated circulating levels of various
inflammatory markers in relation to cancer-related fatigue in long-term survivors of
testicular cancer. Various cytokines and CRP levels were measured. Results indicate
that chronic cancer-related fatigue is associated with higher levels of circulating IL-1ra
and CRP, possibly mitigated by physiological morbidity. It is speculative that low-grade
inflammatory processes are involved in the pathogenesis of chronic cancer-related fatigue
in cancer survivors
In summary, the paucity of studies reveal conflicting results. A small number of
studies have been conducted on the relationship of fatigue and the psychoneuroimmunology system. The majority of the studies do not reveal that there is a correlation
identified.
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Cancer Therapies
Chemotherapy
In addition to the cancer itself precipitating fatigue, the four cancer treatment
modalities also increase the risk of developing fatigue. In breast cancer patients receiving
chemotherapy, fatigue increased significantly following the initiation of chemotherapy,
but the reported fatigue did not differ significantly between the first and last treatment
(De Jong, Candel, & Schouten, 2004). Many chemotherapeutic agents lead to high levels
of circulating cytokines. Osterlund (2001) conducted a study to assess the inflammatory
reaction in colorectal patients who were treated with raltitrexed and oral carmofur versus
5-fluorouracil (5 FU). Compared to the 5 FU patients, the patients treated with the twodrug combination had elevated S-IL-6 and S-TNF alpha. These findings suggest that
these patients possibly developed a drug-related system inflammation, which ultimately
could increase the patient‟s risk for developing fatigue as well as other sick behaviors.
The experimental study was designed well, but small numbers of patients were entered in
the study. The degree of freedom indicates that approximately twenty-five percent of the
patients did not remain in the study.
In addition, there are long- term effects on immune function with chemotherapeutic agents (Osterlund, 2001; Ahles et al., 1998). Bower, Ganz, Aziz and Fahey
(2002) found laboratory value changes in two cell populations among fatigued breast
cancer survivors. There were lower percentage of naive CD4 T cells and NK cells in
these breast cancer survivors. They propose that the changes perhaps are reflective of the
lack of cell recovery from chemotherapy. However, other studies conducted on breast
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cancer patients have shown deficits in naïve CD4 T cells for approximately five years
after therapy has been completed (Hakim, Copeda, & Kaimei, 1997). According to
Bower, Ganz, and Desmond (2000), the prolonged depression of these cells may result
from the immune system remaining activated in order to maintain homeostasis that turn
on the production of cells as they are depleted. The authors also propose, conversely, that
there may be changes in the lymphocyte trafficking that occurs as a result of immune
activation in other parts of the body, thus resulting in decreased circulating levels of
immune cells (Bower et al., 2000). These explanations may provide the answer for the
reason long-term survivors continue to experience debilitating fatigue. Although the
majority of the studies are pilot studies, the results are noteworthy and have led to current
research studies being conducted.
A pilot study assessing the level of fatigue in women receiving dose-dense versus
standard chemotherapy for breast cancer was conducted by Sura, Murphy, and Gonzales
(2006). Fatigue scores were significantly higher in women with the following
characteristics: undergone a mastectomy, working, HER 2 positive, and a tumor size
larger than 2 cm. Women who received dose-dense chemotherapy also had high levels of
fatigue. This is understandable as the women who had larger tumors and were HER-2
positive would have been the patients who received dose-dense therapy.
Hartvig, Aulin, Hugerth, Wallenbery, and Wagenius (2006) conducted a
prospective study evaluating fatigue in cancer patients treated with cytotoxic drugs.
Ninety-two per cent of patients experienced significant fatigue. The lung and breast
cancer patients experienced more fatigue than patients with other cancers. The patients‟
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quality of life was affected. The same level of fatigue was seen both in both out- and inpatient settings.
Radiotherapy
The second modality, radiotherapy, also is linked to causing an increased level of
cytokines. According to Doukas and Gallicchio (1995), irradiation of cell types that are
known constituents of the bone marrow microenvironment stimulates an increased level
of GM-CSF, M-CSF, IL-6 and IL-1. Cytokine release of growth factors from irradiated
endothelial cells in vitro produce platelet-derived growth factor and fibroblast growth
factor. Irradiated alveolar macrophages exhibit enhanced production and release of TGFalpha and THF-beta. Both normal tissues and tumors may elaborate cytokines as part of
the response to irradiation. These cytokines may influence local cellular growth and
cause endocrine effects on other tissues. It appears that IL-1 has a protective role so
normal tissue can repair (Doukas & Gallicchio, 1995).
A study by Greenberg, Gray, and Mannix (1993) assessed sleep and fatigue
associated with radiotherapy. They determined their relationship of the level of fatigue to
interleukin 1 levels. Ranked serum IL-1 rises between weeks one and four of
radiotherapy, as fatigue scores rise. The results suggest that localized radiotherapy is
associated with increased fatigue and sleep requirements independent of depressive
symptoms. It also suggests that the relative serum IL-1 changes may be one signal for
the systemic reaction and the subjective fatigue associated with the acute effects of
radiotherapy.
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Another study conducted on breast cancer patients involves studying women
while they are undergoing adjuvant radiotherapy. The results reveal there is no evidence
that anxiety, depression, serum levels of IL-1 Beta, IL-6 and tumor necrosis factor-alpha,
or declining hemoglobin levels are responsible for the treatment-induced fatigue
(Greenberg, Sawicka, Eisenthal, & Ross, 1992). Both experimental designs consist of an
adequate number of participants. However, the results of the studies are contradictory.
A descriptive study by Hickok, Morrow, Roscoe, Mustian, and Okunieff, (2005)
included 1129 patients who were assessed for various symptoms associated with
radiotherapy. Results showed that the most common symptoms, fatigue, drowsiness and
sleep problems, were the most severe symptoms, with fatigue being the most common of
the 12 symptoms assessed, both at initiation of radiotherapy and during the course of the
therapy. Female patients reported significantly more symptoms than male patients. The
researchers also noted that fatigue worsened in frequency and intensity over the course of
radiotherapy, as has been reported in other studies (Smets, Visser, & Garssen, 1996).
There also was a close association between fatigue, difficulty in sleeping and drowsiness.
Limitations of the study included the symptoms being assessed as rather general
constructs. For example, fatigue could be related to sleepiness or as being associated
with muscle fatigue. Because of the manner in which the questionnaire was constructed,
the fatigue was associated more with tiredness than muscle weakness. Therefore,
construction of the questions should have been clear so the patient responded accurately.
Brown et al. (2006) conducted a study of 115 newly diagnosed cancer patients
randomized to standard arm of care versus standard care plus eight sessions of ninety
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minutes each of structured multidisciplinary interventions. Results showed that the
interventions had no impact on fatigue, and it was suggested that the interventions may
have worsened the fatigue in the intervention group. They did, however, find that a home
exercise program was beneficial in improving fatigue.
The impact of fatigue on overall quality of life in breast and lung cancer patients
receiving high-dose radiotherapy was studied by Dagnelie, Pijls-Johannesma, & Lambin
(2007). Sixty-four patients completed the Treatment of Cancer Quality of Life
Questionnaire. Results reflected that fatigue is by far the predominant contributor to
patients‟ perceived overall quality of life. Findings further substantiate that fatigue in
breast cancer patients is a major problem and warrants proper screening, assessment and
treatment strategies to help reduce fatigue. The researchers recommend replicating the
study in patients with a different tumor type and different stage of disease as well as a
different treatment modality.
Biotherapy
The third modality, biotherapy, is recognized for producing severe fatigue and
often is recognized as the treatment limiting and/or dose limiting side effect that is
overwhelming to patients. In fact, the associated fatigue is the primary reason patients
request to terminate the treatment. Numerous studies convey that biotherapy causes
cancer-related fatigue. Studies from the mid-1980s to the present continue to identify
fatigue as the major complaint that patients experience. Quesada and Talpaz (1986) cite
fatigue as the most prevalent nonacute symptom. Even in low dose regimens of gamma
interferon, 75% of patients experience fatigue. Because of severe fatigue, 75% of the
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patients in a study conducted by Quesada and Talpz (1986) required dose reduction of
gamma interferon with a minimal response to the treatment.
Almost 25 years later, fatigue continues to remain a major concern as cited in a
study by Fu and Anderson (2002) in which fatigue is reported as moderate to severe in
patients undergoing biotherapy for metastatic melanoma. While the studies are
significantly important because of the overwhelming fatigue these patients experienced,
the results are questionable because the researchers did not group the patients according
to type of biotherapy being administered.
Surgery
The fourth modality, surgery, also plays a role in producing cytokines that may
precipitate fatigue. The potential of surgery having a deleterious effect on the immune
function is well established. Ben-Eliyahu (2003) suggests that stress and surgical
excision of the primary tumor may promote tumor metastasis that would result in the
release of cytokines. The surgery itself suppresses the cell-mediated immunity. As a
result, it is possible that inflammation and infection may ensue. Subsequently, proinflammatory cytokines are released which increase the risk of fatigue during the
recuperative period. As a result of the pathways being activated in the patient with the
malignancy as well as the patient undergoing treatment(s) for their malignancy, it is
possible that the release of the cytokines can precipitate an overwhelming fatigue. This
pilot study reveals noteworthy findings; however, further studies need to be conducted.
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Muscle Function
In addition, the examination of muscle function is one way to understand
physiologic mechanisms of fatigue. Potential mechanisms for decreased muscle
contractility include accumulation of metabolic products and loss of muscle protein. The
results of studies in patients and animals with cancer indicate that tumor presence is
associated with decreased synthesis of protein (Pain, Randal, & Garlick, 1984; Svaninger,
Lundberg, & Lundholm, 1983). However, studies of protein loss in tumor-bearing
animals and patients with cancer yield contradictory findings (Svaninger et al., 1983).
The lack of consistent findings between the studies of muscle protein loss and those of
muscle structure may reflect lack of control of confounding variable or methodological
factors.
Yavuzsen et al. (2009) evaluated cancer-related fatigue using an objective
measurement to ascertain whether the fatigue is more a centrally or peripherally mediated
disorder. Both cancer patients and control group (non-cancer patients) underwent
neuromuscular testing as well as measurement of fatigue and hemoglobin levels.
Extensive testing of various muscles for their level of fatigue was completed. Results
showed that cancer patients exhibited greater central fatigue, indicated by shorter
endurance time and less voluntary muscle recruitment during a sustained muscle
contraction.
Anemia and Weight Loss Correlates
Physiologic correlates such as anemia and weight loss are found in some cancer
patients at diagnosis and can be exacerbated by cancer treatments. Cytokines have been
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implicated in the suppression of erythrogenesis (Groopman & Itri, 1999). Studies have
reported an increase in “energy” or quality of life in patients with anemia being treated
with recombinant human erythropoietin alpha (Demetri, Kris, Wade, Degos, & Cella,
1998; Groopman & Itri, 1999), but the precise relationship between fatigue and measures
of energy and quality of life remains to be identified from the study. In addition, patients
who required blood transfusions and/or who did not respond to the epo alfa treatment
were dropped from the study. As a result, the data were skewed.
A relationship between fatigue and anemia in patients undergoing cancer
treatments has been postulated (Blesch et al., 1991; Maxwell, 1984); however, research
has failed to show a consistent relationship between these variables (Irvine et al., 1994).
Research studies specifically examining fatigue have found no correlation between
fatigue and anemia (Brunier & Graydon, 1993; Cardenas & Kutner, 1982). It is known,
however, that reduced erythropoietin production is common in patients with cancer who
are receiving cancer treatment (Robbins et al., 1997) and further assessment of the
relationship of fatigue to anemia is necessary. It is suggested that more attention needs to
be centered on the symptomatic effects of anemia rather than on the physiological data.
Therefore, addressing quality of life issues in relation to fatigue is further warranted
(McCann & Boore, 2000).
Littlewood, Kallich, and San Miguel (2006) conducted an exploratory analysis
that showed treating anemia improved functional health and well-being. An
improvement in hemoglobin was associated with improvement in fatigue. The
researchers recommended confirmation of their results with further prospective trials.
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Cytokines may also contribute to cachexia (Tisdale, 1999). Many different
molecules have been implicated and the most critical ones may vary among various types
of cancer (Inui, 1995). In addition, Inui (1995) suggests that catabolic factors, such as
lipid immobilizing factors and protein mobilizing factor that act directly on skeletal
muscle and adipose tissue, may also play a role in cancer-related fatigue. In one
published study of the relationship between fatigue and nutritional status over time in
patients with lung cancer receiving radiation therapy, fatigue scores and various
indicators of nutritional status were not related (Beach, Siebeneck, Buderer, & Ferner,
2001). However, several variables were not controlled in the study; therefore, the results
are questionable.
Antecedents to Fatigue: Psychologic
Depression and Distress
As mentioned, cancer-related fatigue may be one of the symptoms observed in the
“sickness behavior.” This concept helps to understand both the physiological and
psychological impact of a cancer and the cancer therapy associated with the malignancy.
It is increasingly clear that several of the symptoms, including depression and sleep
disturbances the cancer patient experiences, have a biological component associated with
them and probably exacerbates in an attempt for the host to fight the disease and to
maintain a homeostatic balance. Dantzer (2001) proposes that there is a growing
suspicion that proinflammatory cytokines are involved in the development of feelings of
despair, depression and hopelessness that occur in many cancer patients. This is
substantiated in a large number of patients who are receiving immunotherapy as they
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develop significant depression. The current thinking is that proinflammatory cytokines
are somehow involved in the development of a number of psychiatric disorders in
addition to depression (Dantzer, 2001). It is noteworthy that Capuron et al. (2002)
propose that it is becoming increasingly clear that the “sickness behavior” takes on more
than one form including both a depressive syndrome (major depression) and a
neurovegetative syndrome characterized by fatigue and anorexia.
One of the greatest challenges facing oncology healthcare professionals is
distinguishing cancer-related fatigue from other psychosomatic and psychological
ailments, such as depression. A study including 738 cancer patients revealed an
extensive overlap with depression when utilizing multi-item measures of fatigue.
However, the extent of the overlap between fatigue and depression is reduced when using
a single-item measure for fatigue (Morrow, Hickok, & Raubertas, 2001). Similar results
were observed in a study including 450 patients from an ongoing trial where fatigue and
depression were assessed (Lai, Cella, & Dineen, 2005). Another study by Visser and
Smets (1998) assessed the relationship between fatigue and depression in 308 patients
who had been treated with radiotherapy. Results of the study indicated that depression
and fatigue were independent conditions with different patterns over time. They
concluded that fatigue increased over time but depression did not. It was determined that
fatigue was not predictive of depression, and neither was depression predictive of fatigue.
Collectively, the evidence suggests that psychological distress is a potentially
important variable to consider in studies of fatigue in cancer patients. Prolonged stress is
proposed by Aistairs (1987) as the main cause of fatigue in the person with cancer. Such
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responses may not only cause, but also result in, persistent fatigue. In cancer, depression
and fatigue may co-exist, both resulting from identical biological factors. Aistairs (1987)
proposes that both result from identical biological factors; however, the results reflect
that patients with co-morbid diseases, which may cause depression and fatigue, were not
excluded from the study (Hayes, 1991).
A more recent study by Reuter and Harter (2004) discussed the similarities and
differences in the conception of fatigue and depressive disorders. In oncology, cancerrelated fatigue is understood as a multidimensional construct with physical, cognitive and
emotional factors. A comparison of these three factors with depression symptoms show
that all the symptoms associated with fatigue have their corresponding symptoms in the
concept of depression. Only the psychological symptoms of depression which go beyond
the fatigue symptomatology, allow for a distinction between the syndromes. Reuter and
Harter (2004) point out that it is important to consider the disadvantages of clearly
outlining the diagnostic categories for these disorders. Doing so can “cover one‟s eyes”
to the fact that when viewed from a phenomenological perspective, the boundaries
between the disorders are always fluid. Clinically, these inflexible divisions can be
restricting” (Reuter & Harter, 2004, p.133).
A study by Reuter et al. (2006) explored the relative contributions of coping,
depression, pain and age, and the experience of cancer-related fatigue in a study of 353
women treated for primary breast cancer within one year of diagnosis. Fatigue was
positively associated with depression and pain, but inversely related to age. The
“fighting spirit” of the patient was not associated with less fatigue. Detectable only in the
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multivariate analysis together with depression, the results suggested a weak association
between coping and fatigue. Further longitudinal studies are warranted to explore the
relationship between fatigue, age and coping styles.
A cross-sectional study that described the prevalence and associated variables
with cancer-related fatigue in 79 patients treated with radiotherapy was conducted by
Vistad, Fossa, Kristensen, and Dahl (2007). In a multivariate regression model,
depression was the only variable significantly associated with chronic fatigue. A
weakness of the study was the small sample size.
Von Ah, Kang, and Carpenter (2008) conducted a longitudinal study examining
these potential predictors of cancer-related fatigue before, during, and after adjuvant
therapy in women with breast cancer. Fatigue assessment utilizing Piper Integrated
Fatigue Model and blood collections for cortisol levels, interleukin-1 beta, tumor necrosis
factor alpha, and natural killer cell activity before adjuvant therapy were completed on 44
women. Mood disturbance was the most significant predictor of cancer-related fatigue.
Findings suggest that interventions to reduce mood disturbances might be effective in
decreasing cancer-related fatigue.
In summary, more systematic studies need to be performed to investigate the
relationship between depression, anxiety and the fatigue experience of cancer patients.
The characteristics of the individual including motivation, beliefs and attitudes, and the
individual‟s perception of cancer should be considered.
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Cognition
Though chemotherapy-related cognitive impairment was first described in the
1970s, it emerged as a significant concern both for the patient and healthcare provider in
the late 1990s. “Chemobrain,” a term used in the lay literature to describe the cognitive
changes that occur after chemotherapy is seen in 17 - 75% of patients (Wefel, Lenzi,
Theriault, Davis, & Myers, 2004). In most patients the changes are subtle with reports of
changes in cognition which usually resolve after chemotherapy is completed.
Unfortunately, 17 - 35% of patients experience more severe and long-lasting effects
(Ahles & Saykin, 2002). Domains of cognition that generally are affected are memory,
learning, executive function, speed of information acquisition and processing.
Occasionally both motor functioning and spatial skills also are affected (Ahles & Saykin,
2007). Patients describe the phenomenon as “being in a fog” and “being slow at
completing tasks”; they also voice a sense of “being unable to balance a checkbook” or
“getting lost going to my office.” Cognitive impairment is a great concern for the patient
as it often interferes with their resumption of home responsibilities, work, school and
social activities.
Advancements in neuroimaging assist in determining the functional and structural
central nervous system (CNS) changes that may occur in cancer patients receiving
chemotherapy. Brown, Simon, and Stemmer (1995) conducted a study on 13 breast
cancer patients who had received high-dose chemotherapy regimen in preparation for
bone marrow transplant. Eighty-seven percent of the patients developed white matter
changes in the brain. The authors proposed that the changes occurred as early as 3
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months post initiation of chemotherapy. A longitudinal, prospective follow-up study was
conducted by Brown et al. (1995) to assess white matter changes post-chemotherapy in 8
breast cancer patients undergoing autologous stem cell transplant. Neuroimaging results
demonstrated white matter changes as early as 3 months post-chemotherapy. The authors
concluded in both studies that neuronal changes occurred early post-chemotherapy and
were transient in nature. Limitations of both studies include a small sample as well as
only evaluating patients who received high doses of chemotherapy in preparation for
transplant.
To assess CNS pathophysiologic changes, in a longitudinal randomized study,
Saykin, Ahles, and McDonald (2003) performed computerized tomography (CT) and
positron-emission tomography (PET) scanning in 12 cancer survivors who had received
chemotherapy 5 years ago. White matter changes were seen in the treatment group with
no changes seen in the control group. The CNS changes occurred primarily in the
domains of episodic and working memory as well as executive function of decision
making and psychomotor problem solving.
Silverman, Dy, and Castellon (2007) studied eight breast cancer patients who had
demonstrated significant neurocognitive changes following chemotherapy. Cognitive
testing was conducted after PET scanning was completed. Results showed there were
indications of mental slowness and diminished ability to maintain concentration, recall,
and attention. Limitation of the study is a small sample size.
Researchers have also evaluated the effects of chemotherapy on the hippocampus.
Yoshikawa et al. (2005) determined that hippocampal damage from chemotherapy may
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be associated with memory deficits after studying 31 Japanese breast cancer patients who
had received chemotherapy. They hypothesized that the damage may precipitate
cognitive impairment. A follow-up randomized study was conducted to explore regional
brain volume one and three years post-chemotherapy in breast cancer patients. Results
showed that at one year post-chemotherapy, the right prefrontal volume was diminished;
however, at the three year follow-up, normal volume was noted. The authors concluded
that smaller volume was associated with changes in memory function, especially in areas
of concentration, attention and visual memory. However, over time the volume changes
did return to normal.
Further neurocognitive testing utilizing MRI was conducted by Ferguson,
McDonald, Saykin, & Ahles, (2007). They evaluated CNS structural and functional
changes in monozygotic twins, one of whom received chemotherapy for breast cancer.
The twin who received chemotherapy demonstrated white matter hyper-intensities on
structural MRI; she had experienced higher self-reports of cognitive dysfunction. There
was no evidence of depression or anxiety in either twin. The twin who received
chemotherapy had increased cortical activity, indicating that increased work was required
to overcome the cognitive dysfunction. The authors concluded that the affected twin
compensated for the deficits by working very hard to overcome the cognitive dysfunction
such that she performed well on standardized neuropsychological tests.
Schagen, Das, and van Dam (2009) proposed that because there is ample evidence
that psychological and physical complaints can increase with increased accessibility to
relevant schemata, fatigued cancer patients may succumb to cognitive dysfunction.
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Information about the symptom can be integrated into the memory through priming or
pre-existing knowledge about the symptom. In other words, if the patient is aware of a
possible side effect, such as fatigue and cognitive dysfunction, the patient is more likely
to develop the symptom. The authors interviewed 261 breast cancer patients about their
cognitive problems. Prior to the interview, half of the study participants were primed
with a letter containing information about cognitive dysfunction and its association with
chemotherapy. Results showed that patients who were primed about cognitive
information were more likely to have cognitive problems post-chemotherapy. Results of
the study have relevant implications both for clinical practice as well as future research.
In summary, cognitive disturbances have been observed especially in women
during and after breast cancer adjuvant chemotherapy as well as after breast cancer
surgery (Cimprich, 1992). These disturbances tend to be associated with the fatigue that
as many as 99% of these women experience during and after cancer treatments. To
address this significant problem, clinicians must routinely screen and perform further
assessments to identify patients who are at risk for this debilitating condition and then
implement treatment strategies including physical and psychosocial rehabilitation
programs.

Quality of Life
The Fatigue Coalition Study II results show that fatigue is associated with
significant physical, emotional, psychologic, and social consequences, with virtually
every aspect of daily life being affected (Vogelzang, et al. 1997). Ahlberg, Ekman and
Gaston-Johansson (2005) found highly statistically significant negative correlation
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between fatigue and multiple domains of quality of life, including physical, emotional,
cognitive and social as well as role functioning. They further demonstrated that over
time these domains remained highly negatively correlated with fatigue. There is a
paucity of studies that address these quality of life issues in the cancer patient. Ferrell et
al. (1996) conducted an exploratory descriptive study that described the impact of fatigue
on the quality of life of patients with cancer. The findings reflect that fatigue has an
impact on all dimensions of quality of life including physical, psychological, social and
spiritual well-being. The study is limited due to the methodology used which included
analyzing data from mailed surveys, interview data, and focus groups (Ferrell et al.,
1996).
A second study by Tanaka et al. (2002) compared the impact of dyspnea, pain and
fatigue on daily life activities in ambulatory patients with advanced lung cancer. Results
indicated that dyspnea and fatigue interfered with at least one daily life activity in more
than half of the patients. One limitation of this study is the lack of variance in symptoms.
Those patients who were physically or cognitively not well were excluded. A second
limitation is the assessment form that was utilized; initially, it was validated for pain
assessment. Also temporal sequences cannot be determined from the data because of it
being a cross-sectional study. Difficulty in assessing the impact on daily life is noted as
the severity of the symptoms is unclear.
Camarillo (1991) used case studies to describe perceptual meanings of fatigue
experienced during chemotherapy. Fatigue was viewed as a negative experience that had
impacted normal physical and social activities, challenged personal coping abilities and
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was associated with a diverse symptomatology. Camarillo concluded that fatigue often
disrupted the patient‟s ability and desire to accomplish valuable role functioning,
ultimately diminishing quality of life. However, there was no link established among the
dependent variable, fatigue, and the other independent variables. The study failed to
reflect practice theory, thus eliminating the potential for interventions.
A preliminary study by Cimprich (1993) focused on changes in attention capacity
and cognition in women who had a mastectomy. The experimental group who
participated in the simple restorative activities showed enhanced recovery, including
improved cognition. The study is limited because only thirty-two patients participated in
the study. No identification was completed on the women who were diagnosed
postoperatively with breast cancer. These findings, however, do provide a basis for
further testing of the efficacy of attention-restoring activities.
A more recent study addressing quality of life issues followed a group of
Hodgkin‟s disease patients for five years (Flechtner & Bottomley, 2003). Results reflect
that there is a subgroup of patients whose fatigue persists at a medium to high level after
five cancer-free years. Unfortunately, the researchers did not determine either statistical
or clinical differences.
A cross-sectional study by Diaz et al. (2008) explored the functional and
psychological impact of different cancer symptoms in 505 patients. Fatigue affected the
patient‟s daily routine, social activities and relationships. The patients perceived fatigue
as the symptom with the highest impact on their daily living and reported that it
substantially affected their emotional and social activities. There was lack of monitoring
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the patients as they completed the self-administered survey. Additionally, no resources
were offered to assist them with their fatigue.
A survey totaling 1,933 breast cancer survivors were recruited from five large
hospitals in Korea to examine the prevalence and correlates of fatigue and depression.
They assessed the correlates for relevance to health-related quality of life. Results
showed that fatigue and depression were influenced by sociodemographic factors, comorbidity and symptom characteristics rather than cancer or treatment-related factors.
Both fatigue and depression were negatively associated with survivors‟ health-related
quality of life. The assessment scales utilized for fatigue and depression were
appropriate; however, collection of data was not clearly delineated fully in the study
(Kim et al., 2008).
A structured interview was conducted on 200 breast cancer patients two years
after completion of therapy. The researchers investigated the relationship between
cancer-related fatigue and clinical variables. In addition to interviewing the women,
blood and urine samples were collected for hematological, biochemical, and cortisol
analysis. The results showed that 30% of the women who had completed chemotherapy
had significant negative changes in their quality of life and mood status. There was some
evidence that the fatigue was related to sleep disturbance or to a persistent inflammatory
or immune response (Alexander, Minton, Andrews, & Stone, 2009).
Further research demonstrates that cancer-related fatigue persists long after
treatments are completed and greatly impacts the patient‟s quality of life. Meeske, Smith,
and Alfano (2007) conducted a study on large cohort of disease-free breast cancer
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survivors to assess the prevalence of fatigue, correlates of fatigue and the relationship
between fatigue and quality of life. Results reflected that 41% of breast cancer survivors
were fatigued two to five years post-treatments. Significant correlates of fatigue included
cognitive problems, physical inactivity, pain, changes in physical appearance and use of
antidepressants. Fatigue was associated with poor quality of life, mainly in the area of
role changes and social functioning. Another study by Goldstein et al. (2006) further
reinforced that psychological distress and fatigue persisted four years post-chemotherapy
and radiotherapy in 176 breast cancer patients. These women also reported functional
disability that was caused by their fatigue.
In summary, fatigue is one of the most pervasive symptoms experienced by
patients with cancer. This symptom has the capacity to greatly diminish quality of life
(Glaus, Crow, & Hammond, 1996) as well as negatively impacting treatment outcomes
by reducing survival times (McDaniel, Musselman, & Porter, 1995). Data from Ferrell
et al. (1996) secondary analysis of data determined that rather than being an isolated
physical symptom, fatigue is a “force that has an impact on all dimensions of quality of
life” (Ferrell et al., 1996, p. 1539).
Cella, Lai, & Chang (2002) further clarified this phenomenon by identifying a
strong linear relationship between fatigue and quality of life in his investigation into
factors impacting on the latter. Distress and disruption in patients‟ lives evoked by
fatigue are evident in several qualitative investigations (Glaus et al., 1996; Ream &
Richardson, 1997; Holley, 2000). In addition, two surveys conducted determined that
fatigue causes more impairment to quality of life in patients receiving chemotherapy and
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radiotherapy than other common side-effects of cancer therapy. Furthermore, there is a
financial impact not only for the patient but also for the caregiver caused by cancerrelated fatigue. Approximately 20% of patients needed to employ someone to help with
household chores with 75% of patients having to change their conditions of employment
as a result of fatigue (Breithart, Cella, & Curt, 2000).

Assessment of Cancer-Related Fatigue
Another important aspect in the study of fatigue is the measurement of this
subjective phenomenon. To investigate more control of fatigue, there is the need for
reliable and valid assessment measurements as there is a lack of consensus surrounding
the optimal means of assessing cancer-related fatigue (Jacobsen, 2004). Piper and
associates submit that they were the first to propose a multidimensional measurement
model for fatigue manifestations (Piper et al., 1987). However, a critical literature review
on cancer-related fatigue demonstrates that the measurement of fatigue has been
restricted somewhat due to one-dimensional scales with limited reliability and validity
(Irvine et al., 1994). Over time, approximately 18 instruments to measure fatigue have
been developed. These myriad of fatigue assessment tools sometimes are only onedimensional and tend to be much shorter and more clinically appropriate but do not take
into account the multifactorial nature of fatigue. Conversely, multidimensional scales are
mainly developed for research studies but the length and time required to complete them
make them impractical to use in clinical screening or clinical evaluation. Additionally,
the length of the tools tend to exhaust the patients. Consequently, the effective
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management of fatigue is hampered by lack of a well-validated, sensitive and easily
administered measurement tool (NCCN, 2009).
The Rhoten Fatigue Scale (Rhoden, 1982) is simple and easy to use but does not
describe the fatigue experience comprehensively as it was not developed for measuring
cancer-related fatigue. The second instrument, Profile of Mood States (POMS) is easy to
use; however, it was developed to measure change in mood states in psychiatric
outpatients, not fatigue in cancer patients. The multidimensional fatigue inventory (MFI20) demonstrates good reliability in patients receiving radiotherapy. However, the
instrument needs to be validated with other cancer populations (Smets, Garssen, &
Bonke, 1995). The Functional Assessment of Cancer Therapy Fatigue Scale (FACT-F)
has high internal consistency, is brief, simple and easy to use, but the length of the
questionnaire could burden fatigued patients.
Other assessment tools serve as multidimensional measurements and, as
previously mentioned, tend to be lengthy and more suited for research studies, such as the
Piper Scale. It is the most comprehensive scale; however, it is quite lengthy and is not
designed to be used clinically (Piper et al., 1987). The Multidimensional Fatigue
Symptom (MFSI) has good psychometric properties and does not assume the presence of
fatigue or chronic disease. It, too, is lengthy and could burden the patient (Stein, 1998).
In addition, the Schwartz Cancer Fatigue Scale is highly recognized as it measures
various dimensions of quality of life. It is simple and relatively brief. It has a validation
limitation in that the patients had completed their cancer treatment. Therefore, it needs
further tests of psychometric properties (Schwartz, Jandorf, & Krupp, 1993). Holley
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devised the Cancer-Related Fatigue Distress Scale in 2000. Its strength is that the items
were based on patient interviews and the content was validated by cancer survivors. The
limitation is that it measures only one aspect of the cancer-related fatigue experience,
distress, which may not capture the whole picture of the fatigue experience (Holley,
2000).
A study evaluating screening instruments for cancer-related fatigue in 200 breast
cancer survivors was conducted. The study utilizing a diagnostic interview combined
with a structured psychiatric interview was completed (Alexander, Minto, & Stone,
2009). The patients also were assessed utilizing the Bidimensional Fatigue Scale and the
FACT-F. The researchers concluded that both assessment tools‟ cut-off scores can be
used to identify breast cancer survivors at higher risk of significant ongoing posttreatment fatigue. Because the interviews were lengthy, they may not be conducive to
utilize in fatigued cancer patients and would not be suitable for clinical use.
A recent study by Santana et al. (2009) assessed fatigue in 43 patients utilizing the
FACT-F for the purpose of providing evidence on the magnitude of change in the fatigue
subscale scores. The changes in the fatigue scores correlated with patients‟ perception of
their fatigue worsening or improving. They also requested their participants to complete
a battery of questionnaires, which possibly was exhausting to a fatigued patient.
A systematic review methodology was used to identify scales that have been
validated to measure cancer-related fatigue. The reviewers identified 14 scales that met
the inclusion criteria: validated for use in cancer patients and/or widely used in cancer
patients. They concluded that the unidimensional scales are the easiest to administer and
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have been used most widely. They recommended the use of the EORTC QLQ C30
(fatigue subscale) and the Fatigue Questionnaire (FQ). The remaining scales need further
validation before using in the oncology patient (Minton & Stone, 2009).
In summary, there are several tools available to assess cancer-related fatigue.
Despite efforts to produce fatigue instruments, no gold standard is available. From a
clinical and research perspective, it might be more relevant to use a simple measure that
clearly indicates the presence, absence and severity of cancer-related fatigue during and
after treatment. Unfortunately, there is concern because of lacking uniformity among the
elements that are assessed. In addition, most of the tools are quite lengthy, laborious and
tend not to be user friendly for the patient who is experiencing fatigue. In addition, the
utility of the assessment tools in the clinical setting is in question due to the inordinate
amount of time required to complete them. Finally, due to the lack of uniformity among
the various tools, the results leave the practitioner with a lack of clarity in how to
implement strategies to manage patients who are experiencing the fatigue.

Management Stratégies: Cancer-Related Fatigue
Exercise
The most effective approach to symptom management is to identify the cause of
the distressing symptom and correct it. However, in many patients with cancer, no cause
for fatigue can be readily identified, and the approach to management is a general one.
The most supporting evidence of effectiveness can be found for exercise as an
intervention for cancer-related fatigue (Mock, Atkinson, & Barsevick, 2000). The theory
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supporting exercise as a treatment for fatigue proposes that the combined toxic effects of
cancer treatment and a decreased degree of physical activity during treatment cause a
reduction in the capacity for physical performance. Exercise training leads to a reduction
in the loss or even an increase in functional capacity, leading to reduced effort and
decreased fatigue (Schwartz, 1999).
To date, there are approximately 11 published reports by four research teams of
studies testing the effects of exercise on fatigue during active cancer treatment, and two
additional reports of exercise programs after cancer treatment (Mock, McCorkle, Ropka,
Pickett, & Poniatowski, 2002; Mock, Dow, & Meares, 1997; Mock, 2001). All indicate
significantly lower levels of fatigue in individuals who exercised compared to the control
group. Although the results have been consistent across studies, they are limited in
number, their sample sizes are small, and there are methodological limitations associated
with many. Furthermore, most studies have only included patients with breast cancer.
Two reviews of exercise studies in patients with cancer have also concluded that
exercise reduces fatigue and improves quality of life (Courneya & Friedenreich, 1999;
Pinto, & Maruyam, 1999). Results of a pilot study of increased activity in nine patients
with advanced cancer also showed reductions in fatigue (Porock, Kristjanson, Tinnelly,
Duke, & Blight, 2000). Only one small study (n=5) investigating the effects of exercise
on fatigue involved instituting an exercise program for individuals complaining of high
levels of fatigue (Dimeo et al., 1996).
A few studies have demonstrated that regular exercise improves mood, body
image, self-concept, and sleep patterns (Crews & Landers, 1987; MacVicar &
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Winningham, 1986). Crews and Landers (1987) conducted a meta-analysis of thirty-four
studies including approximately 1500 subjects investigating aerobic fitness and reactivity
to psychosocial stressors. Results indicated that aerobically fit subjects had a
significantly reduced stress response when compared to control group or baseline values.
A more recent retrospective investigation between aerobic exercise and quality of life in
women with breast cancer was compared to a matched control group who did not
exercise. The women who exercised had a significantly higher quality of life (YoungMcCaughan & Sexton, 1991).
In contrast, Losito, Murphy, and Thomas (2006) reported there was no difference
in fatigue in a prospective, pre- and post-test design convenience sample of 12 adults
with various types of cancer. They observed that social interactions resulted in strong
group cohesiveness. Limitations of the study included an inadequate power to
demonstrate significant differences in outcome variables as well as lack of comparison
groups, self-selected participation and lack of formal measurement of the group process.
Conversely, 113 breast cancer patients participated in a supervised exercise
training program. Results showed that moderate intensity, individualized exercise
improved cardiovascular and pulmonary function with reduction in fatigue. However,
fatigue did not decrease on psychologically based domain of affective fatigue and
cognitive/mood fatigue (Schneider, Hsieh, & Spoud, 2007).
According to Schwartz (1999), only a few published studies tested exercise
interventions to manage fatigue during cancer treatment. These studies included
radiotherapy patients participating in aerobic exercise. The results demonstrated lower
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levels of fatigue in the aerobic group. Studies were done in small samples of patients with
breast cancer.
Other studies of exercise during cancer treatment, while not focused on fatigue as
an outcome, have demonstrated positive findings related to physical function during
cancer treatment. Another study (Dimeo et al., 1997), studied the effects of exercise on
bone marrow transplant patients who exercised with a bed exercise bicycle for 30
minutes daily. The results demonstrated increased physical performance and a decreased
white blood cell and platelet count as well as a decreased length of stay when compared
with the control group. Fatigue was not an outcome reported in this study. These studies
do, however, suggest that patients receiving active cancer therapy can exercise safely.
A meta-analysis of exercise interventions for patients with cancer-related fatigue
was completed by Conn, Hafdahl, Porock, et al. (2006). Results indicated that exercise
interventions resulted in small positive effects on health and well-being. However, these
findings suggested that breast cancer patients benefited the most from exercise.
Improvement in mood was found only when exercise was done after completion of
therapy. Limitation of the study included no report of patients dropping out of the
studies.
A more recent study (Winters-Stone, Bennett, Nail, & Schwartz, 2008) conducted
a cross-sectional study to determine whether clinical characteristics, physical fitness or
physical activity predict fatigue in older, long-term breast cancer survivors. The sample
included 47 women who were at least one year beyond treatment completion. Findings
revealed that fatigue was significantly correlated with variables with the exception of
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aerobic fitness. Fatigue was higher with lower age, greater body fat composition, fewer
years after diagnosis, more adjuvant treatments, poorer lower-extremity muscle strength
and less physical activity. Fatigue was linked to physical activity and muscle strength.
Regard for the women being fatigued should have been taken into consideration as a twohour testing session was completed.
Hanna, Avila, Meteer, Nicholas, and Kaminsky (2008) conducted a retrospective
analysis of achieved data of 39 cancer patients who completed a 16-session
comprehensive exercise program. The program consisted of low-to-moderate intensity
aerobic and resistance exercise, education and support twice a week for eight weeks.
Significant improvements in physical function, fatigue and mood were noted.
A biobehavioral model was proposed by Al-Majid & Gray (2009) because the
majority of past exercise studies have not been guided by a consistent theoretical model
nor have they examined biobehavioral mechanisms underlying cancer-related fatigue. As
a result, the mechanism by which exercise reduces fatigue is not fully elucidated. This
model will provide guidance for future research on exercise interventions for fatigue and
will help to identify variables implicated in causing cancer-related fatigue.
Donnelly et al. (2009) conducted a study to establish physiotherapy exercise
management of cancer-related fatigue in the United Kingdom. Results showed that the
most common barrier to implementing an exercise program was lack of exercise
guidelines. Their recommendation included not only teaching exercises to patients but
including strategies to teach the patients‟ energy-conservation techniques.

61

The most recent study conducted by Adamsen (2009) included 296 patients with
various types of cancer receiving chemotherapy. Both male and female patients in the
Danish study were randomized to either standard of care or standard of care plus a
multimodal high intensity exercise intervention. The exercise program included group
exercise three times per week as well as low intensity training with 30 minute relaxation
exercise four times per week as well as a 30 minute massage twice a week. Results
demonstrated that there was a simple reduction in fatigue and improvements in other
measures of well-being in the intervention group; however, these patients did not have an
improved overall quality of life. The patients who completed the 6 week exercise
program showed a 6.6 point decrease in the fatigue scale. The effect size of 0.33
suggested that a small to medium clinically important change in the study‟s primary
outcome measure was noted. Not only was the patients‟ fatigue improved, but also
improvement in physical functioning, vitality, and mental health was noted. The
strengths of the study included a large sample size including both male and female
patients. Additionally, the same results were noted in patients with advanced disease.
Weaknesses of the study included lack of a blinded study as well as the control group was
allowed to crossover to participate in the program. Approximately two-thirds of the
participants in the control group switched over to the intervention group. Additionally,
there were more female than male patients participating in the study.
Energy Conservation
Energy conservation is a frequent treatment recommendation for cancer-related
fatigue. Patients with fatigue are often advised by health-care professionals to get
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additional rest and sleep (Vogelzang et al., 1997). The relation between sleep
disturbances and fatigue has been inadequately investigated (Berger, 1998). Results of
two studies, which used actigraphy to measure activity and sleep, have shown that cancer
patients spend more time resting and sleeping than healthy individuals, but the pattern of
sleep is often severely disrupted with awakening almost every hour (Berger, 1998;
Young-McCaughan, Dramiga, & Yoder, 2002). Berger, VonEssen, and Khun (2002)
conducted a pilot project and found that patients who try additional rest and sleep to
manage fatigue do not report it to be particularly effective.
The research being done to test rest or sleep to manage fatigue is in preliminary
stages (Barsevick, Berger, Bakken, & Cetak, 2007). Although research is limited, results
of a pilot study have been published by Barsevick, Whitmer, Sweeney, and Nail (2002),
and a multicenter randomized clinical trial also has been published (Barsevick, Beck, &
Sweeney, 2002). These studies were designed well; the results indicate a need for
additional studies involving a larger sample of patients.
Stress Reduction/Cognitive Behavior Modification
Studies testing interventions to reduce stress and increase psychosocial support
also have shown reductions in fatigue, usually as a component of mood state (Fawzy,
1995; Fawzy et al., 1990). Because these interventions did not have fatigue as a primary
endpoint, fatigue measures are often limited to a subscale on an instrument to measure
emotional distress, and the interventions generally did not attempt to elucidate a
mediating mechanism of fatigue. In these studies, assessing the validity of the
intervention in relation to effects on fatigue, the content of the intervention, and potential
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clinical confounds that threaten the internal validity of the study were difficult. Because
the original interventions did not target fatigue, the amount and type of information about
fatigue and suggestions for self-care included in the interventions were not described or
controlled, and use of these suggestions by participants was not examined. Interventions
suggested by other patients were adopted during group interventions, or suggestions by
the nurse were used during individual counseling sessions, making it difficult to assess
the overall effect of a fairly broad psychosocial intervention (Fawzy, 1995).
Specific interventions tested have included support groups, counseling, and a
comprehensive coping strategy (Hadorn, Baker, Hodges, & Hicks, 1996). In the studies
of support groups, the experimental groups have shown less overall mood disturbance,
less depression, less fatigue, and greater vigor than control groups on the Profile of Mood
States scale (Fawzy et al., 1990).
A model of cognitive or attentional fatigue in patients with cancer has been
described by Cimprich (2001). She developed and tested an attention-restoring
intervention in post-surgical patients with breast cancer, involving restorative experiences
with the natural environment. Participants in the experimental group showed enhanced
attentional capacity on various neurocognitive tests and returned to work earlier than the
participants in the control group. The research in this area is preliminary and needs
further development. Also, the relationship between attentional fatigue and cancerrelated fatigue is unclear, since no measures of self-reported fatigue levels were used in
the studies (Cimprich, 2001). Neither was a link established between neuropsychologic
function and the general sensation of fatigue.
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Given, B., Given, C., and McCorkle (2002) conducted a randomized clinical trial
to test a supportive care nursing intervention to manage pain and fatigue during
chemotherapy in a sample of 113 cancer patients with mixed diagnosis, including stages
1-4. The intervention was tailored to patients‟ problems and included teaching,
counseling and support, coordination, and communication. Pain and fatigue, as well as
total symptoms, were reduced in the experimental group, and both physical and social
role functions were significantly higher than in control group (Given et al., 2002). The
study is well designed such that the researchers determined the effectiveness of the
interventions. In addition, the sample size is large and stratified well.
Brown et al. (2006) conducted a randomized study of 115 participants to assess
whether a multidisciplinary intervention helped to reduce level of fatigue in patients with
advanced cancer receiving radiotherapy. The 8-session structured psychoeducational
program included didactic and experiential sessions from a psychiatrist or psychologist
collaborating with a nurse, physical therapist, chaplain or social worker, depending on the
session‟s theme. Radiotherapy initially caused a worsening of fatigue but with time
fatigue levels returned to baseline. Clinically, the structured multidisciplinary
intervention had no impact on fatigue, and there was a suggestion the multiple sessions
may have contributed to worsen fatigue during active cancer treatment. The fatigue
assessment utilized was a one-dimensional tool and did not assess the various factors
causing the fatigue. The sessions were 90 minutes in length which probably precipitated
increased fatigue in the participants and subsequently affected their concentration levels
to remember the information provided.
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An exploratory study by Gielissen, Verhagen, and Bleijenberg, (2007) examined
the long-term effect of cognitive behavior therapy in patients who completed the therapy.
Sixty eight patients were assessed pretreatment, post-treatment and at follow-up ranging
from 1- 4 years. The exploratory regression analysis showed that fatigue severity,
psychological distress and somatic attribution at pretreatment contributed to persistent
fatigue severity at follow-up. Cognitive behavior therapy, especially designed for cancerrelated fatigue, was successful in reducing fatigue and functional impairment in cancer
survivors. These effects were maintained after two years completion of cognitive
behavior therapy.
Dirksen and Epstein (2008) studied the efficacy of cognitive behavioral therapy
for insomnia on fatigue, mood and quality of life in 72 breast cancer survivors. The
women were randomly assigned to either cognitive behavior therapy for the insomnia
group or the control group. Findings revealed that the women who received the therapy
for their insomnia had significant improvements in fatigue, anxiety, depression and
quality of life.
A more recent study by Montgomery et al. (2009) evaluated the effectiveness of a
psychological intervention combining cognitive-behavioral therapy and hypnosis to treat
fatigue associated with radiotherapy. Breast cancer women scheduled for radiotherapy
were randomized to receive standard care versus standard care combined with cognitivebehavioral therapy (including meeting with a psychologist) and hypnosis. The fatigue
level was reduced significantly (p = .05) in the intervention group. The researchers
concluded that the cognitive-behavioral therapy with hypnosis intervention was effective
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in controlling and potentially preventing fatigue. Limitation of the study was a small
sample.
Dolbeault, Cayrou, & Bredart (2009) conducted a multi-site randomized study to
evaluate the effects of psycho-educational group intervention. Two hundred and one
breast cancer patients were recruited and randomly assigned either to a treatment group, a
psycho-educational intervention, or to a waiting-list control group. The eight-week
program with two hour classes included thematic discussions and training on stress
management. Results showed a significant reduction in anxiety as well as decreased
anger, depression and fatigue among the group participants. The psychosocial
intervention represents an excellent complement to medical oncology care. This
intervention should be tested in groups with other types of cancer and other phases of
their disease.
In summary, the result of studies utilizing psychosocial interventions portends
lower levels of fatigue in cancer patients who are in active treatment as well as cancer
survivors. Studies further suggest that psychosocial interventions are effective in
managing cancer-related fatigue whether delivered individually or in a group setting
(Given et al., 2002). The benefits of the interventions may continue for months after the
program is completed. Conversely, lengthy interventions and excessive number of
sessions tend to exacerbate fatigue, especially in patients receiving radiotherapy (Brown
et al., 2006).
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Pharmacologic Therapy
Several pharmacologic approaches potentially could provide relief for cancer
patients dealing with fatigue. The most rigorously designed clinical trials to date have
been conducted with colony stimulating factors, epoetin alfa and darbopoetin alfa. Five
large community-based non-randomized studies (Demetri, et al., 1998; Gabrilove,
Cleeland, & Livingston, 2001; Glaspy, Bukowski, & Steinberg, 1997; Littlewood,
Bajetta, & Nortier, 2002; Osterborg, Brandberg, & Molostova, 2002) have shown a
clinical benefit of epoetin alfa treatment for cancer-related anemia and fatigue. These
studies experiential designs reflect significant findings. However, there are concerns that
some of the non-responders were eliminated from the data prior to publishing the
research.
A more recent study (Blair, Bardwell, Podbelewicz-Schuller, & Mortimer, 2008)
assessed the correlation between hemoglobin and fatigue in women undergoing adjuvant
chemotherapy without erythropoieten-agent support. Seventy-five women participated in
the study using quality of life questionnaires to assess changes in the need for
psychosocial support over time. Participants with high fatigue levels at 2 months had
hemoglobin levels 13% lower than those with a low level of fatigue. A larger study
group is warranted before suggesting that chemotherapy-induced decline in hemoglobin
may be a marker of physiologic reserve.
In a small randomized study, amifostine administered with paclitaxel to women
with breast cancer did not affect therapy-induced fatigue (Gutstein, 2001). A pilot study
of 12 patients with melanoma who were receiving interferon compared methylphenidate
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plus exercise to exercise alone to fatigue levels of historical controls. Fatigue was lower
for the methylphenidate plus exercise group than for the comparisons group (Schwartz,
Thompson, & Masood, 2002). Both studies include small numbers of patients in the
sample and neither assessed the level of fatigue the patient was experiencing using a
commonly used fatigue tool.
Few controlled studies have been done to investigate other pharmacologic
therapies for cancer-related fatigue. Other classes of medications, such as CNS
stimulants and psychostimulants have shown promise in open-label prospective designs,
but evidence is lacking in placebo-controlled randomized trials (Burks, 2001). Several
other classes of drugs, antidepressants and cholinesterase inhibitors, have been studied
for the treatment of cancer-related fatigue. Methylphenidate has been studied
considerably and seems to be effective and is tolerated well. Antidepressants studies
have shown mixed results. It is suggested in some studies that Modafinil is helpful for
patients experiencing cancer-related fatigue. Paroxetine has shown some benefit for
fatigue, primarily when depression is present. Bupropion may be beneficial in treating
fatigue, and Donepezil may be beneficial in open-label studies (Breitbart & Alici, 2008).
NCCN (2009) does not advocate utilizing these agents except in cancer patients
experiencing fatigue during terminal phase of illness. Further randomized clinical trials
are warranted to determine the efficacy of these psychotropic medications.
Complementary Therapy
A pilot study by Barton et al., (2009) was conducted to investigate whether
various doses of American ginseng would affect cancer-related fatigue. A secondary
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endpoint was to assess toxicity. The study involved 290 patients and was double-blinded
to three doses of Ginseng: 750 mg. 1,000 mg. or 2,000 mg. per day versus placebo; the
various doses were administered twice a day for eight weeks. The researchers concluded
that there was some activity at reducing fatigue in patients receiving 1,000 – 2,000
mg/day. There were no significant differences in toxicities based on various doses.
Further study is warranted.
Role of Patient Education
Prior to 2003, no research addressed the adequacy of resources that have been
developed for patients with cancer-related fatigue. A qualitative European study was
undertaken to explore how useful educational materials dealing with the management of
cancer-related fatigue would be to patients (Ream, Browne, & Glaus, 2003). In their
study, focus groups with patients in the United Kingdom and Switzerland were
conducted. Findings from the groups fell within two major themes: educational process
and educational materials. In the educational process arena, patients voiced that
information about cancer-related fatigue had not been provided to them. There also was a
perception that healthcare professionals do not view fatigue as important. Participants
also stated that education about fatigue should be delivered slowly and gently, allowing
patients time to talk, reflect and ask questions. The importance of providing the material
verbally was emphasized by the participants. They also stressed the importance of
personal contact when providing the information, and suggested providing information
on fatigue prior to the administration of the treatment. Participants perceived that
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preparation prior to the initiation of cancer therapy would prevent their losing control and
increase their motivation to manage their fatigue.
Evidence from the Ream et al. (2003) study also showed that unless patients had
access to the educational materials before the session, their effect was “purely an
academic issue” (p. 108). The majority of the patients felt that the material helped them;
it provided good advice and reassured them that fatigue was not unusual. There also was
a discussion of the strengths and weaknesses of various types of educational materials
including written material, video resources, poster, and Internet materials. The groups
recommended that quality of life issues be included as it was not advantageous to „fight‟
fatigue; rather the patient should strive to remain motivated despite it. Ream et al., (2003)
participants also felt strongly that healthcare professionals play a major role in facilitating
patients‟ access to materials on cancer-related fatigue as patients were unaware of how or
where to locate existing information. In addition, the patients valued the one-on-one
teaching methodology as being pivotal to their understanding fatigue. A nurse-led
educational session was preferred by the participants because of the therapeutic
relationships that are often established between patients and nursing staff (Ream et al.,
2003).

Summary
In summary, though several strategies have been studied and implemented in the
management of cancer-related fatigue, there is no clear evidence that one strategy will
prevent the number one symptom that cancer patients experience. Rather, a combination
of various strategies seems to provide the best approach to the management of the
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fatigue. Even with the implementation of the various strategies outlined, patients still
experience the unrelenting symptom that impacts their functional capacity and their
quality of life. Thus, with this evidence, it is imperative that cancer-related fatigue is
studied from a phenomenological approach so that researchers have a better
understanding of the experience of the fatigue that patients confront. The derived
information will serve as the framework for future researchers to embark on more
specific and appropriate measures to deal with the phenomenon. Without the answer to
this much needed question: “What is it like to experience cancer-related fatigue and how
does it impact on the quality of life?” healthcare professionals will continue to study
cancer-related fatigue fastidiously, while remaining “blind-folded” to the “essence or
meaning” of the experience for the cancer patient. Without this evidence, researchers
will fail to understand what the patient experiences, thus preventing a protocol being
established to address ways to abate and minimize this debilitating symptom.
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CHAPTER III
METHODOLOGY
In this study the experience of breast cancer patients confronting fatigue will be
explored and discussed. The existential phenomenologic approach is selected because
there first must be an understanding of what the cancer patient experiences with their
fatigue before a conceptual framework or practice guideline can be developed to treat and
manage these patients. At present there is a lack of distinction between tiredness, fatigue,
and exhaustion, despite conceptual differences (Olson, 2007). Therefore, it is important
to go into the world of the cancer patient and hear what is happening to those who are
experiencing the symptom in order to really understand the experience of cancer-related
fatigue.
Existential phenomenology is chosen also because the framework seems to fit
with the phenomena of interest as the way the cancer patient experiences fatigue depends
upon many grounds, the world of objects and physical space, body, time and other people
(Thomas & Pollio, 2002). The experiential meaning to the cancer patient as they deal
with their unrelenting fatigue on a daily basis has not been revealed in previous research.
The philosophical perspective of Merleau-Ponty was introduced in Chapter 1, and
will be further elucidated in this chapter. Additionally, the rationale for utilizing a
qualitative approach to study this number one complaint among cancer patients will be
discussed as well as the link between phenomenological philosophy and the method
utilized in the study. The procedural aspects of conducting the phenomenological study,
such as selection of the sample, data collection procedures, protection of the human
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subjects, data recording procedure, data analysis and validating the accuracy of the
findings also will be reviewed in this chapter.

Research Design
Characteristics of Qualitative Method
Qualitative research focuses on the naturalistic inquiry into everyday living.
Qualitative researchers believe that gaining knowledge from sources that have intimate
familiarity with their issues is much more meaningful than the objective distancing
approach that characterizes quantitative approaches (Taylor & Bogdan, 1984). Only
qualitative research reveals the meaning of what is occurring to those who are
experiencing an event or situation. In other words, to acquire the meaning of human
experiences, the qualitative method is warranted (Thomas & Pollio, 2002). Additionally,
qualitative research views phenomena holistically.
Linking the Phenomenological Philosophy to the Method
To explore the phenomenon of cancer-related fatigue it is essential to understand
what are the meaning, structure, and essence of the lived experience of the patient. It is
important for the researcher to gain access to the individual‟s world of experience, and
then search for the invariant structures of the individual‟s experience or their essence of
the experience. To properly study human events, the research approach must be
congruent with a philosophy designed to encompass human activities. The University of
Tennessee approach is grounded in the philosophy of Merleau-Ponty. This approach
enables the participants to describe who they are and how they live in their world; as
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suggested by Merleau-Ponty, we should always start with the world because it is all we
have. He also suggests that experience is the starting point rather than knowledge.
Additionally, this approach allows consideration of both freedom, which has its own
energy and difficulty, and the responsibility of individuals shaping the situation they are
facing (Valle, King, & Halling, 1989). It thus allows patients with cancer-related fatigue
to describe their experience of fatigue in their own and unique perspective, including
those changes in freedoms and responsibilities that have evolved secondary to the
development of fatigue.
History of Existential Phenomenology
The term “phenomenology” is derived from two Greek words: an appearance
(phaninomenon) and a reasoned inquiry (logos). True to the origin of the term,
phenomenology focuses on the essences of anything that is conscious to us. In other
words, it is concerned with the way things appear to us. It is the “taken for granted”
perspective which is generally unrecognized as part of the phenomenon. It remains with
the person‟s experience and is often described in two stages: first, the individual
providing a description of their experience, and second, the researcher capturing and
explicating the experience through the interview and descriptive efforts (Ray, 1994).
The marriage of the two terms, existentialism and phenomenology, evolved from
two philosophies that both were concerned about the existence of human beings. In the
aforementioned historical perspective, one quickly recognizes that existentialism can be
traced to Kierkegaard from the 19th century in which there was recognition that man‟s
everyday existence is important. To further the amalgamation of questions pertaining to
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human existence as well as a method to study existence, Merleau-Ponty further defined
the path of existential phenomenology. He delineates his perspective by stating, “All my
knowledge of the world is gained from experience of the world.” “To return to things
themselves is to return to that world which precedes knowledge” (Merleau-Ponty, 1962,
p. viii-ix). Merleau-Ponty suggested that his perspective seeks to appreciate an
understanding of a phenomenon in the everyday world as well as assessing experiences
and meanings of these experiences of the subject of interest.
Important to understanding existential phenomenology, one must appreciate that
human existence (consciousness) includes two features, figure and ground as well as
intentionality. Intentionality is the fundamental basis of the world and humans; whereas
existence always connotes that we are in the world, and in that setting is where we
humans know ourselves. Furthermore, it is in that venue that we understand that man
cannot be taken out of the situation.
Figure and ground are equally features of the human experience. “Standing out” is
another way of defining existence. This emerges as a figure against the ground, which
tends to stand out. As described by Thomas and Pollio (2002), when viewing the “face
and vase” drawing, only one aspect of the picture is in focus at one time. Conversely, the
area not in focus is the background. In other words, one does not exist without the other,
but one seems to stay in the background until we have a direct experience with that
particular subject, object or experience. Thereafter, we integrate that important item or
experience into our armamentarium such that it becomes more figural for us. It becomes
more meaningful for us because we notice it more frequently. It is important to recognize
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that these concepts of figure and ground are fluid; sometimes the figural perspective
retreats to the ground, a secondary position, and ground becomes figural. Whatever that
person conveys important as standing out conveys what is meaningful to that person.
Obviously, ground and figure are different components of the same experience; they do,
however, provide a forum for describing and contextualizing a human experience
(Thomas & Pollio, 2002, p. 18).
The researcher learns what is figural and what is contextual through face-to-face
dialogue. In the following section, the procedure for conducting interviews is described.
Procedure
Interviews were conducted in a quiet, private place that was mutually acceptable
to the participant and the researcher. The researcher was cognizant of the lack of energy
these patients experienced; therefore, she offered to visit them in their home if that was
acceptable to the patient. Emphasis was placed on the setting promoting a comfortable
environment for the patient since fatigue was such a debilitating symptom. The patient
was asked to describe how it is to live with being tired. An audiotape recording of the
participant describing their experience of living with fatigue was recorded. At several
times during the interview the researcher summarized what had been heard. The face-toface interviews were conducted either in the participant‟s home or their office, lasting
approximately one hour or until the participant had no further information to share. After
the interview was completed, field notes were summarized by the researcher in the format
of audio taping the experience. Thereafter, a paid transcriptionist who had signed a
confidentiality form transcribed both the interview of the patient as well as the
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researcher‟s field notes. Then the researcher and the Interpretive Research Group at the
University of Tennessee read the transcript for meaning units; it then was reviewed with
the interpretive process, using the part-to-whole process (Thomas & Pollio, 2002).
Sampling and Data Collection
The design included studying twelve breast cancer patients with stage I and stage
II breast cancer that had completed chemotherapy regimens and radiotherapy.
Participants who had co-morbid chronic diseases such as heart, diabetes, and autoimmune
diseases were excluded from the study. Diversity in education, cultural background and
age were considered during the accrual process. After five interviews were completed,
there was evidence of redundancy. A sixth interview was completed to ensure that
saturation had been achieved as described by Denzin and Lincoln (1998).
The study continued over a six month period after a pilot interview was conducted
to test the question and to assist the researcher in identifying areas that needed to be
rectified. As noted in Table I. the sample consisted of six women, ages 36 - 60 years.
One-half of the women had stage I breast cancer and the remaining three had stage II. All
participants were Caucasian and married; however, one participant divorced one year
after completion of her treatments. Five of the women had children, and all the women
worked outside the home. Their treatments had been completed from one to five years.
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Table 1. Participants
Name

Age at

Stage of Breast

Number of

Occupation

Diagnosis

Cancer

Children

Linda

48 years

Stage II

2

Owner Hair Salon

Beth

36 years

Stage II

2

Graduate Student

Judy

60 years

Stage I

2

School Teacher

Jan

49 Years

Stage I

0

Executive Secretary

Elizabeth

55 Years

Stage I

1

Business Executive

Susan

38 years

Stage II

3

Human Resource Associate

Participants
Each participant was very excited about sharing their experience of dealing with
their fatigue. The women conveyed the importance of sharing their story in hopes of
helping future breast cancer patients deal with the unrelenting fatigue they each continued
to experience. As listed in Table 1, the participants included the following:
Linda is a 48 year old married female who owns a hair salon. She described
herself as always being extremely healthy and was shocked when she received breast
cancer diagnosis. She is the mother of two children and has two grandchildren.
Beth is a 36 year old divorced mother of two children. She also is a graduate
student and continues to struggle with overwhelming fatigue five years after treatments
were completed.
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Judy is a 60 year school teacher, a mother and is married. She has two daughters
and three grandchildren. She was overwhelmed not only with the diagnosis of breast
cancer but the unrelenting fatigue that incapacitated her.
Jan is a 49 year old executive secretary who is married and has no children. Jan
described the fatigue as devastating, but admittedly shared she should have taken more
time off work because she did not function well.
Elizabeth is a 55 year old business executive. She is married and has one son in
college. She described the fatigue experience as “devastating……and three years later, it
continues to be devastating to my life”.
Susan is a 38 year old mother of three. She is employed by a Human Resource
Company. Although the fatigue was overwhelming to Susan, she attempted to
incorporate her family and friends into helping care for her.

Bracketing
Prior to the interviewing process of the patients, a bracketing interview of the
researcher was completed and the interpretive research group facilitated the bracketing by
discussing identified assumptions made by the researcher. One interview was completed
in order to “set aside” knowledge, proposed theories about cancer-related fatigue and
various assumptions about the phenomenon. The presuppositions and biases held by the
researcher about cancer-related fatigue are that it is the most debilitating symptomology
the cancer patient experiences. It is also believed by the researcher that the phenomenon
is multifactorial and impacts greatly on every domain of the patient‟s quality of life. It is
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assumed that cancer-related fatigue is so overwhelming that the symptom of fatigue may
be worse that the disease. It is also believed that unrelieved cancer-related fatigue leads
to depression and despair and reduces the patient‟s will to live. It is also the researchers‟
assumption that minimal interventions can be done for the debilitating symptom, and that
it is a most frustrating symptom not only for the patient but also for the family and the
oncology healthcare team.
Protection of Human Subjects
Permission for the interview was obtained after the patient had completed both
chemotherapy and radiotherapy. Since the debilitated patients were considered a high
risk population, ethical consideration was given individually for each patient ensuring
that if they were too fatigued to participate, they had the option to terminate their
commitment. Assurance was provided to the participant that confidentially was
maintained as they may voice discontent about their healthcare professionals for not
addressing their fatigue. In addition, the researcher respected the needs, rights, values and
desires of the participant (Creswell, 2009). With approval from the University of
Tennessee Institutional Review Board, participants were recruited from local community
support groups. An explanation of the study was provided to interested participants. If
the patient was interested, a consent form was completed, and an appointment was set up
to conduct the interview at the participant‟s convenience.
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Data Analysis and Interpretation
The data was scrutinized for meaning units and metaphors. The data analysis
proceeded through a methodology of reduction, the analysis of specific statements and a
search for all possible meanings (Creswell, 2009). Then major themes were clustered,
and the thematic structure was developed and refined. Subsequently, a general
description of the experience was completed by bringing together these transformations.
The thematic structure was submitted to the original study participants who determined
whether the overall findings were reflective of their own individual experience. Then the
findings were reported to the participants and the final report was completed (Thomas &
Pollio, 2002). Since validation of the findings occurs throughout the research process, it
is important to recognize the importance of rigorous implementation of this process.
Rigor of the Study
Since the premise of a phenomenological study is to search for understanding and
meaning with the consideration that no truths or facts are separate from the experience, it
is essential and logical to ensure rigor of the analysis of the phenomenological study.
Ensuring rigor of the study of cancer-related fatigue includes a vigilant and systematic
means of gathering the relevant data that are accrued from the interviews. In addition,
there is a disciplined interpretation of the transcripts, not only interpreting them
individually but also participating in the interdisciplinary phenomenology group that
meets weekly at The University of Tennessee College of Nursing. In the group meetings,
transcripts are read aloud, and tentative interpretations are offered. The perspectives of
group members provide alternative ways to consider the words of the text. Through the
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group interaction there is a confirmation of stable empirically derived results from the
interviews.
There is credibility as the study is carried out methodically while conducting the
interviews, collecting the data, transcribing and reviewing the data. Prolonged
engagement and persistent observation to ensure sufficient time to collect the data and to
understand the patient‟s perspective also produces more credible data. Additionally, the
interviewer was vigilant and methodical in conducting the interviews and reviewing the
transcripts and was available to be critiqued by the research team.
Dependability of the data was reflected as interviews continued to be completed
until there was evidence of redundancy. In addition, to ensure the established criteria set
up prior to the initiation of the study had been met and to guard against bias, an audit trail
was done to include the collection of the transcripts and a record of meetings to discuss
the transcripts. The group discussions about each transcript were recorded.
Validity was ensured by making sure the cancer patient‟s description about the
phenomenon of fatigue was reported as “convincing evidence brought forth in favor of
the description offered” (Thomas & Pollio, 2002, p. 41). The structure was similar from
the standpoint of the researcher and the readers of the interviews (Creswell, 2009).
Validation was confirmed by using the weekly interdisciplinary phenomenology group at
the University of Tennessee to review the transcripts and ensure the interpretation as
being valid and trustworthy. Members of this group had analyzed the researcher‟s
bracketing interview and were vigilant regarding any possible evidence of bias.
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The ultimate validation of a phenomenological study is its reception by the
professional community. According to Thomas and Pollio (2002, p. 57), “validity
depends on the significance of the information gleaned” and “how well it convinces the
reader of its accuracy” (Thomas & Pollio, 2002, p. 41). As Sandelowski stated: “validity
resides in the utility”; to be valid, it must be useful (Thomas, 2004, lecture notes).
Because the structure of the experience of cancer-related fatigue was identified,
transferability to other breast cancer patients may be possible. Subsequently, the goal is
to provide information which may be useful to healthcare providers in the clinical
practice setting and help them develop strategies to help patients manage their fatigue.

Summary
The phenomenological approach to studying cancer-related fatigue provides an
understanding, or the essence, of the unrelenting symptom. The outcome of the study is
to equip the healthcare professional to better understand what it is like for the patient to
experience cancer-related fatigue. With this understanding, strategies can be
implemented to improve the cancer patient‟s quality of life. It is important to study the
problem of cancer-related fatigue by entering the patient‟s world, seeing how they
experience, live, and display the cancer-related fatigue as well as learning how they
perceive the meaning of the experience of their fatigue. It is critical to understand from
the cancer patient‟s perspective what it is like to experience cancer-related fatigue and,
furthermore, what it is like to live with cancer-related fatigue and how it impacts on the
patient‟s quality of life. Although we may be unable to fully understand the world of the
cancer patient, with reflexivity and vigilance in the pursuit of qualitative research, we are
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able to interpret what the world is like for the cancer patient experiencing the
overwhelming fatigue if we are respectful of their language and story. It is hoped that
pursuing a qualitative approach in seeking to understand the phenomenon of cancerrelated fatigue, this research will speed knowledge development about this pervasive and
distressing phenomenon. Thus, the findings may lead to nursing interventions that can
enhance the cancer patient‟s quality of life.
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CHAPTER IV
FINDINGS
While the cancer patients‟ specialists continue their vigilant watch to prevent
recurrence of the malignancy post-treatment, patients share a totally different perspective
on their primary focus as they navigate through the cancer trajectory. They continue their
daily struggle of living with unrelenting fatigue, which impacts every facet of their lives.
The lived experience of ongoing fatigue during and post-treatment greatly impacts the
women‟s quality of life. These patients face profound physical, psychological, social and
financial challenges as they continue to live with the most common and distressing
symptom, fatigue, that seems to persist long after the treatments are completed.
We know that, for better or worse, cancer changes lives forever and in a multitude
of ways. For these breast cancer women dealing with ongoing fatigue, their lives have
been changed in dramatic ways, even causing some to question their identity. These
women question, “Who am I?”; “It‟s not my life anymore.” and “Where is my old self?”
Questions like these were foreign to these participants prior to receiving the diagnosis of
cancer. These women are married, have children, and work outside the home. They
were very active and employed full-time, either professionally or as owners of
businesses. They were very involved in their children and grandchildren‟s lives. These
working mothers also were very involved in their communities, not only being soccer
moms but some were active in church and school activities. Then there was a sudden
shock and disbelief of receiving the news: diagnosis of breast cancer. Immediately their
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thoughts focused on survival: “Am I going to die?” They also questioned who would care
for my family if I die? There also were fears surrounding the treatments, perhaps
including financial concerns about the inordinate costs of cancer care. There also were
fears of pain and suffering….”not that I am afraid to die, rather how will I die?” There
were concerns about dealing with the side effects of cancer treatment; however, these
were fleeting thoughts as they were self assured that the side effects were short-lived and
dealing with the symptoms would be well worth it to be cured of one‟s breast cancer.
Their healthcare professionals reinforced these sentiments; they assured the patients that
supportive care would minimize/alleviate the side effects from the therapies. This,
however, was not the lived experience for these women. Yes, their lives did
change…..never to return to the pre-cancer status of their life‟s course.
Figure 2. depicts the figural themes of the women‟s experience of fatigue. Before
explaining the figural themes, the contextual ground “Shadow of Death” will be
described. Dealing with the prevailing and profound fatigue has entrenched these
women‟s lives with an overarching sense of living in the “Shadow of Death” (the
contextual ground). Surrounding their daily lives are constant reminders of their cancer
and the sequalae of their treatments.
They search for meaning and freedom from being “exiled on an island with their
fatigue” and hope to regain some normalcy in their lives. Yet, as much as five years
later, these women struggle with the one symptom that connotes that “They saved my
life, but it‟s not my life anymore…..I am never going back to my „old self‟.”
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Figure 2: Contextual Ground of the Experience of Fatigue: Shadow of Death

The constant reminder of the “death of my body I once knew” is promulgated by
the treatments the women received. They conveyed that they were not worried about
their breast cancer, rather, the way the treatment made them feel. The treatments were
described as terrible and were characterized as “brutal and violent.” Their descriptors of
the experience were: “chemotherapy poisoned me,” “it robbed me of my body,”
“Chemotherapy was not my ally,” “Chemotherapy and radiation therapy beat me down.”
In the words of one participant, “My body knew chemotherapy had tapped every single
piece of me…there was nothing left of me.” They also resented what the treatments did
to their body as well as how it impacted them financially: “It wiped me out financially
and I probably will never recover!”
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The patients felt their bodies deteriorating as they dealt with the fatigue. The
effects were all inclusive: “Besides tapping on my whole body, it plays with my head
also.” In addition, they questioned the residual effects from the unrelenting fatigue:
“Since it lasts forever, does it increase my risk for a recurrence?” It is noteworthy that
these women conveyed a sense of appreciation for surviving this catastrophic event;
however, there is a lack of gratitude for the oncologists treating their breast cancer
successfully. As one patient shared: “I am grateful for the era (21st century) in which I
received my treatment, but I am coping with it for the rest of my life.”
While the completion of therapy is an important milestone in the successful
treatment of cancer, these survivors find themselves facing a variety of challenges as they
continue dealing with their fatigue. These women had confronted the stark reality of
possibly dying from their breast cancer. Fortunately, they survived without any
recurrences. Yet, though survived, they question, “Who am I?” They described
themselves:

I look like walking death and Frankenstein‟s bride.” Another patient described
herself as “scary with no hair, eyelashes, eyebrows…..my breast had been taken
off…..I was pale…..I was no longer a woman….I kept telling myself: “self, don‟t
think about it.”
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As another patient described her experience of “trying not to go stir crazy” it
becomes apparent that the patients had sensed a level of death as they viewed their bodies
differently and questioned their own destiny and identity.
Though the physical body was insulted greatly by the fatigue as they mourned the
loss of what the body was to what it is now, their world and their relationship with others
as they once knew it also was greatly impacted in the daily lives of these women. As
described by one of the younger mothers:

Living with fatigue is part of the weaving of the fabric of my life; while weaving,
it is never a complete tapestry….there are lots of holes and imperfections in the
weaved fabric…there are lots of unusual colors of thread woven in certain parts of
the fabric…some are pink…some are green….and they really are not part of the
selected threads to weave the tapestry. Yet, there is a common thread that runs
through the fabric….that common thread is the “Sisters in My Sorority” that
belongs there. These sisters understand me because they, too, are living with the
fatigue that impacts our daily lives in ways that I cannot even describe how
horrible the fatigue is (Beth).

These “threads” that appear to be woven throughout the fabric of the lives of these
fatigued breast cancer patients emerge as four figural themes. The themes are: “Being
Alone in My Cave,” “Coming Out of the Cocoon,” “It‟s a Lost Fight,” and “Who am I
Now? It‟s Not My Life”
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Themes
Theme One. “Being Alone in My Cave”
Participants described overwhelmingly loneliness and despair experienced during
their fatigue, and these feelings served as reminders of how sick they were. Their fatigue
made them feel “insecure, dependent, self-doubting and incompetent.” They felt “beaten
down” and “kicked in the butt” and made to feel that a “Mack truck had run over me” as
well as being “rammed into a brick wall.” They often described the fatigue as the “walls
were coming down” and “it made me stop in my tracks.” There also were feelings of
“insecurities, ineptness, guilt, helplessness, defeat, worthlessness, incompetency,” and a
sense of “being out of control.” Coupled with these overwhelming concerns, patients felt
their fatigue was not fixable because it made them feel horrible. Additionally, women
reported that their healthcare professionals did not assess their fatigue nor did they offer
assistance when the patient mentioned their fatigue.
The unpredictability of the fatigue often made the patients cry and “feel bummed
out.” Because of the sense of “permanent exhaustion” the patients felt a sense of “doom
and gloom”…sensing that death had occurred to a part of their life. There was a sense
that “I should be doing better” but there was an “on and off switch” that impeded the
patients doing anything other than vegetate. There also was a sense of “being on a roller
coaster” with the evolving emotions precipitating “sadness, disappointment and
depression.”
Participants reported sleeping the majority of time. Their sleep patterns varied
widely; some patients slept a two-day stint and others slept eleven days at one time. One
91

patient described “Getting chemotherapy on Monday and waking up on Friday.” When
they were not sleeping, they described the fatigue as “making me just sit and stare at the
wall” or the “fatigue was so overwhelming it was indescribable.” They also described
“going to my cave as I was down for the kill.” The majority stayed in bed the entire time
while undergoing treatment, whether they were asleep or not; it was their way of “dealing
and surviving the ordeal.” They voiced concern that often they were so exhausted that
they were “unable to talk, eat or even keep their eyes open.” They often became angry
with their family because of their exhaustion:

I was angry with my three-year-old daughter because I was so exhausted; all I
wanted to do is sleep. I would put a movie in DVD player and hoped she would
be entertained while I slept.

Most patients described receiving their chemotherapy and “staying in my cave”
for several days until they felt better. While in the cave, time surfaced as very important
to these women. The fatigue was described as “lasting forever; it seemed like an
eternity.” Days were described as “like a million years” and “nights were even worse”
with darkness being described as “being in a tunnel” and “even getting in and out of bed
took me a half day.” Some described the exhaustion as being so overwhelming that “I
knocked myself out most of the time”; “it lingered on and on and I could not shake it.”
It is noteworthy to appreciate these women never felt normal as their lives
evolved from being “a normal working mom” to a woman dealing with fatigue on a daily
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basis…this became commonplace for them. They always felt their life had been taken
away from them because of the unrelenting fatigue. They described feeling that “I will
never return to normal; I feel defeated, it is a lost fight.”
The women also retreated to their cave because of their disappointment in self.
They sensed their body being recalcitrant as they described “my body not responding and
not holding up its part of the deal.” Mundane physical activities became overwhelming
as one patient shared, “It was a huge effort to crawl into my recliner; I had expectations
of myself but could not do them because I had no energy.”
The world became restricted with the women retreating to their caves. The
narratives of the women reflected loneliness and despair as they moved to their caves: “I
wanted to be alone; I cried when I was alone; my bedroom was my cave.” Linda also
related, “I didn‟t care…I was in my cave and I would sit and stare…I just wanted to
forget it…I needed space from other people.”
The existential ground of “other people” also became restricted as the women
described “feeling totally alone with no one there to help me through the ordeal; it was
my battle and I felt closed off from my family.” It also affected the family system as
Susan and Linda described, “being removed from family and friends and sensing a
terrible heaviness and burden to carry all the time.” They also shared a sense of
frustration that they were unsure others recognized how badly they felt.
Participants also “felt out of control” in everything that happened they had “no
control of the situation.” In many ways that felt robotic as they described “having an on
and off switch” and “I had a „turn off‟ mode, and my family knew to leave me alone so I
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could get plenty of rest.” They also felt out of control emotionally as the young mother
described her fatigue: “The more fatigued I became the more moody I became….I would
eat people for lunch and then feel very guilty about it.”
The patients viewed their fatigue as a “permanent visitor” and as “a new way of
life.” In essence, the patients summarized the fatigue as “changing my life; it is not the
same, not in any form or fashion as it was before, not physically, emotionally, spiritually,
socially or financially.” To deal with these life-changing events, often their only recourse
was to retreat to a quiet place, “being alone in my cave.”
Theme Two. “Coming Out of the Cocoon”
As the overwhelming fatigue began to lessen, the patients described beginning to
engage in the outside world, though they were trapped in bodies that were not working
as they would have liked to participate in life. As they began to integrate back into
“being a human being again,” they described the experience as “coming out of the
cocoon.” They were the first to admit they were not fully recovered as one patient
shared, “I still felt subpar, I was below baseline.” While functioning minimally, they
were nonetheless elated to begin integration into society. Often they described looking
for “small windows of hope,” such as watching children get off the school bus or
listening to birds singing. Beth even questioned how fatigue had affected her motivation
in some activities as she described:

Feeling warped because I „enjoyed‟ going for my chemotherapy treatment
because someone was taking care of me without me having to ask for
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everything…it also was the only time that I could rest for 4-6 hours without
feeling guilty that I couldn‟t do things….it was a respite for me….I didn‟t feel
incompetent during this time.

The patients recognized their limitations as they transitioned into previous roles.
One patient described feeling like a “rubber band…I made an effort to help my son with
homework, but I could not do it….I kept bouncing back like a rubber band into my wiped
out mode.” Others described the ongoing fatigue as “a wave…my body wants to move
forward and in doing so, it is washed back…..I just wanted it to move forward but the
waves kept getting bigger and bigger and pushing me back.”
Quickly the women recognized that increased time was required to complete
minor tasks. One patient described the feeling as “being in catch-up mode all the time.”
Another patient, Linda, described, “It‟s taking me five times longer than normal to
complete things.” Even completing personal hygiene was difficult for the majority of the
women. Some stated they were unable to complete simple tasks, such as shampooing
hair, and others shared that an inordinate amount of time was required to shower because
they had to sit down and rest several times before they were done. Three women shared
that after showering they slept for the rest of the day.
The women discovered that their level of enjoyment had changed while they were
hibernating in their caves. One patient described the change as “What typically was
pleasurable or comforting….now it is a burden or energy draining.” She continued by
sharing the example of always enjoyed attending her children‟s soccer games but found
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them to be overwhelming even if she only attended the game and skipped the pre- and
post-game activities. Another patient related an instance of taking her niece to an
amusement park they visited frequently; while there, the participant became so
exhausted she could not pick up her foot to take another step; subsequently, she lay on a
bench in the park for several hours while the family enjoyed the activities. Other patients
felt it was not worth “getting dressed and going out” as it demanded too much energy.
Though the fatigue persisted, women exhibited fortitude and tenacity. One of the
participants, Linda, shared that though she could hardly walk into the grocery store with
her husband, “I refused to ride in a cart.” She also shared how “peering through the
window panes” helped her to have hope; however, though she was becoming integrated
back into the world she still removed herself from being active in the world. Examples
cited were taking a ride in a car and watching the children get off the school bus or
driving along the street enjoying the beautiful spring flowers. She also enjoyed doing
mundane activities such as riding to Wal-Mart and the drive-in at Sonic. Her appearance
was extremely important to her; therefore, she did not get out of the car as “I looked like
death warmed over.” She protected herself from the world, at the same time peering into
it…..through a “window of hope”.
In the throes of what they perceived as being “permanent exhaustion,” these
women conveyed an inordinate level of motivation and persistence. They described
having layers and levels of being tired. They shared how they kept peeling the layers off
to find that fatigue was still there. Once the last layer was removed, there was a huge

96

disappointment to realize the fatigue was “lingering on” and sadly they admitted, “I never
knew how tired I was until I dealt with this unforgiving exhaustion.”
Even in the midst of “being wiped out with fatigue” those who spoke persevered.
Jan shared:

My boss depended on me; I am unsure he could do anything without me. I
somehow drove to work totally exhausted, walked into the office, collapsed at my
desk and sat there all day. I think he knew I was wiped out; so he assigned my
work to my colleagues. The only thing I had to do was answer the phone….I
could not even pick up the phone…..it was too overwhelming. I only missed 29
days of work during my treatments; in all honesty, I should have not worked at all
because I didn‟t feel like it.

Though the interviewed women continued to work, there was a sense of “not
caring” about the quality of their output because they felt so exhausted. One of the
patients, Judy, shared that in the past, when she assigned her educator colleagues to help
with a project, “I am standing over them like a hawk ensuring that everything is perfect.”
In contrast, she admitted, “While I was undergoing chemotherapy I would pass projects
off to them and never checked with them to ensure everything was going OK because I
really did not care!”
As the women “transcended from the cocoon” there was a sense of disconnect.
Beth shared that she felt disjointed and there was:
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A separation of my body and me…..I didn‟t feel like myself….I am struggling to
regain but no matter what I do, I am unhappy with myself…I am very
disappointed that self will not do anything…I wanted to cook but I was too tired
to even think about it.

Others questioned how this persistent fatigue had overtaken their body. They
conveyed feelings of “what once was” to “what it is now.” They shared, “How can this
be happening to my body?” Judy shared, “I have always been extremely motivated,” a
“workaholic”, a “big driver,” and proud that I could multi-task while teaching in high
school and caring for my family.

A subtheme that emerged as these women were reintegrating into their roles is
“the desire to but cannot muster up the energy to do.” Several of the women shared
stories of their attempts to participate in activities that were “near and dear” to them. A
young mother, Susan, shared her disappointment in being unable to shop with her
children at Christmas. She continued:

It was Saturday morning and we all were so excited about shopping…I attempted
to get out of bed and my body would not budge…I attempted again to no avail…I
spent the entire day in bed crying…
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Normally, I sang in the choir…I could not sing during the Christmas Cantata
because I felt that I was drawing attention to myself as my choir colleagues were
so concerned about my energy level…they thought I would literally crumble to
my feet during the performance!

The women who spoke were proactive in attempting to manage their fatigue as
their body attempted to recover. Elizabeth described frustration in trying to exercise to
reduce her fatigue:

Walking, as I understand it, helps those of us who are fatigued….let me tell
you….when you are so exhausted you cannot even think…..exercise is not
possible…..I tried real hard to walk everyday and I crashed every time.

Even doing activities to enhance one‟s sense of well-being seem to minimally
improve their fatigue. Another patient shared: “I tried to feel better by getting regular
massages but I was still tired when I finished; it may have taken the edge off a tad, but I
still was just as exhausted.” Others described that no intervention helped them: “Nothing
helped the fatigue…I mean nothing overcame it…I progressively worsened at times and
had to go back into my respite spot, my bedroom.”
Most, even while attempting to recover from the fatigue, described it as “being
overwhelming in every aspect of life….even eating out…..shopping…it was a
disaster….looking at racks of clothes, trying to figure out the correct size, color…..I just
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could not do it!” Though they left their cave and emerged from the cocoon, life and
living had changed dramatically….and the majority stated that perhaps for a long time.
Theme Three. “It’s a Lost Fight”
There were significant and major losses identified among the breast cancer
patients as they dealt with their persistent fatigue. They lost their freedom, as they could
not make choices because of being too tired. They had no drive to fight their cancer, as
typically one would expect in an oncology patient. In fact, “this permanent visitor called
fatigue” had caused them to lose control. The fatigue impacted every facet of their life,
including physical, mental, emotional, spiritual and financial aspects. No matter how
small the task to complete nor how hard they worked to accomplish an assignment, they
did not succeed. In other words, it seemed their “losses” filled their days with
disappointments and despair. The fatigue seemed sequential and eternal as the patients
worked to overcome the challenges. The losses were so overwhelming this major theme
is foundational to all other identified themes. Because of the prevalence of the losses,
subthemes emerged and are identified as: “Loss of Body,” “Loss of Brain Function,”
“Loss of Control,” “Loss of Family Roles, Work, Financial Status” and “Loss of
Precious Moments in Time.”
Subtheme One. “Loss of Body”
The women graphically described how riddled their bodies became as the
treatments usurped every tiny molecule of energy their body produced which resulted in
only “gas fumes in my tank.” They described themselves as having no energy, not
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enough to open their eyes or to lift a glass of water from the bedside table. One patient
shared: “I had no energy to talk; I didn‟t even want to think; everything required more
energy than I had; I didn‟t want to do anything.”
Another patient described not being able to function: “I was so exhausted I could
not even make a grocery list for my husband.” Yet another patient described the fatigue
as “unbearable”; “it is really extreme”; “I planned a Christmas party and my family had
to do everything….I could not even mail one Christmas card.” Their lack of energy
caused them to be unable to participate in activities with their family, including dining
with their loved ones at mealtime. The majority of the patients preferred to “remain on
the sofa rather than eating…that‟s how tired I was.” They admitted to consuming
minimal food, as the fatigue was so severe, “it took my appetite away.”
They viewed the body as betraying them and being left with a recalcitrant body
that could not be controlled; it made “me feel like I was not even a woman.”
One patient, Beth, stated:

My body said: you can push me so far and then I am shutting down…This
prevailing tiredness caused an “extreme heaviness on me…I felt like I had twenty
pound weights on my extremities.

The patients also were concerned about long-term effects of the fatigue and whether it
potentially increased their risk of a recurrence. Beth continued by questioning:
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How incompetent is my immune system? ...I am so afraid of succumbing to some
overwhelming infections because the fatigue has affected their immunity
big time.

Their bodies not only deceived them but their independence was taken
away causing them to feel “helpless and defeated.” They also felt worthless because their
“permanent exhaustion” interfered with their completing their normal activities. Not only
did their bodies fail them but not matter how hard they tried, they could not overcome the
fatigue. They talked of struggling to fulfill their role as a mother, to complete an
important project at work or to drive to the grocery store. One of the patients, a student,
shared that her exhaustion caused her to fall asleep in class. She continued by stating she
pushed herself, and it required an inordinate amount of effort just to make it through
class.
They also experienced ambivalence about their bodies, especially when their
bodies failed them. One of the patients described “loving my body at times, and at other
times I wanted to leave it…all I got out of the treatment was this fatigue…I cannot
determine whether the treatment was worth it…my body is not holding up its end of the
deal.” Another patient stated: “I am very disappointed because self will not do anything.”
Because of the overwhelming fatigue, the women were emotionally exhausted.
Their fatigue was onerous; there was nothing that either helped nor was anything
pleasurable in life, mainly because they were constantly fighting to overcome their
tiredness. They admitted to struggling to become happy but were unsuccessful in
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achieving this goal. They also shared that many of their feelings were kept secret
because “no one understood me.” In fact, one of the patients admitted to “being lost and
having no feelings.”
It is paramount to appreciate that no matter how much energy was exerted by
these women in an attempt to complete tasks, all failed! Their failure to perform
activities precipitated more feelings of self-doubt and defeat. In addition, their inability
to remain active caused them to feel guilty, worthless, and helpless as they became
weaker. They described these feelings as making them feel “stuck” and realized that “no
matter how much mind over matter you tried to do you couldn‟t master it,” Susan shared
a story of how her husband attempted to improve her well-being but did not help her:

Bob played easy listening music to help me relax. The lit candles were nice but
really didn‟t help and neither did the lavender bubble bath. Even with these
niceties I still was too tired to sleep. I couldn‟t concentrate on TV or reading…so
I would lay and stare at the walls.
Subtheme Two. “Loss of Brain Function”
The impact of the cognitive changes these women experienced during and posttreatment affected them immensely. In fact, all study participants spent more time
discussing their fears and concerns about changes in their memory than all other issues
combined. These changes affected their decision-making and problem-solving ability as
well as made them question their confidence, competence and self-esteem. Several of the
women described themselves as “going crazy because I could not remember,” and found
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these changes to be very frightening. Cognitive impairment impacted greatly on their
quality of life. Not only did it affect them physically but also emotionally, socially and
financially. Beth shared:

My thinking was affected big time…I was and am in a fog and I finished all my
treatments two years ago…to this day, I blame my memory on chemotherapy.

Another patient, Elizabeth stated:

Oh, it is really scary, that‟s scary because I‟ll think of one word but sometimes
another word comes out. My friends always try to make me feel better by saying,
“Oh, we can‟t think at times either.” But honestly, I think it‟s really, really worse,
I do. And sometimes it scares me, I think, oh my gosh, I think I‟m in early
Alzheimer‟s. I think my husband recognizes it too; he never says anything. I am
losing my keys often and he just quietly starts looking for them and when he finds
them he doesn‟t say anything…I remember the first time I wrote a contract after I
finished chemotherapy. I ask my co-worker to check the document because I was
not sure my thinking was good enough to do something so important. So I really
lost confidence doing everything, even driving. It took me several months to start
feeling more confident enough to drive, even locally, and two years later, I am
still uncomfortable driving out of town, though I may be familiar with the area I a
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going…..its like I don‟t have a recall of places I used to drive to all the time.

Beth shared the changes in memory that affected her greatly, especially while attending
school:

My eyebrows and eyelashes started to grow back and I kept thinking, OK, you
ought to feel good…and it would be, you tell me something and if it didn‟t have a
long-term memory attachment to it, I couldn‟t remember…and sometimes just
trying to remember stuff, I became exhausted…like studying for an exam…I
shoved information in my brain and it wouldn‟t stay…like I have taken the
Graduate Entrance Exam three times and cannot pass it…I have problems with
holding on to memories, remembering to go to grocery store to get milk…to, to
try to remember all that was exhausting….it was like mental fatigue…And it is
scary, if I already have all these memory problems at my young age, what will I
be like with age dementia?...So I am already doing things that stroke patients do
to remember…like making checklists in the morning. I find myself asking, “What
has happened to my neurons?...What have these drugs done to my brain and how
can we train my neurons to hold on to information again?...What happens if my
body doesn‟t rejuvenate…its not functioning like it did before they dumped that
entire toxin inside of me…If we hadn‟t done it, there may be a chance I wouldn‟t
see my daughters walk down the aisle…So I‟m not saying I shouldn‟t have done
what I did…But there‟s a level of, was it worth it when I think how it has affected
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my memory.”

The patients describe their daily activities being affected by everything “slowing
down” with their thought processes being significantly affected. They often described
cognitive effects from the chemotherapy and coined the term “chemo brain” because they
felt “fuzzy about details” and “everything was hazy and blurred.” They shared that the
brain only “functioned partially at times.”

Another patient, Susan, shared how difficult her daily life was dealing with the
“chemo brain”:
There were things I could not think through…even a menu…I couldn‟t think
through what to do once I got to the grocery store….I would just wander around
for an hour and finally go home without groceries…It definitely affected my
thought processes…It made it real hard to think all the way through things…Most
of the time I could think but I had to do it more methodically, more
deliberately…much more slowed than before…it was terrible… It was like I was
always looking through a fog…So, you really had to concentrate on who‟s talking
to you and what they‟re saying to you….otherwise you would get lost.
It wore me out to concentrate…I couldn‟t think through long enough to help my
children with their homework…My mind would get tired…To really describe the
true impact of my fatigue is impossible…I couldn‟t concentrate long enough to
read a whole book…I ended up reading short stories, devotion books, Reader‟s
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Digest…After reading the last chapter in a book, I couldn‟t recall how the story
ended…I couldn‟t even concentrate on watching my favorite TV shows, not even
commercials.

Not only were their daily activities affected as their cognitive status continued to
change, some of the patients shared experiences of having total lapses of memory. Judy
shared the following story of her family planning their traditional Christmas party in
which they invited several family and friends. She recalls being totally exhausted though
she rested throughout the party. Several weeks after the holidays were over, her husband
shared the photographs of the party. Judy questioned the taking of the photographs. Not
only did she have no recall of photographs being taken, she did not remember having a
Christmas party! Other patients shared driving to and from their physicians‟ offices and
not recalling how they got home.
The women discussed the difficulties with having memory problems. They
described themselves “as looking ok” but, instead, they shared they were so exhausted
they could not think. They also described as “getting lost because I was trying to
think…it was too fatiguing to think...I could not focus; I was at a level where I
consciously had to think about thinking, such as holding on to a thought.” The only way
they managed their memory problem was to make lists, even to manage their doctor‟s
visits. One patient graphed her lab values and test results as she felt that was the only
recourse she had “to keep things straight in my mind.” They continued by sharing how
they “felt like I was going crazy because I could not remember things.” Several shared
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that their body was not as tired as the mind. Others described not feeling coordinated,
coherent or connected. It was hard for “words to come….I did not want to think…it was
too exhausting.”

Subtheme Three. “Loss of Control”
The patients perceived that the chemotherapy administered for their breast cancer
violated their bodies in many ways. As a result, their body‟s integrity was not intact and
had resulted in impacting various aspects of their life. They lost control of their body,
their relationship with others, their ability to fulfill previous roles as well as their inability
to complete their job responsibilities.
First, they lost control of their bodies. The women described their bodies not
functioning properly by stating, “My body does not respond and it is not holding up its
part of the deal.” Another patient remarked: “My body says I am shutting down because
I have pushed me too far.” “There was desperate isolation and betrayal by my body”
shared another patient. “I am very disappointed that self will not do anything.” As
mentioned previously, regardless of how committed these women were to “making their
bodies work” they were unsuccessful. They pushed themselves, trying to fight the
overwhelming fatigue. They also restricted what they did in order to conserve energy.
They activated the self-protective mechanism by choosing not to think and trying not to
feel guilty when they did nothing other than rest. As the body continued to deteriorate
with the unrelenting fatigue, it seemed the body became foreign to self and further
promoted the sense of living in the “Shadow of Death” as their bodies became
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recalcitrant and subsequently lost control of the body they once knew. One patient
describes the change as: “It is a new way of being…where is the old self. I thought I
would return to my old self but it is gone.”
The loss of control in relating to families and friends is a significant area of
concern for these women. Inability to maintain relationships and fulfill roles and
responsibilities greatly impacted how these women perceived their well-being. Ms. M.
related:

I had a hard time doing things with my children…I struggled with that all the
time. My family and friends had a hard time adjusting to my level of
energy…They also were bothered that my alertness varied. I dealt with that by
removing myself from them….I needed space in order to deal with this…I could
not go out with family and friends…it was so frustrating.

One of the young mothers shared her feelings:

My mother role was removed…my total life was disrupted…My husband became
mother and father…It impacted my entire family…that was very upsetting to me
because I could not participate in outings with my family because I was a party
pooper.
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Subtheme Four. “Loss of Work, Family Roles, Financial Status”
The loss of various roles, responsibilities and time impacted greatly on this group
of women. As their fatigue worsened their identity was affected as they relinquished their
roles as mothers, wives, daughters, sisters and friends. Their relegation to a nonparticipative role in social activities with family and friends further ostracized them.
Subsequently, they retreated to their cave. These feelings of isolation and guilt were
apparent among all women as they described the various losses they experienced.
Elizabeth shared the following:

Being the only daughter in my family, I was used to taking care of other
people….now my role has changed…people are taking care of me. That made me
feel badly. My fatigue affected my family system…it affected everything and
everyone. It was a terrible heaviness and burden to carry all the time.

I tried to make myself feel better snuggling with my three-year-old daughter
because I felt so alone. At the same time I needed to sleep because I was so
wiped out but felt very guilty about it. I could do nothing but sleep. I couldn‟t
come to the table to eat. I needed to be fed for physical reasons but the aura part
of me needed to be fed also. The fatigue made me sad and disappointed. I could
not do things I enjoyed with my two daughters, agrees three and six. It was hard
to give these things up. I struggled with that constantly. I was so alone…I often
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went to my cave.

Work and school continued to be very important to these women. Though they
admitted to not feeling like continuing employment/attending school, they displayed a
tremendous fortitude in remaining committed. Each of the women modified their work
schedules to accommodate their days of not feeling well enough to work full-time. Their
employers were extremely supportive of providing a flexible schedule as well as reducing
their workload. Unanimously, they acknowledged their work performance as being
“lackluster” and “only going through the motions of work.” Admittedly, they did not
care their performance was below average because the fatigue was so consuming.
The fatigue experienced by the women also impacted their careers negatively.
One patient has been unable to complete graduate school; therefore, she has taken an
inordinate number of student loans out in order to work toward a degree so she can
become gainfully employed. Another patient shared that her ongoing fatigue has
incredibly affected her financially. Elizabeth related how difficult the financial impact
continues to be:

My fatigue impacted my work tremendously…I think that year I was on chemo, I
think it was probably going to be one of the best years that I ever had in my
business because of my referrals…So I just knew that I could not meet with
clients and show houses when I was so fatigued…There was just no way…So I‟d
have to refer them…Then to make things worse, my referrals stopped from three
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different companies… They went overboard not wanting me to have
customers…not wanting to send me customers because I was going through this
process…And everyone said, “Well, you know, the most important thing is for
you to get well”…well of course it was…but financially its, its devastating…So,
since being diagnosed with breast cancer it has been my fatigue that has
financially impacted me unbelievably…It has been absolutely devastating, and it
is devastating to this day…I will never recover from it!

Another patient, Judy, related how being unable to work full-time affected her:
I think I have pretty high-esteem, but the fatigue almost makes me feel worthless
because I had just always worked, and all of a sudden, you know, I‟m not
working…So it makes you feel like you‟re supposed to be doing something but
you don‟t know what it is that you are suppose to do…Because, I think in this
particular business, you have to kind of keep that going, and I would be so tired
sometimes you just don‟t care. I just didn‟t care whether I met with a client or not
because I was so zonked.

Subtheme Five. “Loss of Precious Moments in Time”
The inability to recuperate time lost during the periods of overwhelming fatigue
was paramount in the minds of the women interviewed. The memory of losing precious
time with loved ones was almost unbearable to the majority of these patients. They spoke
candidly about the difficulties, even today, they confront while realizing they lost huge
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“chunks of time”….time that is irretrievable. Their words reflected sadness and regret as
all five women‟s narratives conveyed:

I lost lots of time…..time that was very special to me….it is time I will never get
back. But at the time I was so exhausted I really didn‟t care what I was missing.
There are many regrets but there isn‟t anything that I can do to make it different.

I lost one year of my life…that is really bothersome to me because I don‟t recall
my grandson being born and the first year of his life…That saddens me
tremendously.

Another patient, Susan, shared:
I lost six months of healthy living…Not only that, I gained 45 pounds staying in
bed all the time…So that really made me feel even worse about how I look.

Theme Four. “Who Am I; It’s Not My Life”
Over time, the breast cancer patients initiated the transition from their “cave” into
the “cocoon” as they revivified into a person who had undergone an incredible
metamorphosis. As a result of the major insults to the “old self” (pre-cancer treatment
state) to the “new self” (post-cancer treatment state) these metamorphic changes have
emerged as major changes to “who the present person is.” Undeniably, these women
shared stories of how they searched for the “old me”… never to find her. The changes
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that brought these women face to face with their “Shadow of Death”, and to face the
“new me,” were precipitated by the major losses engendered during their tenure of cancer
therapy. Not only did they lose attributes of their body and its functioning, but they also
lost what they considered major: loss of brain functioning. To further add insult, they
also lost control of their life as well as their work, family, friends and financial security.
In time, these women recognized they never would be the person they once were. They
talked about “then and now” and “before and after.” They acknowledged they would
“never be returning to me.” Life as they knew it was over. They searched for the old self
and finally acknowledged that “my life was saved but it‟s not my life anymore.” Their
perspective about life correlated with Heidegger describing “being thrown into the
world” which involves redefining the self (the patient) as living with fatigue and wanting
to be the “old self” again. The person and the world ”co-create” each other (Heidegger,
1962).
These women stressed that it is impossible to really describe the pervasiveness of
the fatigue and how it impacted their lives. They described the fatigue as a “permanent
visitor.” Admittedly, their words richly conveyed their sentiments though they are pale
compared to how they lived their lives from day to day as they dealt with this devastating
symptom. Several patients shared the following:

Before, I had a purpose. Now I am uncertain I know who I am. I finished my
treatments about 13 months ago and to be honest I am still exhausted. At first I
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thought once these treatments are over I will be my old self again and so far that
has not happened at all. I still have the fatigue today (Elizabeth).

My life was saved but it‟s not my life anymore. I am still stuck and it makes me
feel worthless because I don‟t have the same stamina I once did. I finished my
treatments two years ago and I still have significant fatigue (Linda).

There is no return to normal for me. I still don‟t have the „good energy‟ I used to
have. I have learned to adjust to a new way of life. I have to be more disciplined
and think about everything I do so I can conserve my energy for things that are
important (Susan).

Life is not like it used to be…not in any form or fashion…not physically,
emotionally or spiritually. My old self is gone. I question what others expect of
me since I have a new self. I am convinced I will never go back to my old self
(Beth).

The patients conveyed a sense of not recognizing their body as they talked about
the “new me.” Not only did they not feel “like a woman” because their appearance had
changed but their roles had been relinquished to family and friends. The majority of the
patients felt they never recuperated the life they once enjoyed. They described their body
as an “object for others” and the “dark night of the soul”; the “body for others”

115

disappeared at night, and they were able to become their “self,” especially as they
retreated to their cave and dealt with the “Shadow of Death.”

Summary
The four themes that evolved from the richness of the words the breast cancer
patients shared about their debilitating fatigue evoke an overwhelming sense of isolation,
despair, disappointment, and a subsequent sense of living but losing one‟s life as it once
was. The fatigue experienced by the women was abrupt and incapacitating in every
aspect of their life, including physically, emotionally, psychologically and financially.
This devastating symptom caused betrayal of the body, role changes, both personally and
professionally, as well as permanent adjustments to how their future lives will be lived.
Because of the overwhelming sense of their body reverting to a survival mode of
being “alone in the cave,” these women experienced a sense of exile, “being on an island
by myself.” In time, often described “as feeling like a million years” elapsed, these
women began to emerge from their morphologic state, “coming out of the cocoon,” to
discover an overwhelming life full of losses. The losses were overwhelming and
devastating to these women. Not only did they lose their bodies to the fatigue but also
their focus, memory and ability to concentrate. As the patients moved from
disengagement to engagement they also discovered that there was loss of control. In other
words, the “fatigue is not fixable.” No matter how much one places “mind over matter,”
the fatigue cannot be mastered. Therefore, it becomes a “permanent fixture” in these
women‟s lives and affects every remnant of their life.
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As the body transforms and adjusts to the many changes in their life, the women
quickly understand that their lives have been changed permanently. Often they
questioned, “Who am I now?” and “What is the meaning of my life?” As they surveyed
the many changes in their life and made subsequent adjustments in their personal and
professional life, there was a major question ensuing: “What is the meaning of my life
now?” For all, the fatigue seemed permanent, and adjustments in their life appeared
challenging. Roles changed, traditions were altered, and professional responsibilities
were adjusted to accommodate their fatigue. Admittedly, the patients continued their
adjustments to the losses on a daily basis. The greatest challenge they faced each day
was living in the “Shadow of Death” and questioning who they were as they adjusted to
the new life cancer and cancer treatment had handed them.
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CHAPTER V
DISCUSSION
The purpose of this study was to understand the meaning of the fatigue
experienced by breast cancer patients who had undergone chemotherapy and
radiotherapy. Utilizing a phenomenological approach based on the works of MerleauPonty, the researcher conducted six interviews with stage I and stage II breast cancer
patients who received both chemotherapy and radiotherapy post-mastectomy. A
bracketing interview was completed prior to the interviews with the patients to identify
the researcher‟s preconceived impressions and suppositions. Each patient was asked to
share their experience of living with the fatigue that occurred during and following their
cancer treatments. Each interview was audio-recorded and then transcribed verbatim.
Each transcript was analyzed using a hermeneutic method developed by Pollio (Pollio,
Henley, & Thompson, 1997) and then brought before and reviewed by the Interpretive
Research Group at The University of Tennessee chaired by Thomas and Pollio (Thomas
and Pollio, 2002). Each transcript was studied and reviewed with the interpretive process
using the part-to-whole method as well as within the context of all the interviews with
subsequent themes identified throughout the documents.
The interviewed patients described the meaning of fatigue they experienced
during and after the completion of chemotherapy and radiotherapy. Their treatments had
been completed from one to five years. Interestingly, all the patients continued to
experience the fatigue, regardless of the time lapse since the completion of their therapy.
During active treatment, the fatigue was more acute and more overwhelming; however,
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with time, the fatigue lessened to some degree, but remained a constant reminder of their
cancer and treatment sequelae. It is noteworthy to recognize that the patients had an
immense recall of the experiences and continued to converse about the residual fatigue
that persisted long after their therapies were completed. Obviously, this connotes a
significant meaning attached to these experiences as they vividly shared the major
changes that occurred in their life secondary to the unrelenting fatigue.
The majority of the focus was on the impactful side effect of the therapy causing
this persistent fatigue. The discussion centered around the effects of the fatigue on their
body and mind with significant losses of control as well as negative effects on family
roles, work, finances and quality of life. Additionally, they shared how the fatigue had
affected them personally, especially the effects on their body as well as the significant
losses experienced from the fatigue. The end result is a major and persistent insult to
their recalcitrant body that consequently cause the patients to question who they are, as a
person, and will they ever return to their “old self.”

Relevance of Study Findings to Phenomenology of Merleau-Ponty
Human Experience of Human Body
The body of the cancer patient is viewed through the world of major changes in
body image as effects from the disease and treatment have played havoc on the integrity
of the human body. Because of the many body image distortions, the patients‟ self
perception of their body is often devastating to them as they potentially have lost major
body parts, such as a breast, as well as body functioning. These feelings of loss are often
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intensified in the patient who is dealing with cancer-related fatigue as they are unable to
manage the side effects of treatment and deal with their losses due to the overwhelming
fatigue. This disabling phenomenon also is overwhelming to the patient because of the
fatigue often being equated with that they are doing poorly and thus reflects a poor
prognosis.
In addition, the cancer patients‟ life world is virtually restricted to their body
experiencing the overwhelming fatigue. As such, this pervasive fatigue affects every
facet of their life including their world and the people within in their world. As described
from Merleau-Ponty‟s perspective, the element of time and the non-human world are also
affected. Each of these perspectives will be described in the forthcoming section.
The Experience of Other People
The “human experience of other people” becomes an extremely important topic of
interest when studying the phenomenon of cancer-related fatigue. According to Thomas
and Pollio (2002), when significant relationships are lost, feelings of loss and defeat
manifest. The breast cancer patients‟ social role enactments are affected greatly when
fatigue is present. Though the patients fully understands their role and wishes to fulfill
that position, whether as an employee, a mother, a wife or a friend, they may be unable to
fulfill that because of the incapacitating fatigue. The fatigue affects the three domains of
role performance as they may be unable to meet the mutual goals of role for themselves
as well as others. The fatigue also affects how the breast cancer patient will feel about
their body when they are attempting to move to enact their role. Because of the lack of
energy manifested with the fatigue, often the patient cannot physically enact the role. In
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addition, Merleau-Ponty proposes that there are important benefits to connecting with
other people and suggests that reciprocity exits. Unfortunately, because of the fatigue,
often these women are unable to connect to the people important in their lives. As a
result, lack of fulfilling their role and being unable to connect socially may lead to
depression, despair, isolation and a fading will to live.
Human Experience of Time
The “human experience of time” is a critical aspect of the breast cancer patient‟s
life. Merleau-Ponty proposes that we look at the past and anticipate expectation of the
future. The fatigued breast cancer patients‟ perception is skewed by the meaning of what
their life was like prior to the fatigue and perhaps what it will be in the future (Thomas &
Pollio, 2002). In addition, time becomes paramount in their lives due to the fear of dying
because of the disease being incurable. Often the cancer patients views their lives from a
Heideggerian‟s perspective in that the meaning of time from a futuristic point of view is
with certainty. They are well aware of their morbidity and recognize they may die from
their disease (Thomas & Pollio, 2002). This overwhelming sense of doom and gloom is
exacerbated in patients who are experiencing the incapacitating fatigue.
In addition, the experience of time is greatly affected in the breast cancer patients
with fatigue who are experiencing cognitive dysfunction. Both clock time and lived time
become important as these patients require increased time to complete tasks, experience
the inability to complete executive decisions, and tend to have poor memory and
forgetfulness.
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Human Experience of Non-Human World
Whether the breast cancer patient experiencing fatigue is considered from an
objective point of view or from the perspective of being found and understood only as
“meaningful being-in-the-world,” it serves as the fourth contextual ground of human life.
Merleau-Ponty proposes that we capture the meaning of special places in our lives, as
these women resorted to “caves” as their respite place (Thomas and Pollio, 2002). The
breast cancer patient with fatigue experiences changes in relationships of people in their
lives and often these changes result in the patient feeling very insecure and thus affecting
their space and place. As the study participants shared their stories, it became evident
that major changes occurred in every aspect of their life. In the aforementioned
paragraphs Merleua-Ponty‟s philosophical perspective about the human experience to the
body, others, time and the non-human world are described. As illustrated in the
following section, the human body was affected in drastic ways. Additionally, how they
dealt with “other people” and “their world” were greatly changed as was the element of
time.

Overview of Thematic Structure
Each patient shared stories of their life before being diagnosed with breast cancer.
They were working mothers, soccer moms, students, professional and businesswomen.
They were involved in church and community activities and seemed to be enjoying life to
its fullest potential. Suddenly, a “lightning bolt” flashed before them as they received the
most frightening three words one can ever hear: “You have cancer!” Being totally
devastated with the overwhelming news, these tenacious women sought the best medical
122

and surgical oncology treatment available, with some seeking second opinions at major
cancer centers. After the initial shock and disbelief, with great fortitude the women
underwent breast cancer surgery, received chemotherapy with subsequent radiotherapy.
It was during the treatment phase their lives further fell apart as they described their
chemotherapy as “toxins being poured into my bodies.”
Understandably, during this active phase of their breast cancer treatment the
fatigue surfaced. The life of the patient transformed substantially with major changes in
their quality of life. It was at this point in the cancer trajectory that a fourth word,
fatigue, was added to their repertoire of their cancer experience. This was the turning
point; their lives changed dramatically…never to return to the life they once enjoyed.
Because of the radical changes associated with being diagnosed with breast cancer and
having received cancer treatments, the experience of the patient was grounded in body
and time as previously described. Out of these experiences, the meaning of their fatigue
unfolded and the thematic structure evolved as: “being alone in the cave,” “coming out of
the cocoon,” “it‟s a lost fight,” and “who am I now, it‟ not my life.”
During this experience of transitioning from a “normal working mom” to a person
cloaked with a new body lacking vitality, a “subpar” level of cognition as well as newly
defined roles, these women quickly saw their life being lived in the “Shadow of Death.”
Pollio, Henley, and Thompson, (1997) propose that according to Heidegger, when one
faces death, the impossible possibility of “not being in the world,” is when a person
chooses to live an authentic life. Therefore, one could propose that “being in the world”
is a “being toward death.” For these women being in the world reflected this position as
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they dealt with their pervasive fatigue of being in two worlds as they faced the “Shadow
of Death.”
The first world was very hard and demanding. In this world, they tried to fulfill
roles and responsibilities to no avail. The harder they tried to complete various duties
and responsibilities, the more difficult the tasks became. Their energy waned and
eventually became nonexistent as they described themselves as “looking like death
warmed over.” This was followed by despair, disappointment, despondency and isolation.
Food became unimportant, donning clothes and applying makeup were too exhausting,
and socializing with family and friends was overwhelming. Subsequently, the
participants described “running on fumes” as they succumbed to defeat and resorted to a
safe place, their refuge. Each theme will now be further elucidated.
Theme 1. “Being Alone in the Cave”
Resorting to a cave, their refuge, is the second world, which is safe and one in
which the patient felt secure though they still described it as being exiled from everything
important in life. The patients shared “looking through a window” as they viewed the
outside world; however, it was a vicarious experience for them as they could look out but
no one could see inside their room, the cave, because they were disappointed in their
physical appearance. They enjoyed the mundane scenes of everyday life, such as
watching children get off the school bus, listening to birds sing outside their bedroom or
enjoying a ride in the neighborhood. Their stories reflect the poignant experiences they
endured:
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My fatigue affected everything about me and around me; I wanted to be alone.
At this point I went to my little cave…I was in my cave….my own little cave… I
just crawled in it and stayed there. I cried once I was by myself. While I was
in my cave I could see the world but it could not see me. I looked and felt terrible;
I didn‟t want anyone to see me. I looked through the little windowpanes from
time to time so I stayed connected with the outside world.

The participants also questioned the entire ordeal and asked why they were
dealing with this catastrophic event. They questioned why the rest of the world didn‟t
feel like they did. At times they displayed anger as one patient, Linda, described the
following:

I was in my cave…all alone…I could not sleep at night. I just stared at the walls. I
really couldn‟t watch TV because I couldn‟t concentrate, but in the middle of the
night TV got my attention. Those infomercials or people exercising or trying to
sell weight loss stuff…that drove me crazy! Every time I heard the
advertisement, I wanted to slap those feisty young girls who were wiping me out
just watching them. I hated it. It reminded me what I had lost and probably was
not going to get back.

As the women continued to hibernate in the cave, their temporal world broke
down. They described the fatigue as lasting forever and that time was running together.
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For these patients, time was a benchmark to normalcy. Time was very heavy. Before
being diagnosed with cancer, the tempo was great because they felt well. When they
became ill, time was blank as they “sat and stared at the walls.” In addition, the tempo
was lost, and nighttime became an existential crisis, as they described not having to be
strong for anyone. Linda shared the following:

The days were like a million years long, and the nights were even worse. I
remember laying in the darkness and just thinking, oh when will the daylight ever
get here? Because darkness, I don‟t know what it is about darkness, but you seem
to be worse at night than you are in daytime. I guess the light coming through the
window helps. But you think you are never going to get through the darkness.

In addition to their feeling of the fatigue lasting “forever,” the patients lost
orientation in time as the hours ran together. When they were “down for the kill” time
ran together as there was no purpose. Time also fell apart when the patients had a sense
of “not caring” because nothing helped the fatigue. Whereas, when they began to feel
better they left their cave and came out of their cocoon.
Theme 2. “Coming Out of the Cocoon”
As they began feeling better, time became more important and was more
structured. In addition to time becoming more important as they were transformed from
the cave to the cocoon, they became more engaged in themselves and others. Because of
the continued lack of vitality, the patients often described their “bodies were for others”
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as they attempted to dress and apply makeup so that did not “look like walking death,”
They often described not appearing as a female. In contrast, some women preferred the
night as “my body for others disappeared…I was able to be myself.”
These women also discussed the difficulties of having “others in their life” as they
dealt with their fatigue. Some family and friends actually did not acknowledge how
badly these women felt. The patients stated that they “looked OK”; so people did not
realize how exhausted they were most of the time. They also shared that their loved ones
were not very helpful at times nor were they empathetic; perhaps they did not know how
to help, they suggested. The patients embraced major changes as their roles changed. In
essence, the women did not convey a substantial degree of others being important as they
dealt with their fatigue. Rather, it was not about others, it was a lost fight these women
experienced, as the fatigue was meaningless. Also, it precipitated a lack of freedom as
well as loneliness and a meaningless existence. Making choices did not change the
outcome; these women were impotent in changing the outcome of the level of exhaustion
as nothing helped their fatigue! One of the participants, Susan, shared the difficulties she
experienced as she dealt with fulfilling her role as a mother while being fatigued:

It was a very hard time for my children. I lost my role as a mother; I continue to
struggle with that, even today. Our total life was disrupted. It is very upsetting to
me as it has impacted the entire family. It was hard on the children to adjust to the
unpredictability as my level of alertness and activity varied widely. It was a very
hard time for me and probably always will be as I feel like I have lost a big chunk
of my children‟s life. I felt exiled from the family. The entire family system is
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affected. It affected everything and everybody. It‟s a heaviness, and I have to
deal with it because it will not go away.

The fatigue also affected how the patients interacted with people; they felt they
were always in “catch up “mode. The patients compared themselves to other patients as
well as healthy individuals. They felt there was a perception from the healthcare
professionals that they “looked OK”; as long as their blood counts were normal the
physicians were not interested in talking about their fatigue. The healthcare providers
also offered no strategies in helping to manage the fatigue.
Theme 3. “It’s a Lost Fight”
As the patients dealt with their fatigue, they experienced an overwhelmingly sense
of loss. The encompassing theme of the study, “it‟s a lost fight” reflects major losses
including physical changes but also cognitive aberrations as well as role changes, both
personally and professionally. Their quality of life was affected physically but also
functionally, cognitively, psychologically and socioeconomically. These losses serve as
the foundational basis of the study results and are interrelated with the other themes. This
thematic structure emerges as the patients deal with their ongoing fatigue. Not only are
they dealing with being alone in the cave but also experiencing an inordinate level of lost
time. There also is a major offense to the patients‟ body integrity. As alluded to, the
patients are completely unable to will their body to do things. No matter how hard the
patients attempt to conquer their overwhelming fatigue, the body is flattened and will not
respond. One of the young mothers, Beth, described the effects fatigue had on her body:
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My body knew when it has tapped every single piece of my energy. I was so
wiped out I could not stay awake though I had 2 young children to care for. I felt
my body had betrayed me. In fact, I felt disjointed; there was a separation of my
body and me. I mean I could not function; I could not even make a list for
someone to grocery shop for me.

Another patient, Linda, describes how energy becomes relative to the tiredness and the
difficulties of dealing with the fatigue:

Tiredness is an understatement! It‟s not like being tired after a busy day. When
you wake up, you are just as tired as you were when you went to sleep. It is
totally overwhelming; I really cannot think of words that really describe it. You
run out of steam. You literally run out of energy. I don‟t know what else to say
other than it is the worst thing that I have ever dealt with and the problem is that I
don‟t think it is ever going away…that is scary.

As cited in a study by Breithart et al. (2000), 91% of breast cancer patients
reported their fatigue prevented them from having a “normal” life. Interestingly, the
women‟s stories conveyed a powerful description of the difficulty living each day
knowing they would not feel like doing things they wanted to accomplish. Obviously,
this defeat led to feelings of isolation and loss of control and function. The furtherance of
feeling a sense of loss and their bodies conquered by their fatigue, these women dealt
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with an indescribable change in their cognitive functioning. This loss of memory and
concentration was and still is very frightening to these women. In fact, it is the most
prevalent symptom the women continue to experience. Their concerns are expressed as
they share their daily living with these changes:

I feel like am I am out there; I am not with it. I am not competent and I cannot
problem-solve as I once could. There is nothing connected; I got lost when I tried
to think…so all I did was sit and stare. I am in a fog; I think there is only one
piece of my brain that comes and goes. My mind is hazy and blurred….I cannot
concentrate and hold on to any thoughts. Sometimes I have problems getting
home from work (Jan).

All the patients conveyed their concern about their memory being affected
permanently. They acknowledge that forgetfulness, poor memory and lack of
concentration continue to be apparent, and they fear for their future. They recognize their
cognitive functioning has deteriorated since receiving chemotherapy, and half of the
patients mentioned their “brain needed to be retrained.” Conversely, the patients also
acknowledged that as they began recovering from their fatigue, they began to “think” first
and then they “got a little energy and then could do a little more.” As they continue to
improve slightly, they move into a new phase of their life, “Who Am I Now.”
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Theme 4. “Who Am I; It’s Not My Life”
As these women began to slowly improve, there were glimpses of freedom and
normalcy. While the patients evolved from a sense of being alone with a meaningless
life, there was a sense of relinquishing the bondage they had experienced since the
inception of the fatigue. The changes that brought these women face to face with their
“Shadow of Death”, and to face the “new me”, were precipitated by the major losses
engendered during their tenure of cancer therapy.
Not only did they lose attributes of their body and its functioning, but they also
lost what they considered major: loss of brain functioning. However, they continued
living in the throes of coming “face to face” with the “new me” which was precipitated
by my major losses engendered during their tenure of having cancer. Therefore, they
often described living in the “Shadow of Death” which represents the ground. This
prevailing theme is woven throughout their stories. The end result is that though they
survived their cancer and the cancer treatment, the subsequent fatigue rendered their
bodies, mind and lives different. Their voices convey a question of asking “where is the
old me” and “will I ever be the same; is the old me gone….never to return again?”
The patients‟ stories parallel closely to Viktor Frankl‟s, Man’s Search for
Meaning, (Frankl, 1992), in which he discusses the experience of the incarcerated
prisoners in the Nazi death camps attaining freedom in the midst of despair and
desolation, though the possibility of death still existed…yet, that was the ultimate horizon
they sought. As Frankl argues, suffering cannot be avoided but we choose how we cope
with it, finding meaning in our suffering and then move forward with renewed purpose.
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This position is similar to the experience of these breast cancer survivors who were
weighted down with their fatigue. Their experiences were similar as both the cancer
survivors and Frankl describe the experiences of loneliness, desolation and despair. They
questioned their existence many times as they sought answers, as their lives had no
meaning while they fought the demons bestowed upon them. Though they faced the
“Shadow of Death” every day of their existence, they eventually sensed freedom.
Though their bodies and minds were not the same, there is the possibility of perceiving
freedom to discover and pursue what is personally meaningful to them. With the “new
me,” these patients could continue to strive and pursue worthwhile goals…goals with
meaning and a desire to find significance in their future lives and, hopefully a feeling of
nirvana.
Albeit the breast cancer patients surviving the many catastrophic events leading
up to the phase, “Who Am I, Its Not My Life Anymore?” in their cancer trajectory, the
majority of the women admit they have yet to identify new personal goals. They are still
dealing with what they once were and attempting to negotiate how to deal with their
losses. Similar findings are noted in several cross-sectional studies as well as a study by
Byar, Berger, Babken, and Cetak (2006), and in which breast cancer patients‟ fatigue did
not return to low levels after active treatment after completion of therapy. The
problematic symptoms associated with the unrelenting fatigue were sleep disturbances,
anxiety, depression and poor quality of life.
A paucity of qualitative studies has studied the meaning of the fatigue
experienced by cancer patients and even less in breast cancer patients. There are no
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studies identifying the losses revealed in the interviews of these women. Neither has the
questioning of identity been noted in prior studies, as seen in these patients who
confronted evolving into a new person. It is not surprising that previous research has
failed to reveal these concerns; the focus on cancer-related fatigue research for the past
25 years, for the most part, has been on quantitative studies focusing on measurement of
fatigue, causes of fatigue and interventional approaches in the management of fatigue.

Implications for Theory
When comparing cancer-related fatigue to normal fatigue that is experienced after
a busy day, they are very different. Cancer-related fatigue is more intense and pervasive
and tends to be persistent for an indefinite period of time. Generally speaking, rest does
not lessen the symptomatology of the exhaustion experienced in the cancer patient. The
cancer-related fatigue also tends to impact more on the patients‟ quality of life and may
extend for months to years after the therapy is completed. Because of the challenges in
managing this type of fatigue as well as the impact cancer-related fatigue has on quality
of life issues, nurses should explore the following models that may be helpful in
attempting to better understand and manage cancer-related fatigue.
Nurses continue to be at the forefront in addressing these various issues
precipitated by the cancer patients‟ fatigue and actively utilizing the conceptual
frameworks identified while managing their cancer patients‟ fatigue. Using the models in
their clinical practice may contribute to improving the patients‟ quality of life through
direct care but also will address issues for ongoing research in the field. From the
findings of the study, there are five theoretical models that may be consistent and
133

relevant: Ferrell‟s Quality of Life Model, Levine‟s Conservation Model, Roy‟s
Adaptation Model, Neuman‟s System Model, and Dodd‟s Conceptual Model of Symptom
Management. These models not only address the quality of life issues that confront the
patients but also serve as conceptual frameworks to pursue future research studies for the
furtherance of better understanding the meaning of the fatigue these women eloquently
shared. Moreover, middle-range nursing theory could be derived from these theories to
apply to cancer patients in both in-and-outpatient treatment.
Ferrell’s Quality of Life Model
Ferrell‟s Quality of Life Model consists of four domains of quality of life that are
interrelated (Ferrell, 2008). They include physical well-being and symptoms, such as
functional activities, fatigue, strength, sleep, rest and overall physical health. The second
domain is psychologic well-being and includes control, anxiety, depression,
enjoyment/leisure, and cognition/attention. The third domain is the social well-being,
which addresses role/relationships, family distress, appearance, isolation, enjoyment,
finances and work. The fourth domain is spiritual well-being and includes meaning of
illness, hope, uncertainty and inner strength. These domains address the issues that the
participants shared about their lives. Their shared experiences about these issues
reflected how much their quality of life was affected with the major changes that
occurred, including physical, psychologic, social and spiritual changes. Interestingly, this
model can be expanded to address survivorship issues that are also pertinent to this group
of women as five years post-therapy they voiced major concerns about persistent fatigue.
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Levine’s Conservation Model
The second theory selected to discuss the patients‟ perception of cancer-related
fatigue and quality of life is Levine‟s Conservation Model. The model is an adaptation
model that portrays the maintenance of life by conserving individual integrity (Fawcett,
1999). Three major concepts form the basis of the model and its assumptions:
conservation, adaptation, and wholeness. Levine proposes that individuals continuously
defend their wholeness. Conservation connotes the keeping together of the life system.
This maintenance promotes a proper balance between the nurse‟s intervention and the
patient‟s participation. The patient interacts with the environment on a continual basis. In
order to maintain this integrity, the individual is continually safeguarding his integrity by
choosing the most economical and energy-sparing options.
Levine proposes that adaptation is the ongoing process of change; as a result,
individuals maintain their integrity (level of energy) within the realities of their
environment. Every individual possesses a range of adaptive responses that is unique to
that person (Fawcett, 1999). When dealing with an illness, such as cancer, these ranges
may vary.
In the Levine model, redundancy represents the physiological and psychological
options available to the patient to ensure continued adaptation. When an interaction or
constant adaptations to the environment permits the assurance of integrity, the wholeness
exists, thus allowing the individual to become the focus. This wholeness occurs when
there is recognition of an open, fluid, constantly changing interaction between the
environment and the cancer patient. When the patient is diagnosed with cancer, there is a
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maladaptive interaction with the environment. As a result, cancer-related fatigue evolves
and thus produces the potential of functional disability.
The cancer patient adapts to forces surrounding him as he deals with the internal
environment (the malignancy) that combines the physiological and pathophysiological
aspects of the illness. The internal environment (accumulation of metabolites from the
tumor, changes in energy and energy substrate patterns caused by anemia, psychological
patterns and symptom patterns) is constantly challenged by the external environment (life
event patterns, social patterns, environmental patterns), which includes those factors that
impinge on and challenge the individual. According to Fawcett (2004), the Levine model
purports that health and disease, such as cancer, are patterns of adaptive change, the goals
of which include well-being. In addition, nursing is to promote adaptation and maintain
wholeness. Through the conservation of energy as well as through the structural,
personal and social integrity, this goal is met for the cancer patient (Alligood & Toomey,
2006).
Four conservation principles underlie the model and include: conservation of
energy; conservation of structural integrity; conservation of personal integrity and
conservation of social integrity. Conservation of energy relies on an exchange between
free energy and the living systems that are continually replenishing their energy supplies.
Conservation of energy is critical to the cancer patients‟ range of adaptive responses to
the fatigue. The conservation of structural integrity relies on an intact defense system of
which exercise plays a key role. This system repairs and heals, and it is responsive to the
challenges from the internal and external environment. The conservation of personal
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integrity recognizes that the cancer patient maintains his physical stamina through
exercising on a regular basis, thus reducing his level of fatigue (this establishes his
wholeness in response to the environment). It acknowledges that the patient strives for
independence and self-awareness. The conservation of social integrity acknowledges that
the functioning society the person cancer lives in is part of the patients‟ established
boundaries. This includes the impact the cancer diagnosis has on work, finances, leisure
activities, family roles and relationships, affection and sexual function.
The fourth conservation principle focuses on the patients‟ perception of fatigue
and quality of life, while maintaining social integrity. Conservation of personal integrity
is demonstrated when a cancer patient reports low levels of emotional distress and high
levels of quality of life, which conceivably could occur as physical activity is increased.
Conservation of social integrity is represented by the maintenance of social functioning,
which may improve as fatigue lessens (Fawcett, 1999).
Roy’s Adaptation Model
The third model to consider in the context of understanding the meaning of the
patients‟ fatigue is the Roy Adaptation Model. Roy describes humans as biopsychosocial
beings who are in a constant state of adapting to external and internal environmental
stimuli. The cancer patient functions as a unity and has an innate or acquired way of
dealing with the fatigue while utilizing various coping processes. The person and
environment are based on the cancer patients‟ ability to adapt to his diminished energy
level. According to the Roy Model, the cancer patient initiates the adaptive process and
is not passive in the process. To help the cancer patient cope with fatigue, he subscribes
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to the subsystems of the coping process: regulator (chemical process of the tumor
burden), cognator (cancer patient‟s level of consciousness), stabilizer (accomplish
primary purpose of social system for the cancer patient and significant others) and
innovator (structure and process changes for cancer patient after performing an activity,
such as walking). Adaptation is an active process, which is initiated by the individual, of
adjusting to environmental changes through physiological and psychosocial modes, and
in turn, affecting the environment (Fawcett, 2004).
The physiological mode is associated with physical responses to stimuli. For
cancer patients with solid tumors, such as breast cancer, physiological adaptation often
includes recovery from surgery and physiological responses to radiotherapy and
chemotherapy. Psychosocial modes defined in the Roy model are self-concept, role
function, and interdependence. Self-concept is a composite of the individual‟s beliefs
and feelings about the physical self and psychological state. In patients with cancer, selfconcept is characterized by emotional reactions and often alterations in body image that
may occur secondary to their fatigue. Role function and performing behaviors that are
expected because of one‟s position in society, are reflected in the level of functional
status in relation to job, home, and significant others. The functional status may be
affected significantly in cancer-related fatigue. The interdependence mode focuses on
affectional relationships with significant others and support systems and thus involves
maintaining nurturing relationships with the partner, family, and close friends. In cancerrelated fatigue patients, the interdependence mode is severely affected because of the
diminished energy level. The stresses associated with a cancer diagnosis and treatment
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may affect psychosocial adaptation by threatening the patient‟s ability to maintain
employment, perform home and child care functions, or communicate affection to his/her
partner.
Environmental stimuli may arise within or around the person and may be focal,
contextual, or residual. Focal stimuli, those that most immediately confront the cancer
patient, are diagnosis and the treatment regimen, as well as the treatment-related
symptoms such as fatigue. Contextual stimuli are other contributing factors that
influence the situation. For the cancer patient, contextual stimuli include the social
support, perceived prognosis and coping strategies. Residual stimuli have undetermined
effects and may include factors such as age, developmental stage, culture, and health
beliefs (Alligood & Toomey, 2006).
In the Roy model, health is a reflection of successful adaptation to the fatigue
with the goal of being and becoming an integrated and whole person. Adaptive responses
are those that promote this integration. The goal of nursing is to promote adaptation to
the fatigue in physiological and psychosocial modes, thereby contributing to the person‟s
health and quality of life.
Neuman’s System Model
The fourth model for consideration in explaining cancer-related fatigue is
Neuman‟s System Model. Neuman proposes that the model presents a structure
consisting of parts as well as subparts that are interrelated. As a result, the patient is
considered as a whole in a complete system (Alligood & Tomey, 2006). Neuman
purports that environmental stressors constantly bombard the cancer patient. In
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Neuman‟s model, the individual cancer patient is considered an open system that
experiences stressors developing from an internal environment (the malignancy itself as
well as the side effects from the cancer treatment, such as fatigue) or an external
environment (the life event patterns and social patterns). The cancer patient is constantly
confronted with various stressors including a deteriorating disease state, changes in blood
counts, interruption of sleep and rest patterns, symptom patterns and psychological
patterns. This model suggests that while these stressors are constantly bombarding the
patient, who is protected by a series of concentric buffers that minimize the impact of
stressors. The cancer patient is equipped with various concentric circles that interact
simultaneously and ultimately could impact on the patient‟s level of energy. The level of
energy is affected as the patient system experiences disequilibrium, which occurs when
there is a disruption in the basic structure that houses the energy resources (e.g. the
central core of the patient‟s system). This interruption of the patients‟ energy resources
can be affected by physiological, psychological, sociocultural, developmental and
spiritual variables. The physiological variables include changes in the energy and energy
substrate patterns level secondary to cancer treatment (causing nausea, vomiting, pain,
cachexia, anemia and drug interactions) as well as accumulation of metabolites. These
variables result in a decrease in the synthesis of protein and muscle contraction with a
resultant muscle loss and extreme weakness. The psychological variables include
anxiety, frustration, and fear of the meaning of fatigue, coping and acceptance, loss of
independence, cognition and depression. The sociocultural and developmental variables
include impact on work/finances, family roles and relationships and sexual function. The
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spiritual variable includes changes in spirituality, altered priorities to balance diminished
energy, hopelessness and meaning of fatigue. Consequently, these variables impact
greatly on the patient‟s level of fatigue as the protected concentric buffers are ineffective
due to the impact of the stressors. According to the Neuman Model, as the protective
mechanisms are breached, the intrapersonal stressor (cancer) precipitates the fatigue
experienced by oncology patients. Nurses are considered healers and have a goal of
conserving the patient‟s energy to keep the system harmonious, while facilitating change
toward optimal health (Fawcett, 2004).
Wellness is a central focus of the Neuman Model; therefore, prevention of the
cancer-related fatigue becomes paramount in the model. The strategy includes primary
prevention of the fatigue through various approaches including exercise and secondary
prevention in which exercise could decrease the level of disequilibrium (fatigue). The
tertiary prevention goal is to restore equilibrium to a seriously impacted system. This
becomes the challenge as these women continue to experience the unrelenting fatigue.
Dodd’s Conceptual Model of Symptom Management
Dodd‟s Symptom Management Model (Dodd, Janson, & Facione, 2001) focuses
on symptom management strategies for the oncology patient. The model encompasses
three interrelated dimensions: symptom experience, symptom management and symptom
outcomes. The symptom experience component is very pertinent to the study as the
focus is on understanding the symptom, such as fatigue, from the patient‟s perspective.
Components of the symptom management strategies are factors to be considered when
designing, delivering and prescribing interventions for the fatigue in order to achieve a
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desired outcome. Adherence to a selected intervention for the fatigue can be influenced
by different factors and ultimately affect the outcome. For the patients in this study, their
overwhelming fatigue obviated most interventions during the acute phase of their fatigue
(Dodd et al., 2001).

Practice and Policy Implications
The breast cancer women in the study reported their physicians did not assess
their level of fatigue. In fact, physicians did not question whether they were experiencing
fatigue. Neither did they offer suggestions once the patient complained about their
overwhelming fatigue. The patient‟s impression was that “as long as my blood count was
OK, the physician was not concerned about my fatigue.” From the study results, it is
clear that education of physicians about fatigue is warranted. These findings are
substantiated by a recent NCCN survey (NCCN, 2009) of a convenience sample in which
1,000 oncology clinicians responded to a questionnaire assessing their knowledge and
management strategies for cancer-related fatigue. Though the NCCN provides evidencebased practice guidelines utilized by oncologists in their practice, approximately onethird were not aware of the cancer-related guidelines, while only 17% of advanced
practice nurses were unfamiliar with the guidelines. This recent survey further
substantiates that medical schools, training programs for interns, residents and oncology
fellows as well as healthcare institutions implement a curriculum that includes the
importance of understanding and managing cancer-related fatigue. This becomes
extremely important as studies show there is a disparity between physicians‟ and patients‟
perception of fatigue. More than 60% of cancer patients cite fatigue as their most
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important symptom and only 20% of patients cite pain as a major concern. However,
physicians rank fatigue only slightly above pain as the most important symptom, and they
further minimize the importance of the patient‟s fatigue (Einhorn, 2009). The NCCN
panel recognizes that education and training programs are needed to prepare oncology
experts in fatigue management. Institutions must become involved in ensuring these
professionals become skilled in managing cancer-related fatigue (NCCN, 2009).
Since cancer-related fatigue is the most prevalent symptom experienced by cancer
patients, national guidelines should be implemented to promote understanding and
treatment of the fatigue. The Joint Commission of Accreditation Hospital Organization
(JCAHO) should include cancer-related fatigue as a standard just as pain is a recognized
standard. Subsequently, institutions and practitioners would be held accountable.
Institutions should hold physicians with hospital privileges accountable for implementing
the NCCN Guidelines on Fatigue. Additionally, the institution‟s continuous quality
improvement (CQI) committee should identify quality of fatigue management as a
clinical focus and implement a CQI plan hospital-wide. Monitoring of adherence and
progress with the guidelines could be evaluated using a CQI plan. As a result, evidencebased practice guidelines on management of cancer-related fatigue could be implemented
in both in- and out-patient oncology programs.
Additionally, cancer-related fatigue should be included in clinical health outcome
studies, and assessment of fatigue levels should be included in outcome research (NCCN,
2009). Institutions should develop comprehensive exercise programs using cancer-
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related resources and collaborate among departments to mitigate short and long term
effects of fatigue with resultant improvement in the patients‟ quality of life.
The NCCN Cancer-Related Fatigue Guidelines (NCCN, 2009) recommend
education and counseling as central to effective management. Therefore, the nurse‟s role
is pivotal in ensuring these strategies are implemented in all healthcare settings. Nurses
should serve on key committees that address clinical practice issues related to fatigue in
the in- and out-patient setting. Because of their patients‟ stories about their fatigue, the
nurses are key to recognizing provider and system-related barriers that exist. Because of
the knowledge the nurses have about the patient‟s fatigue, they are equipped to work with
other healthcare professionals and administrators in a systematic and collaborative
fashion within the system to address the various issues pertinent to improving the
patient‟s fatigue. Nurses serve in a pivotal role to assist hospital administration and
clinical cancer boards to understand how to effectively manage cancer-related fatigue.
An informed and supportive oncology care team that assesses the patient‟s fatigue,
counsels and educates patients regarding strategies for coping with their fatigue is
essential. The oncology team must recognize when to refer patients with unresolved
fatigue to experts. The team also must identify the patient, system-related and provider
behaviors that may impede effective fatigue management. They should be proactive in
provider policy making to ensure that diagnostic related group (DRG) includes the
sequalae of treating cancer-related fatigue. Included in the policy coverage is screening
for the fatigue, treatment strategies as well as the myriad of other symptomology
associated with cancer-related fatigue, such as depression, sleep and cognitive
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dysfunction, built into healthcare plans. The nurse helps the team to understand these
barriers can be reduced by using available resources and evidenced-based guidelines for
patients with fatigue (Piper et al., 2008).

Nursing Implications
In 2009, cancer-related fatigue is still highly under-recognized, under-reported,
under-diagnosed and under-treated. This fatigue is identified as a lasting and debilitating
health problem that affects a substantial number of cancer patients and may persist long
after treatments are completed. This most pervasive symptom may affect cancer
treatment by compromising the timing or completion of treatment regimen, either
because fatigue is a dose limiting adverse effect or because it reduces the patient‟s
willingness to adhere to the treatment (Hofman, Morrow, & Roscoe, 2004). It has a
strong and direct negative impact on all aspects of the breast cancer patient‟s quality of
life that may persist in 34% - 40% of breast cancer survivors for 5-10 years after
completion of treatment (Bower et al., 2006; Servaes, Verhagen, & Bleijenberg, 2002).
Not only does it greatly impact their physical well-being but also diminishes their ability
to participate in leisure activities, to sustain meaningful relationships with their family
and friends, to work, and to engage in social activities. They also become dependent on
others for assisting them with personal activities and often succumb to having to rest and
nap frequently in an attempt to cope with their fatigue. Because of the changes in their
daily lives, the patients may feel very discouraged and experience psychological distress
as they deal with a significant financial burden with their limiting ability to work.
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Many healthcare professionals admit that fatigue is perhaps even more difficult to
treat than other problems experienced by cancer patients. Admittedly, these professionals
continue to be challenged in their efforts to assist patients manage this distressful
symptom and to help them remain fully engaged in life. At present, there are several
facts known about cancer-related fatigue. Cancer chemotherapy not only eradicates
malignant cells but also causes deleterious effects on healthy tissue, resulting in acute and
chronic side effects. Fatigue is one such side effect that is precipitated by several
proposed causes, including both physiologic and psychological factors. It also is
suggested the causes of the fatigue may even be multifactorial in nature. It is a known
fact the majority of patients‟ fatigue cannot be explained nor successfully treated.
It also is recognized that for the past several years research has been conducted on
cancer-related fatigue. The focus of the research primarily has been on causation of
cancer-related fatigue, assessment of fatigue, development and utilization of various
screening instruments as well as management strategies for fatigue. Interventions to
assist patients in dealing with this most common complaint affecting as many as 96% of
cancer survivors (Nail et al., 1991) has fallen short of expectations. Researchers have
demonstrated that fatigue has significant effects on physical functioning during treatment,
and there is uncertainty that patients regain total functioning when treatments are finished
(Mock, Pickett, & Ropka, 2002). For many reasons, fatigue continues to be the most
prevailing side effect of the patients‟ experience. Though committed researchers
continue to search for ways to prevent or at least minimize this overwhelming side effect
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that creates functional, cognitive, psychological and socioeconomic issues in patients, our
patients continue to struggle.
With cancer-related fatigue being a subjective experience, it becomes extremely
important the oncology team appreciates there is a discordance in perception of cancerrelated fatigue between the patient and the healthcare professional team. Therefore, we
must listen to their words to better understand the meaning of their fatigue. After
listening to the captivating stories shared about the breast cancer women‟s experiences
with fatigue, it is the researcher‟s belief, unequivocally, that until we learn to appreciate
the words of the patient as they describe this unrelenting symptom, further research will
not discover what is needed to obviate the patient‟s suffering. The first step to
understanding the direction that research should be directed is to listen to the voice of the
patients from the lived world of their fatigue. As healthcare providers, we must learn to
bring the patient‟s own voice into both the nursing and physician encounter. We must
understand the meaning of the lived experience of this overwhelming symptom that
greatly impacts the patient‟s quality of life. Our patients can be real-life teachers and can
help the healthcare professional understand what it means to live daily with the fatigue.
Listening to their experience helps the healthcare team to delve deeper into understanding
their fatigue, and then work toward establishing an evidenced-based practice to manage
cancer-related fatigue.
Presently, treatment strategies in place to reduce fatigue at best are elusive.
According to the Oncology Nursing Society‟s resource, “Putting Evidence Into Practice,”
the only intervention considered “recommended for practice” is exercise (ONS, 2006).

147

Though several studies support that exercise is recommended for patients suffering with
fatigue, the participants in the present study conveyed that exercise did not relieve their
fatigue. At best, the exercise may be therapeutic physically and mentally. Admittedly,
even with the most researched management strategy not working effectively, we must
commit to first understand what the patients are telling us about their fatigue. We must
understand their experience before a framework for treatment strategies can be
researched, developed, tested and implemented. Because of the researcher‟s passionate
commitment to this cause, it is the belief that the oncology nurse serves in a pivotal role
to search for the meaning of fatigue as he/she enters into a dialogical encounter with the
patient. Through practice, education and research, the oncology nurse will pave the way
in searching for understanding the meaning of the patient‟s fatigue and then establish a
framework to identify management strategies.
Awareness of patients experiencing fatigue is imperative to be recognized by the
patient, their families and healthcare professionals if successful quality of life and clinical
outcomes are to be obtained. Nurses can be leaders in ensuring that fatigue is addressed
and managed because they often are the most present and available healthcare
professional on the healthcare team. Perhaps fatigue should be anticipated in each
patient. Then the nurse could conduct preemptive planning with each patient as the
patient meets with their oncologist to discuss an initial treatment plan. Doing so would
equip each patient then to deal with the symptom as it occurs. Therefore, the nurse would
play an integral role in fatigue screening and assessment as well as management and
evaluation of interventions to manage the fatigue (Cleeland & Wang, 2001). Typically,
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oncology nurses have a natural propensity to express concern and empathy for patients
(McDonald et al., 1999). Their primary goal is not only to recognize fatigue and screen
patients for their level of fatigue, but they are also responsible for management of the
patient‟s fatigue throughout the illness trajectory. Nurses serve an important role
assisting other healthcare providers realize the prevalence and significance of cancerrelated fatigue. Additionally, nurses can help cancer patients/survivors articulate the
impact their fatigue has on their quality of life as well as their significant others. Nurses
are the key to empowering the patient to report they are receiving inadequate information
about how to manage their fatigue. Patients report difficulty in accessing information on
how to manage fatigue and typically resort to resting and sleeping more or curtailing their
activities in an attempt to conserve energy (Messias, Yeager, Dibble, & Dodd, 1997).
Having fatigue may adversely affect general well-being and quality of life. It is
incumbent for the nurse to recognize if these patients become too exhausted to participate
in activities or to fulfill their roles that make life meaningful as quality of life may be
impacted greatly. Nurses remain in the forefront of patient care and should become
advocates for patients. As Newman proposes in her model nurses are considered healers
and have a goal of conserving the patient‟s energy to keep the system harmonious while
facilitating change toward optimal heath (Fawcett, 2004). They are positioned to identify
patients who are struggling with fatigue early in the cancer-treatment process and should
become the voice of the patient. Therefore, nurses need to ensure that all healthcare
professionals recognize fatigue as a significant symptom, similar to how pain is
addressed today. Their role also is very important as they ensure teamwork, patient
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assessments and evaluation methods are in place when addressing fatigue management
with the team (Jakobsson, Ekman, & Ahlberg, 2008). A comprehensive multidisciplinary
treatment approach should be used to determine the best intervention for the patient.
Treatments should be based not only on physical examination and laboratory values but
also cognitive and psychosocial assessments of the individual.
The nurse plays an integral role to ensure that the patient‟s fatigue is addressed.
Every cancer patient should be screened for fatigue. If present, this subjective experience
should be systematically assessed using patient self-reports as well. Because fatigue is
perceived by the patient, it is a symptom that is described most accurately by self-report
(NCCN, 2009). Additionally, a quantitative or semiquantative assessment should be
performed. According to Jean-Pierre et al. (2007), it may be more relevant, both
clinically and for research purposes, to use a single measure that could clearly indicate
the presence and absence as well as the severity of fatigue. The fatigue assessment
should begin before treatments are initiated, utilizing a 0 – 10 visual analogue scale, with
0 being no fatigue to 10 being the worst fatigue ever experienced. Fatigue studies in
cancer patients have revealed a marked decrease in physical functioning at a level of 7 or
more (Cleeland, 1999). With each patient encounter there must be an assessment
completed as symptoms may be underreported because fatigue often is expected and
accepted. An assessment of the patient‟s fatigue should be taken, much as pain is
assessed today. In fact, assessing fatigue could become the sixth vital sign as pain is
considered the fifth vital sign (Given, 2007). Part of the assessment should include
assessment for poor sleep patterns in patients who report fatigue of 4 or higher. Wielgus,
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Berger, and Hertzog (2009) concluded in a randomized study that patients who have good
sleep each night experience less fatigue. Encouraging the patient to keep a self-report
diary throughout the course of cancer therapy also helps the healthcare practitioner to
assess not only fatigue but also sleep (Wielgus et al., 2009).
In addition to assessment of fatigue, a focused history including an in-depth
fatigue history should be conducted for a fatigue level of 4 or more. Assessment of
treatable contributing factors, such as anemia, pain, depression, anxiety, sleep
disturbances, nutritional assessment and activity level should be completed. An
assessment of side effects of medications the patient is consuming is also important to
determine. Co-morbidities also should be assessed as part of the evaluation of the patient
as various health conditions and medications may precipitate significant fatigue (NCCN,
2009).
Subsequently, the nurse must communicate the assessments to the practitioners as
the study participants conveyed their physicians did nothing to manage their fatigue.
Nurses must advocate with physicians to seek better ways to address the patient‟s fatigue.
A recent survey showed that although patients continue to have unmet communication
needs related to fatigue, patients find these discussions extremely useful when they occur
(Butt, Wagner, & Beaumont, 2008). Educating the patients about the importance of
communicating their level of fatigue to their healthcare professional is of paramount
importance. The patient should describe specifically their fatigue so the healthcare team
can explore possible etiologies. Their fatigue tends to be underreported because patients
often do not want to “bother” healthcare providers nor do they want to be labeled as a
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complainer. They also worry that the symptoms may delay their staying on schedule
with their cancer treatments, thus allowing their tumor to recur. Complaining about their
fatigue also may imply their disease is worsening; therefore, patients may prefer not to
inform their healthcare professional. The patients may believe their fatigue is an
inevitable part of their cancer trajectory and must learn to live with it. They also may not
realize the importance of reporting their fatigue or they may feel that nothing can be done
to help; therefore, there is no reason to report it (Borneman, Piper, & Sun, 2007).
Nurses are the voices for their patients, especially as it relates to their fatigue. It is
important for the nurse to assist the patient in removing the communication barriers that
may impede the patient from talking about their fatigue with their healthcare
professional. Coaching the patient and family to initiate the discussion about their fatigue
with the practitioner is very important. Helping the patient to recognize that nurses are as
interested in their fatigue as pain will improve the patient‟s comfort level in reporting
their fatigue. Encouraging patients, caregivers and family to access the patient dedicated
NCCN website will provide essential information on cancer-related fatigue. The goal of
the website is to educate patients to become engaged in more informed conversations
with their healthcare provider (NCCN, 2009).
The Oncology Nursing Society identified strategies for management of cancerrelated fatigue that reflect evidence-based practice. These strategies include screening,
exercise, energy conservation and activity management, measures to optimize sleep
quality, education, counseling, relaxation and massage, and correction of anemia.
Interventions for which there are insufficient data or inadequate quality research evident
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include individual and group psychotherapy, expressive writing, yoga, acupuncture,
distraction, nutritional counseling, reflexology and/or aromatherapy (Mitchell, Beck, &
Hood, 2007). Albeit some management strategies may have no scientific basis, the
researcher will cover the majority of these approaches in the following section.
Advocating for the cancer patient with fatigue is very important also. Referrals to
programs that will assist patients in dealing with the physiologic and psychosocial
changes are very important. Consultative services for nutritional support are pertinent as
the women lost and gained considerable weight while in were in “their cave” and “their
cocoon”. A nutritional counselor ensures that the patient receives adequate caloric
intake, proteins and fluids to help prevent fatigue and increase energy level.
Emotional distress was very apparent both during the acute and chronic fatigue
these women still experience. Quality of life improves when distress is alleviated (Sloan
et al., 2002). Therefore, counseling including stress reduction and management of
depression and anxiety can be useful in reducing fatigue (Stark, Kiely, & Smith, 2002).
Kim, Hickok, and Morrow (2007) further substantiated that stress reduction ameliorates
high levels of fatigue. The researchers examined 549 patients undergoing chemotherapy.
The purpose of the study was to assess the degree to which two dimensions of emotion
assessed as psychological factors, arousal and violence, served as predictors of change in
fatigue and depressive symptoms. Findings demonstrated that fatigue is associated with
increases in anxiety and confusion. Recommendations for the healthcare professional to
help cancer patients with increased anxiety are guided imagery, relaxation and use of
positive coping strategies. The researchers also suggested special guidance and education
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about self-care as well as other strategies targeted at restoring direct attention and
capacity for concentration in order to minimize cognitive impairment.
Randomized trials have demonstrated that cognitive-behavior strategies, such as
relaxed breathing or progressive muscle relaxation, may improve fatigue in patients with
cancer (Kim & Kim, 2005). Support groups also would be very beneficial in helping
patients cope with the major changes they have experienced. Referrals to the American
Cancer Society and Wellness Community for local support groups in the patient‟s area
also helps the patient deal with their emotional issues and subsequently fatigue. `
Nurses are in a key role to educate patients and caregivers about potential
cognitive dysfunction post-chemotherapy. Because of the cognitive changes experienced
by these women, the nurse‟s goals for the patient include increasing the patient‟s
functioning to the highest level feasible, follow-up with a multidisciplinary team
including a neurologist, counselor and a neuropsychologist. A neuropsychologist is
skilled in the administration and interpretation of neurocognitive tests which link
behaviors to underlying normal and abnormal brain processes. Their role is very
important in assessing, diagnosing and counseling the patient with cognitive impairment.
The neuropsychologist can facilitate psychosocial support to improve the patient‟s coping
with lifestyle changes. They also can serve as a guide in cognitive retraining. Cognitive
and vocational rehabilitation can be very helpful to this group also (Meyer, 2000).
The effects of cognitive behavioral therapy in severely fatigued patients was
studied by Gielissen, Verhazen, & Witjes, (2006). The researchers randomized 112
cancer survivors to either an intervention arm (cognitive behavioral therapy) or a control
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arm (standard care). Patients in the intervention group reported significantly greater
reduction in fatigue severity than the control group. It also is noteworthy to recognize that
quality of life is negatively affected when patients with cognitive dysfunction do not have
access to a multidisciplinary team (Grober, 2002). Therefore, the nurse should identify
support groups and cognitive retraining programs for these patients. These nurses also
should be instrumental in the development of clinical pathways to identify patients
experiencing cognitive changes.
The nurse also can provide information about attention restorative exercises to
help increase memory and concentration (Jansen, Miaskowski, Dodd, Dowling, &
Kramer, 2005). Involvement in activities that engage patients‟ fascination or have other
restorative properties that improve attentional capacity may be helpful (Page et al., 2006).
Engaging in renewal through nature activities such as sitting near water, gardening,
walking, bird-watching, and arts and crafts can improve concentration and problemsolving skills (Syrop, 2008). In a randomized study of 157 women with newly diagnosed
breast cancer, Cimprich and Ronis (2003) reported that regular exposure to the natural
environment demonstrated improved attentional fatigue. Though limited, existing data
indicate that restorative therapy provides benefits for the sensory dimension of cancerrelated fatigue. Cimprich (1992) noted improvement in attentional fatigue in a
randomized controlled trial involving 32 women after breast cancer surgery.
Educating the patient about expected treatment plans, support groups and
counseling can be very beneficial to the patient. Educating the patient and caregiver
about web sites that provide information on chemotherapy-related cognitive impairment
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resources is also helpful. Additionally, training programs that focus on cognitive
behavioral treatment have been used to treat breast cancer patients. Ahles and Saykin
(2007) piloted a study that included four cognitive areas of study, including memory and
attention education, self-awareness training, self-regulation with a focus on relaxation
training, activity scheduling and pacing and strategies to compensate for cognitive
dysfunction. Five neuropsychological tests were completed on all 29 breast cancer
patients who completed chemotherapy 8 years ago. Results showed improvement in selfreport of cognitive function, quality of life and neuropsychological test performance.
Generalizability of the study is limited because of the small sample size. Additionally,
only one type of cancer was studied. There also was a high level of education among the
participants.
In an effort to alleviate fatigue and improve the patient‟s quality of life, yoga is
another integrative intervention that may be useful. Cohen, Warneke, and Fouladi (2004)
reported that 39 lymphoma patients participated in a randomized study including an
intervention group of yoga, postures, visualization, breathing and mindfulness.
Participants in the control group had increased fatigue compared to the intervention
group. Though the results are encouraging and suggest that yoga may be a viable
intervention for improving cancer-related fatigue, the evidence is preliminary.
Danhauer et. al. (2009) conducted a pilot study of 44 breast cancer patients posttreatment to assess if restorative yoga improved emotional, health-related quality of life
and symptom outcome. The women were randomized to a treatment group and a control
group. Group differences favoring the yoga group were seen for mental health,
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depression, positive effect and spirituality. The yoga group demonstrated a significant
improvement in fatigue. Study limitations included small sample size and the
participants were at different points of time post-chemotherapy completion.
Another intervention that may be helpful to the patient with cancer-related fatigue
is mindfulness-based stress reduction (MBSR) (Mustain, Katula, & Zhao, 2007). The
program consists of yoga, mediation, group processing and discussion as well as
educational materials related to mindfulness, relaxation and yoga. A study conducted by
Carlson, Speca, and Patel (2004) reported improvement in cancer-related fatigue in the
MBRS intervention group of 59 breast and prostate cancer patients compared to the
control group. While the results are promising there is a need for more appropriately
powered randomized clinical trials.
Polarity therapy is another intervention that may improve fatigue in the cancer
patient. The therapy employs a gentle human touch in an effort to balance the electrical
energy fields. A randomized, controlled pilot study conducted by Roscoe, Matteson, and
Mustain (2005) investigated the efficacy of polarity therapy for improving cancer-related
fatigue. The results demonstrated that breast cancer survivors receiving the interventions
during the course of radiotherapy demonstrated significant reductions in their fatigue
level compared to the control group only receiving radiotherapy. Since this is the only
published study investigating the efficacy of polarity for controlling cancer-related
fatigue, further research is warranted.
The question of whether Reiki is effective in decreasing fatigue levels in cancer
patients was studied by Tsang, Carlson, Crossover, and Olson (2007) in a pilot study
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including 16 patients. Results suggested that Reiki was effective in decreasing fatigue.
Pain and anxiety also decreased cumulatively over the course of five sessions. Overall
quality of life also improved among the study participants. The researchers suggested
that Reiki is an ideal intervention for patients with limited energy. Limitations of the
study include a small sample and lack of a control group
Mao et al. (2009) conducted a clinical trial to determine the feasibility of
acupuncture preventing cancer-related fatigue in patients undergoing radiotherapy.
Patients received up to 12 treatments of acupuncture over the course of their radiation
therapy. Thirty-seven percent of the patients had improvement in their fatigue.
Researchers concluded that acupuncture has the potential to prevent radiotherapy-related
fatigue. Limitations included a small sample size, and the study was not a randomized
controlled trial.
In assessing patients with cancer-related fatigue, it is important to differentiate
between fatigue and depression. Assessment of mood changes that persist for 2 weeks or
more and cause distress, impair functioning or are associated with other symptoms such
as poor sleep or feelings of hopelessness should be included in the evaluation for
depression. Cancer patients whose depression is characterized by the presence of somatic
symptoms, such as fatigue and sleep disturbance can make the differential diagnosis of
depression more challenging. Though it is noted that depression alone does not entirely
explain feelings of fatigue in cancer survivors, referral to mental healthcare professional
for evaluation and treatment is recommended for patients who exhibit symptoms of
depression (Bower et al., 2000). Additionally, distraction, relaxation therapy, educational
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and support group interventions are shown to be beneficial for fatigued cancer patients
who also experience depression (Bower, 2008).
Assessing for distress in the cancer patient is also important as distress may
precipitate fatigue. According to the NCCN Guidelines, distress represents a complex,
multifactorial experience that include depression and anxiety (Mock et al., 2000).
Assessing for levels of distress using the distress thermometer is important in determining
the level of fatigue. It is recommended by the NCCN guidelines that a score of 4 or
higher (moderate to severe distress) warrants a referral to a specialist. If the distress in
mild (less than 4), the oncology team can provide supportive care (Holland, Andersen &
Breitbart, 2007).
A higher level of cancer-related fatigue that occurs before and during
chemotherapy treatments in patients with breast cancer may be related to less robust
circadian activity rhythm (Ancoli-Israel, Liu, & Marler, 2006). Therefore, improving
sleep disturbances is also important in managing cancer-related fatigue. ONS guidelines
for pharmacologic management of sleep-wake disturbances specify that clinicians and
patients should carefully weigh the benefits and potential harmful effects of
pharmacologic sleep interventions (Page, Berger, & Johnson, 2007). Minimal evidence
exists to support the effectiveness of herbal supplements (Berger, Parker, & YoungMcCaughan, 2005). Because cancer-related fatigue and sleep disturbances are closely
linked in terms of prevalence, often occurring as part of a multisystem cluster, both need
to be addressed with the patient. According to Hickok et al. (2005) the close association
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between fatigue, drowsiness, and sleep disturbances, interventions to improve sleep may
also alleviate drowsiness and fatigue.
There needs to be a better understanding of the nature of sleep disturbances, the
complex relationship seen with sleep and fatigue and the association with other
symptoms commonly reported by the patient, such as anxiety, pain and depression.
Assessing for these symptoms and suggesting interventions targeting disordered sleep
and daytime sleepiness should be a primary focus of the nurse (Savard & Morin, 2001).
Berger, Kuhn, and Farr (2009) conducted a randomized-controlled trial on 219
breast cancer patients to determine whether sleep quality and fatigue associated with
chemotherapy treatments can be improved with behavioral therapy (individualized sleep
promotion plan, including modified stimulus control, modified sleep restriction,
relaxation therapy and sleep hygiene). The intervention group showed improved sleep
quality over time and better sleep. Perceptions of improved sleep quality did not result in
lower fatigue.
Berger (2003) recommends improvement in sleep hygiene as a critical
intervention in managing sleep disorders. The behavior sleep intervention program
includes sleep restriction, stimulus control, relaxation therapy and sleep hygiene
counseling (Wielgus et al., 2009). Evidence-based practice guidelines for improving
quality of sleep include following sleep hygiene: going to sleep at same time each
evening and rising at similar time every morning; limiting time spent in bed; utilizing bed
only for sleep and sexual activity; eliminating evening stimulation, such as intake of
caffeine, nicotine and alcohol and exercise within four hours of bedtime; exposure to
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bright lights and sun upon wakening; and routine times for meals and exercise (Berger et
al., 2002). Relaxation training, such as a warm bath, massage, reading and relaxing
music, also is an evidence-based practice that helps to optimize sleep quality. Replacing
the mattress every 10-12 years also improves the quality of sleep (Berger and Mitchell,
2008).
In addition to sleep hygiene, stimulus control and sleep restriction are important
cognitive behavioral therapies to enhance sleep. Stimulus control includes encouraging
the patient to go to get out of bed after 20 minutes being unable to go to sleep (Hofman,
Ryan, Figueroa-Moseley, Jean-Pierre, & Morrow, 2007). Sleep restriction includes
avoiding long naps and limiting time in bed (Bootzin, Epstein, & Wood, 1991). In a pilot
study by Berger, VonEssen, and Khun (2002) these behavioral therapies were
implemented in women during adjuvant breast cancer therapy. The sleep and wake
patterns remained consistent with normal values except for increased periods of nighttime
awakenings (Davidson, Waisberg, Brundage, & MacLean, 2001). Several studies show
that cognitive-behavioral therapy interventions designed to promote quality sleep in
cancer patients may also improve fatigue (Savard, Simard, Ivers, & Morin, 2005;
Quesnel, Savard, Simard, Ivers, & Morin, 2003; Davidson, Waisberg, Brundage, &
MacLean, 2001). Patient education to promote quality sleep should be implemented prior
to the first cancer therapy. Additionally, an intervention that is evidence-based, such as
behavior sleep intervention, should be initiated in women who label themselves as “poor
sleepers” prior to the initiation of cancer therapy. There is minimal empirical evidence
for pharmacologic agents to be used to help manage sleep disorders (NCCN, 2009).
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Several aforementioned studies substantiated that enhancing the quality of sleep
tends to reduce the level of fatigue. Other researchers‟ findings do not support this
position. Fernandes, Stone, Andrews, Morgan, and Sharma (2006) determined that
fatigue was significantly correlated with low quality of life, depression and diminished
self-reported physical functioning. However, despite the patients having greater
impairments of sleep and circadian rhythm, the severity of fatigue did not appear to be
related to these impairments. There is an accumulating body of evidence that the elusive
concept of symptom clustering is becoming more evident as fatigue, insomnia, pain and
depression are further studied in the oncology arena. There is now moderate evidence
and the research is sufficient to accept that symptom clustering has validity as a scientific
construct and is a clinically relevant problem. There is less evidence indicating an
underlying mechanism as well as lack of validity that a few treatments would address all
the symptoms (Barsevick, Berger, Bakken, & Cetak, 2007).
Additional integrative non-pharmacologic behavioral treatments should be
implemented for the effective management of cancer-related fatigue. A wide range of
interventions including educational programs and counseling are particularly beneficial to
cancer patients experiencing fatigue. Education about fatigue and its natural course
should be offered to all patients, especially as therapy is initiated (Roscoe et al., 2005). It
should be stressed to patients that fatigue is not indicative that treatment is not working
nor that the disease is progressing (Cella, Peterman, & Passik, 1998). Several studies
support the role of educational interventions, such as providing physical sensory
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information, anticipatory guidance, coping skills training and coaching to reduce fatigue
levels (Allison et al., 2004; Fawzy el al., 1990; Given et al., 2002; Yates et al., 2005).
Additional interventions include supportive-expressive group therapy, supportive
intervention therapy including psychosocial support, monthly home visits by support
nurses to assess fatigue, provide psychological support and coach participants in self-care
may be helpful. Ream, Richardson, and Alexander-Dann (2006) evaluated a supportive
intervention for fatigue in patients undergoing chemotherapy. Approximately 100
patients were stratified to either an intervention group (fatigue packet, fatigue diary,
support nurses to visit monthly in home to coach patients on self-care) or standard of
care. The intervention group reported significantly less fatigue, lower distress and less
impact of fatigue on valued past times than the control group. They also reported less
anxiety and depression and displayed more adaptive coping.
Studies testing psychosocial interventions to increase psychosocial support and
reduce stress in cancer patients have shown decreased levels of fatigue. Interventions
included education, support groups, stress management program, individual counseling
and a tailored behavioral intervention (Given et al., 2002). Therapies to relax the patient
such as breathing control, progressive muscle relaxation, relaxation and guided imagery
techniques have been evaluated as effective in controlling fatigue in the patient. Cohen
and Fried (2007) conducted a study in which patients were randomized to either
imagery/relaxation or a control group with a cognitive behavioral plan. Levels of fatigue
and sleep difficulties decreased in both intervention groups; however, there was only a
significantly difference noted in the relaxation and guided imagery group. Armes,
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Chalder, and Addington-Hall (2007) conducted a randomized controlled trial to evaluate
the effectiveness of a behaviorally oriented intervention for cancer-related fatigue. Sixtyfour patients were randomized to receive an intervention consisting of education on
cancer-related fatigue, self-monitoring of fatigue and a cognitive approach for helping
patients clarify the meaning of cancer-related fatigue and the effectiveness of current
coping strategies. The intervention group showed significant improvement in physical
functioning and indicated a trend toward improvement in their fatigue. There was no
effect on distress, anxiety and depression. The power of the study was low because of
sample size.
Activity enhancement, such as exercise interventions, exercise conservation and
energy management may also be helpful. There is strong evidence to support the benefits
of exercise for cancer-related fatigue management. Patients benefit from a low-intensity
exercise program as well as aerobic interval training with appropriate monitoring.
Strength resistance exercise also may be beneficial to these patients. A home-based
exercise program would be beneficial to the cancer patient. Mock et al. (1997) conducted
a study that showed a home-based program exercise programs was beneficial during
chemotherapy and radiation therapy. A more recent meta-analysis review of 19 articles
by Kangas, Bovbjerg, and Montgomery (2008) reported the effectiveness of physical
exercise on fatigue-related outcomes. Exercise interventions were more effective when
administered during therapy as opposed to after completing therapy. Patients with breast
cancer had a better response than other types of cancer.
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In addition to implementing an exercise program to reduce fatigue, energy
conservation also is an important intervention in the management of cancer-related
fatigue. Strategies utilized to teach coping with fatigue include energy conservation and
activity management. Barsevick et al. (2004) conducted clinical trials that showed
patients with cancer benefit from learning energy conservation. Energy conservation
includes teaching the patient about one‟s planned management of activities and personal
energy resources. Rest and activity are maintained while participating in activities
important to the patient. Planning, pacing, scheduling and prioritizing activities,
delegation and resting are important strategies to include in the management plan.
General strategies, such as purchasing labor-saving devices and postponing nonessential
activities help to conserve energy. Naps should be limited to 20-30 minutes or less in
order to prevent interference with sleep (NCCN, 2009).
Complementary therapies and supplements, drug treatments including
hematopoietic growth factors in the anemic patients may also play a role in controlling
the cancer-related fatigue. ONS guidelines for fatigue management emphasize that
clinicians and patients should carefully evaluate potential benefits and harmful effects of
recombinant erythropoietin for individual patients (Mitchell et al., 2007). A recent metaanalysis including 10 studies indicated that treating anemia with erythropoieten did
improve the level of fatigue (Minton, Richardson, Hotopf, & Stone, 2008).
Stimulants, such as methylphenidate hydrochloride has been tested in clinical
studies for use in relieving cancer-related fatigue. Evidence is inconclusive and future
research is warranted (NCCN, 2009).
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Depression and distress identified as a contributing factor to fatigue must be
treated. Andrykowski, Curran, and Lightner (1998) conducted a study with breast cancer
patients to ascertain the correlation between depression and fatigue. Results
demonstrated that the breast cancer group demonstrated significantly higher levels of
fatigue than the matched group of participants with benign breast problem. However, the
two groups did not differ with respect to the amount of depression reported. A study by
Servaes et al. (2002) concluded that there was no causal relationship between
anxiety/depression and fatigue. The two phenomena are closely related, but it appears
another variable might be causing the increase in cancer-related fatigue.
Pharmacologic management of depression may be effective in controlling cancerrelated fatigue (NCCN, 2007). Combining antidepressants and counseling may benefit
the cancer patient with fatigue. Counseling strategies should include education and
behavioral therapy. Counseling becomes very important in helping the patient with
fatigue because in clinical studies indicates that serotonin reuptake inhibitors have no
significant effect on fatigue in the absence of depressed mood (Morrow, Hickok, &
Roscoe, 2003; Roscoe et al., 2005). Antidepressants are not recommended to lower
fatigue (NCCN, 2009). Studies utilizing paroxetime showed that the antidepressant had
no effect on fatigue in patients receiving chemotherapy (Morrow, Hickok, & Roscoe,
2003; Roscoe, Matteson, & Mustain, 2005).
In addition to the various treatment strategies outlined in the aforementioned
section, nursing leadership also serves a pivotal role in recognizing the prevalence and
significance of cancer-related fatigue. Fatigue must be recognized as a serious clinical
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issue that is highly prevalent in this population and is associated with decreased quality of
life. They must understand that the etiology remains to be fully elucidated, and, to date,
there is no universally accepted standard. Healthcare leaders also need to believe that
fatigue is important to assess and manage in both in- and out-patient settings.
Infrastructure and personnel issues need to be controlled in these settings so that strategic
plans can be implemented to assess and manage cancer-related fatigue. Cancer-related
fatigue needs to be made a clinical priority just as pain was several years ago. Healthcare
administrators should be proactive in implementing the National Comprehensive Cancer
Network (NCCN) Guidelines and work with other key leaders in recommending the
guidelines become legally mandated, as with the assessment and management of pain.
Unfortunately, assessment and management of fatigue are not viewed as practice
priorities despite its prevalence. It is incumbent for nursing and hospital administrators to
recognize that managing the cancer patient‟s fatigue will require a team approach as well
as a system that will support understanding and listening to the words of the patient,
assessment of the fatigue and the creation of an environment that encourages
individualized patient care with appropriate staff available to manage the patient‟s
fatigue.
Leadership needs to ensure that the healthcare teams takes deliberate steps to
assess and intervene in improving quality of life beyond the acute stage of illness and into
survivorship. These key leaders also need to take the lead with the oncology healthcare
team in helping cancer patients obtain and retain disability benefits from insurers. The
team also should advocate for cancer patients who require disability. Insurers need to be
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educated about the sequalae of cancer-related fatigue and extend healthcare coverage to
patients experiencing long-term fatigue, such as referrals to physical therapists,
occupational therapists and dieticians. Additionally, disability insurance and coverage
should be available to patients whose fatigue persists with subsequent disability. They
should provide ongoing holistic care including rehabilitation to these patients along with
disability compensation.

Nursing Education Implications
Students as well as professional nurses need to be educated about the severity and
prevalence of cancer-related fatigue. Nursing educators need to increase their focus on
teaching fatigue assessment and management as a way to increase the knowledge and
skills of nurses who can then better manage fatigue. Educators need to teach students to
develop care plans that use evidenced-based interventions for cancer patients
experiencing fatigue. Understanding how pervasive fatigue is among cancer patients is
extremely important to the nursing student. They also must have an understanding that
cancer-related fatigue has a more rapid onset, is more intense, persistent, exhausting and
longer lasting and not relieved easily. Additionally, there needs to be an understanding
that fatigue is not routinely assessed in many clinical settings and often goes unreported,
undiagnosed and untreated. They also need to appreciate that cancer-related fatigue is
different from other types of fatigue and should be assessed and managed differently.
Faculty in schools of nursing also play a role in educating future nurses about the
importance of listening to their cancer patients as they share their stories about their
fatigue. The undergraduate curriculum should include undergraduate nursing students
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being mentored by graduate students in phenomenology studies. This would encourage a
comfort level in interviewing patients in the clinical setting after graduation. Helping
students become proficient with supportive skills to help the patient cope with their
fatigue by listening, clarifying concerns, encouragement, reassurance and demonstrating
empathetic responses is important. Additionally, plans of care should be developed by
the student that include interviewing patients about their fatigue and then developing a
plan specific for the patient‟s story. Additionally, role-playing with students may be
helpful in promoting a comfort level as they initiate a discussion about the fatigue.
Additionally, educators need to integrate the importance of patient education in
the oncology curriculum with a focus on management of cancer-related fatigue. Godino,
Jodan, Duran, Martinez, and Schiaffino (2006) conducted a study to determine whether
patient education decreased perception of fatigue in cancer patients. Results reflected
that individualized and structured patient education reduced the patient‟s level of fatigue.
They also concluded that individualized education and counseling, as well as
individualized support by a trained nurse, provided patients with an effective tool to
manage their fatigue.
In addition, nursing students should be encouraged to utilize non-traditional
approaches in dealing with the patient‟s fatigue. Encouraging patients to journal would be
helpful as well as imagery and relaxation. Visual journaling that allows the patient to
combine words with images would be helpful to the patients in dealing with their feelings
and stress related to their fatigue.
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Both nursing students and nurses should be educated on the various resources
available to both them and their patients. In addition to the Oncology Nursing Society
and the National Comprehensive Cancer Network being resourceful, there are several
websites available that address cancer-related fatigue, both for the professional as well as
the patient (Piper et al., 2008).

Nursing Research Implications
Cancer-related fatigue continues to be a complex phenomenon without a widely
accepted definition. The NCCN has attempted to define cancer-related fatigue but has
failed to recognize that experienced fatigue is disproportionate to the patient‟s level of
exertion. Neither does the definition include that rest does not relieve the patient‟s
fatigue. Therefore, cancer-related fatigue remains one of the least explained phenomena
in oncology. It is the most frequently anticipated side effect of cancer treatment.
Approximately 95% of patients scheduled for cancer treatments expect to experience
some level of fatigue. Cancer-related fatigue also continues for months and even years
following completion of therapy in one-third of patients (Hofman et al., 2004). The
findings of this researcher‟s study revealed that as much as one to five years later, all
patients were continuing to experience fatigue that impacted their physical and cognitive
functioning. Additionally, the findings revealed there were considerable psychological
distress and social isolation as well as significant financial burdens by limiting the
patient‟s ability to work. While understanding the prevalence and chronicity of the
fatigue as well as the impactful effects on the patient‟s quality of life, it is incumbent that
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research continues at full speed ahead in order to relieve suffering associated with this
devastating symptom.
Healthcare professionals have become increasingly aware of the clinical relevance
of cancer-related fatigue and its debilitating effects on the patient. Albeit with this
knowledge, the effect of fatigue on the patient‟s quality of life underscores the need for
more effective management strategies to control the symptom. Essential to the
investigation of better control of this pervasive symptom is the need to understand the
patient‟s perception of their fatigue. In other words, their voices establish the platform
from whence the research begins in understanding what is fatigue, how it affects their
lives and what management strategies need to be developed. Before a standard
methodology to measure fatigue is established, we must understand the words of the
patient. Furthermore, before conceptualizing the definition of cancer-related fatigue, we
need to listen to the words uttered by the patients who endure cancer-related fatigue
today, tomorrow and interminably. Before formulating a comprehensive,
multidisciplinary plan of care for breast cancer patients to help maximize their quality of
life, we must hear their words. Obviously, when there is a better understanding of the
phenomenon by understanding the meaning of fatigue to the patient, then and only then
evidence-based clinical practice guidelines for the management of cancer-related fatigue
will be successfully developed. Until the patient‟s words are heard and understood, this
first step in reducing this unrelenting symptom will not occur.
To further develop nursing science, future studies would be helpful in determining
the usefulness of the themes about the fatigue in clinical practice. By understanding the
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meaning of the symptoms fatigue precipitates will help tailor interventions to the
individual patient population. To increase theoretical understanding and improve
therapeutic nursing interventions, further research on understanding the experience of
cancer-related fatigue with resultant identification of strategies to minimize or ameliorate
the fatigue is warranted. In addition, further research is needed to document the
progression of fatigue over the course of a cancer treatment, such as radiotherapy and
chemotherapy. A nursing theory about fatigue that examines the relationship between the
cancer patient‟s fatigue, the perception of the patient‟s quality of life (subjective) and
various changes in interleukin-6 and /hemoglobin level (objective) responses also would
be useful to healthcare professionals.
Further research is needed to identify a standardized way of measuring fatigue as
well as strategies to prevent physical deconditioning thereby allowing patients with
fatigue to continue engaging in meaningful activities. Also additional research is needed
to develop effective strategies that help patients to decrease barriers to exercise and to
increase adherence to exercise programs. Further research is needed to test the efficacy
of self-care activities that may reduce the fatigue and thus improve quality of life of the
cancer patient. Research also is needed to evaluate whether reducing depression and
changing coping strategies improve cancer-related fatigue. In order to assess cancerrelated fatigue more in-depth, additional research involving the trajectory preceding
adjuvant chemotherapy and longer study periods after completion of chemotherapy is
warranted.
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The strategy proposed by the researcher identifies themes about the experience of
cancer-related fatigue which will serve as the basis to develop strategies for reducing the
patient‟s level of fatigue. The findings of such research provide nurses with a sound
empirical basis for recommending effective self-care activities to relieve the fatigue.
Given the magnitude of the women‟s complaint about changes in cognitive
functioning and the significance of cognitive dysfunctioning post-chemotherapy in the
oncology literature, the oncology nursing community must remain up-to-date in its
knowledge of cognitive changes in this patient population. Appropriate assessments,
interventions, patient education and referrals to specialty services are paramount for the
nurse to implement with these patients. To better understand cognitive dysfunction, the
nurse should spearhead clinical studies to address specific assessments and interventions.
Subsequently, the results could be implemented into evidence-based practice and clinical
pathways to enhance the patient‟s quality of life while they are dealing with both fatigue
and cognitive dysfunction. Additionally, further phenomenological studies are warranted
to specifically address the cognitive changes in fatigued cancer patients since this was
such a major concern for the breast cancer patients in the study.
Continued research is warranted in understanding the etiologic factors that cause
fatigue as well as management strategies. However, as mentioned previously, to
successfully address this debilitating symptom, the research focus also must change.
Conducting phenomenological studies in order to understand the patient‟s perspective is
the first step before further qualitative and quantitative research should be embraced and
pursued. Understanding the meaning of the fatigue for each patient is necessary before
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there can be a furtherance of controlling and managing the patient‟s fatigue.
Understanding the experience of the patient‟s fatigue serves as the foundation from which
other research studies can evolve. It is felt that researchers will continue, “to spin their
wheels” until we have a clear understanding what it is like to walk in the patient‟s
moccasins.
By looking through the lens of the patient‟s experience, nurses can began to
articulate those findings to practitioners and other healthcare team members as well as
hospital administrators. Sharing those findings with reimbursement specialists also will
reinforce the major problem to third party reimbursement companies. They, too, need an
appreciation of the problem as the debilitating fatigue increases healthcare costs as well
as impacts not only the patient but also family members who cannot remain fully
employed as they care for their loved one with ongoing fatigue.
In addition to understanding fatigue in breast cancer patients, it is also important
that further research is needed to address patients with different types of cancer. To
appreciate the true experience of the cancer-related fatigue phenomenon, further studies
need to be conducted with other groups of patients, not only including different cancers
but different age groups. Studies are also warranted in long-term survivors as well as
patients at different points in the illness experience including both male and female
participants.
Understanding the level of fatigue in patients prior to the initiation of therapy
would also be beneficial. Understanding the patient‟s health status at the beginning of
treatment may be helpful to the healthcare provider. Listening to the words of the patient
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as he/she describes the meaning of the onset, duration and pattern on the fatigue may help
identify treatment strategies early in the treatment continuum. Not until we have a fuller
understanding of the phenomena can we began to appreciate what cancer-related fatigue
is and neither can we begin to identify interventions nor develop evidenced-based clinical
practice guidelines. Without the patients sharing their stories about their experience of
fatigue, these goals are non-existent and at best, are only words. They are only words
written in textbooks and journals to perhaps help healthcare professionals feel less guilty
and more confident as they address and manage the number one complaint cancer
patients have had for the past 25 years.
In summary, cancer patients perceive fatigue as the symptom with the highest
impact on their daily living as well as substantially affects and creates functional,
psychological, cognitive and socioeconomical issues. This symptom is deserving of
clinical attention and clinicians must be aware of this phenomenon and undertake
methods of amelioration. This debilitating symptom, without a doubt, is one of the most
discussed and researched topics in the specialty of oncology, but only from a quantitative
perspective. Despite the plethora of studies focused on answering the question of how to
manage fatigue, inconsistencies still prevail and a general conclusion cannot be made.
Unfortunately, these studies have not translated into improved management strategies for
the suffering patients with diminished quality of lives secondary to their fatigue. Despite
efforts to determine causative factors and to identify better treatment strategies, fatigue
remains the most common and pervasive symptom cancer patients experience. To
address these issues, we must listen to the words of our patients:
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Being tired is an understatement! My tiredness was not the tiredness I had after a
busy day. It was like you stayed up all night and then heavy weights were placed
on your entire body. I would try to lift my left arm and it would take everything
in my body to slightly raise it and then it was so hard to put my arm back down.
My legs were so heavy…it took everything in me to take a few steps. Just putting
my makeup on literally wore me out. I was so tired I could not even button my
shirt or zip my pants. I was even too tired to sing a song. I could not even eat.
The thought of eating made me tired. I was too tired to pick up a glass of water at
my bedside….it was the worst thing imaginable….I cannot describe how awful it
was. The worst part was that it affected my mind. I couldn‟t remember things. I
couldn‟t balance my check book. I forgot how to get home one day….that was
really scary to me. Though the tiredness was overwhelming I could not let it
consume me…I could not let it get me down. I kept up the faith by peering
through my window pane and having “small windows of hope”.

176

LIST OF REFERENCES

177

References

Adamsen, L. (2009). Effect of a multimodal high intensity exercise intervention in
cancer patients undergoing chemotherapy: Randomized controlled trial. British
Medical Journal, 339, b3410.
Ahlberg, K., Ekman, T., & Gaston-Johansson, F. (2005). Fatigue, psychological distress,
coping resources, and functional status during radiotherapy for uterine cancer.
Oncology Nursing Forum, 32, 633-640.
Ahles, T., & Saykin, J. (2007). Candidate mechanisms for chemotherapy-induced
cognitive changes. Nature Reviews Cancer, 7(3), 192-201.
Ahles, T., & Saykin, A. (2002). Breast cancer chemotherapy-related cognitive
dysfunction. Clinical Breast Cancer, 3 (suppl. 3), S84-S90.
Ahles, T., Saykin, C., Furstenberg, C., Cole, B., Mott, L., Skalla, K., … Silberfarb, P.
(1998). Neuropsychologic impact of standard dose systemic chemotherapy in
long-term survivors of breast cancer and lymphoma. Journal of Clinical
Oncology, 485-493.
Aistairs, J. (1987). Fatigue in the cancer patient: A conceptual approach to a clinical
problem. Oncology Nursing Forum, 14, 25-30.
Alexander, S., Minton, O., Andrews, P., & Stone, P. (2009). A comparison of the
characteristics of disease-free breast cancer survivors with or without cancerrelated fatigue syndrome. European Journal of Cancer, 45(3), 384-392.
Alexander, S., Minton, O., & Stone, P. (2009). Evaluation of screening instruments for
cancer-related fatigue syndrome in breast cancer survivors. Journal of Clinical
Oncology, 27(8), 1197-1201.
178

Alligood, M.A., & Tomey, A.M. (2006). Nursing theory utilization and application. St.
Louis: Mosby.
Allison, P., Edgar, L, Nicolau, B., Archer, J., Black, M., & Hier, M. (2004). Results of a
feasibility study for a psycho-educational intervention in head and neck cancer.
Psycho-Oncology, 13 (7), 482-485.
Al-Majid, S., & Gray, D. (2009). A biobehavioral model for the study of exercise
interventions in cancer-related fatigue. Biologic Research Nursing, 10(4),
381-391.
Ancoli-Israel, L., Marler, M., & Liu, L. (2006). Fatigue, sleep, and circadian rhythms
prior to chemotherapy for breast cancer. Support Care Cancer, 14(3), 201-209.
Andrykowski, M., Curran, S., & Lightner, R. (1998). Off-treatment fatigue in breast
cancer survivors: A controlled comparison. Journal of Behavioral Medicine,
21, 1-18.
Armes, J., Chalder, T., & Addington-Hall, J. (2007). A randomized controlled trial to
evaluate the effectiveness of a brief, behaviorally oriented intervention of cancerrelated fatigue. Cancer, 110, 1385-95.
Barsevick A., Berger, A., Bakken, S., & Cetak, M. (2007). The elusive concept of the
symptom cluster. Oncology Nursing Forum, 34(5), 971-980.
Barsevick, A., Dudley, W., Beck, S., Sweeney, C., Whitmer, K., & Nail, L. (2004).
Randomized clinical trial of energy conservation for cancer-related fatigue.
Cancer, 100(6), 1302-1310.
Barsevick, A., Whitmer, K., Sweeney, C., & Nail, L. (2002). A pilot study examining
energy conservation for cancer treatment-related fatigue. Cancer Nursing,
25, 333-49.

179

Barsevick, A., Beck, S., & Sweeney, C. (2002). A randomized clinical trial of energy
conservation training versus attentional control during cancer treatment.
Oncology Nursing Forum, 29, 377.
Barton, D., Soori, G., Bauer, B., Sloan, J., Johnson, P., Figueras, C., et al. (2009). Pilot
study of panax quinquefolius (American ginseng) to improve cancer-related: A
randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA.
Supportive Care Cancer. Retrieved November 14, 2009 from
http://www.springerlink.com/content.
Beach, P., Siebeneck, B., Buderer, N., & Ferner, T. (2001). Relationship between fatigue
and nutritional status in patients receiving radiation therapy to treat lung cancer.
Oncology Nursing Forum, 28, 102-10.
Ben-Eliyahu, S. (2003). The promotion of tumor metastasis by surgery and stress:
Immunological basis and implications for psychoneuroimmunology. Brain
Behavior and Immunology, 17(1), S 8.
Berger, A., Kuhn, B., & Farr, L. (2009). Behavioral therapy interventions trial to
improve sleep quality and cancer-related fatigue. Psychooncology, 18(6),
634-646.
Berger, A., & Mitchell, S. (2008). Modifying cancer-related fatigue by optimizing sleep
quality. Journal National Comprehensive Cancer Network, 6, 3-13.
Berger, A., Parker, K., & Young-McCaughan, S.(2005). Sleep wake disturbances
in people with cancer and their caregivers: State of the science, online. Oncology
Nursing Forum, 32(6), E98-E126. Retrieved August 30, 2009 from
http://ons.metapress.com.
Berger, A. (2003). Treating fatigue in cancer patients. The Oncologist, 8, 10-14.
Berger, A., Higginbotham, P., & VonEssen, S. (2002). Outcomes of a sleep
180

intervention following adjuvant chemotherapy. Oncology Nursing Forum, 29 (3),
334-391.
Berger, A., VonEssen, S., & Khun, R. (2002). Feasibility of a sleep intervention
during adjuvant breast cancer chemotherapy. Oncology Nursing Forum, 29, 431441.
Berger, A. (1998). Patterns of fatigue and activity and rest during adjuvant breast cancer
chemotherapy. Oncology Nursing Forum, 25, 51–62.
Blair, S., Bardwell, W., Podbelewicz-Schuller, Y., & Mortimer, J. (2008). Correlation
between hemoglobin and fatigue in women undergoing adjuvant chemotherapy
without erythropoietin-stimulating agent support. Clinical Breast Cancer, 8(6),
522-526.
Blesch, K., Paice, J., & Wickham, R. (1991). Correlates of fatigue in people with
breast or lung cancer. Oncology Nursing Forum, 18, 81-87.
Bootzin, R., Epstein, D., & Wood, J. (1991). Stimulus control instructions. In P. Hauri
(Ed.), Case studies in insomnia (pp. 19-28). New York: Plenum Press.
Borneman, T., Piper, B., & Sun, V. (2007). Implementing the fatigue guidelines at
one NCCN member institution: Process and outcomes. Journal of the National
Comprehensive Cancer Network, 5 (10), 1092-1101.
Bower, J. (2008). Behavioral symptoms in patients with breast cancer and survivors.
Journal of Clinical Oncology, 26, 768-777.
Bower, J., & Ganz, P. (2007). Cancer related fatigue: A focus on breast and Hodgkin‟s
disease survivors. Acta Oncology, 46(4), 474-479.
Bower, J., Ganz, P., Desmond, K., Bernaards, C., Rowland, J., Meyerowitz, B., … Belin,
R. (2006). Fatigue in long-term breast carcinoma survivors: A longitudinal
investigation. Cancer, 106 (4), 751-758.
181

Bower, J., Ganz, P., Aziz, N., & Fahey, J. (2002). Fatigue and proinflammatory cytokine
activity in breast cancer survivors. Psychosomatic Medicine, 64, 604-611.
Bower, J., Ganz, P., & Desmond, K. (2000). Occurrence, correlates, and impact on
quality of life. Journal of Clinical Oncology, 18, 743-753.
Breitbart, W., & Alici, Y. (2008). Pharmacologic treatment options for cancer-related
fatigue: Current state of clinical research. Clinical Journal of Oncology Nursing,
12(5 Suppl.), 27-36.
Breithart, W., Cella, D., & Curt, G. (2000). The impact of fatigue on patients with
cancer: An overview on the lives of patients. The Oncologist, 5 (2), 2-12.
Brown, P., Clark, M., Atherton, P., Huschka, M., Sloan, J., Gamble, G., et al. (2006).
Will improvement in quality of life (QOL) impact fatigue in patients receiving
radiation therapy for advanced cancer? American Journal of Clinical Oncology,
29(1), 52-58.
Brown, M., Simon, J., & Stemmer, S. (1995). MR and proton spectroscopy of white
matter disease induced by high-dose chemotherapy with bone marrow transplant
in advanced breast carcinoma. American Journal of Neuroradiology, 16(10),
2013-2020.
Brunier, G., & Graydon, J. (1993). The influence of physical activity on fatigue in
patients with ESRD on hemodialysis. ANNA Journal, 20, 457-461.
Burks, T. (2001). New agents for the treatment of cancer-related fatigue. Cancer, 92,
1714-1718.
Butt, Z., Wagner, L., & Beaumont, J. (2008). Longitudinal screening and
management of fatigue, pain, and emotional distress associated with cancer
therapy. Support Care Cancer, 16, 151-159.
Byar, K., Berger, A., Bakken, S., & Cetak, M. (2006). Impact of adjuvant breast cancer
182

chemotherapy on fatigue, other symptoms, and quality of life. Oncology Nursing
Forum, 33(1), E 18-26.
Camarillo, M. A. (1991). The oncology patient‟s experience of fatigue. In M. Whedon
(Ed.), Quality of life: A nursing challenge (pp. 39-44). Philadelphia: Meniscus.
Capuron, L., Gumnick, F., & Musselman, D. (2002). Neurobehavioral effects of
interferon alpha in cancer patients: Paroxetine responsiveness of symptom
dimensions. Neuropsychopharmacology, 26, 643-652.
Cardenas, D., & Kutner, N. (1982). The problem of fatigue in dialysis patients.
Nephron, 30, 366-340.
Carlson, L., Speca, M., Faris, P., & Patel, K. (2007). One year pre-post intervention
follow-up of psychological, immune, endocrine and blood pressure outcomes of
mindfulness-based stress reduction (MBSR) in breast and prostate cancer
outpatients. Brain Behavior and Immunity, 21(8), 1038-1049.i8.
Carlson, L., Speca, M., & Patel, K. (2004). Mindfulness-based stress reduction in
relation to quality of life, mood, symptoms of stress and levels of cortisol,
dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate
cancer outpatients. Psychoneuroendocrinology, 29, 448-474.
Cella, D., Lai, J., & Chang, C. (2002). Fatigue and cancer patients compared with
fatigue in the general population. Cancer, 94, 528-38.
Cella, D., Peterman, A., & Passik, S. (1998). Progress toward guidelines for the
management of fatigue. Oncology, 12 (11A), 369-377.
Cimprich, B. & Ronis, D. (2003). An environmental intervention to restore attention in
women with newly diagnosed breast cancer. Cancer Nursing, 26, 284-294.
Cimprich, B. (2001). Attention and symptom distress in women with and without breast
cancer. Nursing Research, 50, 86–94.
183

Cimprich, B. (1995). Symptom management: Loss of concentration. Seminars in
Oncology Nursing, 11, 279-288.
Cimprich, B. (1993). Development of an intervention to restore attention in cancer
patients. Cancer Nursing, 16, 83-92.
Cimprich, B. (1992). Attentional fatigue following breast cancer surgery. Research in
Nursing and Health, 15, 199-207.
Cleeland, C. (2001). Cancer-related fatigue: New directions for research. Cancer, 92,
1657-1661.
Cleeland, C., & Wang, X. (1999). Measuring and understanding fatigue. Oncology, 13,
91-97.
Cohen, M, & Fried, G. (2007). Comparing relaxation training and cognitive-behavioral
group therapy for women with breast cancer. Research on Social Work Practice,
17, 313-323.
Cohen, L., Warneke, C., & Fouladi, R. (2004). Psychological adjustment and sleep
quality in a randomized trial of the effects of a Tibetan yoga intervention in
patients with lymphoma. Cancer, 100, 2253-2260.
Collado-Hidalgo, A., Bower, J., Ganz, P., Cole, S, & Irwin, M. (2006). Inflammatory
biomarkers for persistent in breast cancer survivors. Clinical Cancer
Research, 12 (9), 2759-2766.
Conn, S., Hafdahl, A., Porock D., McDaniel R., & Nielsen P. (2006). A meta-analysis of
exercise interventions among people treated for cancer. Supportive Care,
14, 699–712.
Courneya, K., & Friedenreich, C. (1999). Physical exercise and quality of life following
cancer diagnosis: A literature review. Annals of Behavioral Medicine, 21, 17179.
184

Creswell, J. (2009). Research design qualitative, quantitative, and mixed methods
approaches. Thousand Oaks: Sage Publications.
Crews, D., & Landers, D. (1987). A meta-analytic review of aerobic fitness and
reactivity to psychosocial stressors. Medicine and Science in Sports and Exercise,
19, 5114-5120.
Dagnelie, P., Pijls-Johannesma, M., & Lambin, P. (2007). Impact of fatigue on overall
quality of life in lung and breast cancer patients selected for high-dose
radiotherapy. Annals of Oncology, 18, 940-944.
Danhauer, S., Mihalki, S., Russell, G., Campbell, C., Felder, L., Daley, L., et al. (2009).
Restorative yoga for women with breast cancer: Findings from a randomized pilot
study. Psychooncology, 18(4), 360-368.
Dantzer, R. (2001). Cytokine-induced sickness behavior: Where do we stand? Brain
Behavior and Immunology, 15, 7-24.
Dantzer, R., & Bluthe, R. (1993). Behavioral effects of cytokines: An insight into
mechanisms of sickness behavior. In E. G. DeSouza (Ed.), Neurobiology of
Cytokines (pp. 130-151). San Diego: Academic Press.
Davidson, J., Waisberg, J., Brundage, M., & MacLean, A. (2001). Nonpharmacologic
group treatment of insomnia: A preliminary study with cancer survivors.
Psychooncology, 10, 389-397.
Dean, G., & Spurs, L. (1999). Fatigue in patients with cancer receiving interferon
alpha. Cancer Practice, 3 (3), 164-172.
Dean, G., & Ferrell, B. (1995). Impact of fatigue on quality of life in cancer survivors.
Quality of Life, 4:25–28.

185

De Jong, N., Candel, M., & Schouten, H. (2004). Mental fatigue and motivation in breast
cancer patients receiving adjuvant chemotherapy. Annals of Oncology, 16, 372382.
Demetri, G., Kris, M., Wade, K., Degos, L., & Cella, D. (1998). Quality of life benefit
in chemotherapy patients treated with epoetin alfa is independent of disease
response or tumor type: Results from a prospective community oncology study.
Journal of Clinical Oncology, 16, 3412-3425.
Denzin, N., & Lincolon, Y. (1998). The landscape of qualitative research. Thousand
Oaks, CA: Sage Publication.
Diaz, N., Menjon, S., Rolfo, C., Garcia-Alonso, P., Carulla, J., Magro, A., et al. (2008).
Patients‟ perception of cancer-related fatigue: Results of a survey to assess the
impact on their everyday life. Clinical Translation Oncology, 10(11), 753-757.
Dimeo, F., Tilmann, M., Bertz, H., Kanz, L., Mertelsmann, R., & Keul, J. (1997).
Aerobic exercise in the rehabilitation of cancer patients after high dose
chemotherapy and autologous peripheral stem cell transplantation. Cancer, 79,
1717–1722.
Dimeo, F., Berzt, H., Fink, J., Fetscher, S., Mertelsmann, C., & Keul, J. (1996). An
aerobic training program for patients with hematological malignancies after bone
marrow transplantation. Bone Marrow Transplantation, 18, 1157-1160.
Dirksen, S., & Epstein, D. (2008). Efficacy of an insomnia intervention on fatigue, mood
and quality of life in breast cancer survivors. Journal of Advanced Nursing,
61(6), 664-675.
Dodd, M., Janson, S., & Facione, N. (2001). Advancing the science of symptom
management. Journal of Advanced Nursing, 33(5), 668-676.
Dolbeault, S., Cayrou, S., & Bredart, A. (2009). The effectiveness of a psycho186

educational group after early-stage breast cancer treatment: Results of a
randomized French study. Psychooncology, 18(6), 647-656.
Donnelly, C., Lowe-Strong, A., Rankin, J., Campbell, A., Allen, J., & Gracey, J. (2009).
Physiotherapy management of cancer-related fatigue: A survey of UK current
practice. Support Care in Cancer.
Doukas, M., & Gallicchio, V. (1995). Cytokine modulation of radiation injury. In B.
Aggarwal and R. Puri (Eds.). Human cytokines: Their role in disease and
therapy (pp. 565-566). Massachusetts: Blackwell Science, Inc. Retrieved
November 15, 2009 from http://www.springerlink.com.
Einhorn, L. (2009). Persistent Fatigue. Journal of Supportive Oncology, 7, 30.
Fawcett, J. (2004). Contemporary Nursing Knowledge: Analysis and evaluation of
nursing models and theories. Philadelphia: F. A. Davis Company.
Fawcett, J. (1999). The relationship of theory and research. Philadelphia: F. A. Davis
Company.
Fawzy, N. (1995). A psychoeducational nursing intervention to enhance coping and
affective state in newly diagnosed malignant melanoma patients. Cancer
Nursing, 18, 427-38.
Fawzy, F., Cousins, N., Fawzy, N., Kemeny, M., Elashoff, R., & Morton, D. (1990). A
structured psychiatric intervention for cancer patients: Changes over time in
methods of coping and affective disturbance. Archives of General Psychiatry, 47,
720-725.
Ferguson, R., McDonald, B., Saykin, A., & Ahles, T. (2007). Cognitive-behavioral
management of chemotherapy-related cognitive change. Psychooncology, 16(8),
772-777.

187

Fernandes, R., Stone, P., Andrews, P., Morgan, R., & Sharma, S. (2006). Comparison
between fatigue, sleep disturbance, and sleep disturbances, and circadian rhythm
in cancer inpatients and healthy volunteers: Evaluation of diagnostic criteria for
cancer-related fatigue. Journal of Pain Symptom Management, 32(3), 245-254.
Ferrell, B. (2008). From research to practice: Quality of life assessment in medical
oncology. Journal of Supportive Oncology, 6, 230-231.
Ferrell, B., Grant, M., Dean, G., Funk, B., & Ly, J. (1996). “Bone tired”: The experience
of fatigue and its impact on quality of life. Oncology Nursing Forum, 23 (10),
4-8.
Flechtner, H., & Bottomley, A. (2003). Fatigue and quality of life: Lessons from the real
world. The Oncologist, 8 (supplement 1), 5-9.
Frankl, V. (1962). Man’s search for meaning: An introduction to logotherapy, Boston:
Beacon Press.
Fu, M., & Anderson, C. (2002). Patients‟ perception of fatigue in response to biotherapy
of metastatic melanoma: A preliminary study. Oncology Nursing Forum, 29 (6),
961-966.
Gabrilove, J., Cleeland, C., & Livingston, R. (2001). Clinical evaluation of onceweekly dosing of epoetin alfa in chemotherapy patients: Improvements in
hemoglobin and quality of life are similar to three times weekly doing.
Journal of Clinical Oncology, 19, 2875-82.
Gielissen, M., Verhagen, C., & Bleijenberg, G. (2007). Cognitive behavior therapy for
fatigued cancer survivors: Long term follow-up. British Journal of Cancer. 97
(5), 612-618.
Gielissen, M., Verhazen, C., & Witjes, G. (2006). Effects of cognitive behavior therapy
in severely fatigued disease-free cancer patients compared with patients waiting
188

for cognitive behavior therapy: A randomized controlled trial. Journal of Clinical
Oncology, 24 (30), 4882-4887.
Given, B. (2007). Cancer-related fatigue: The sixth vital sign? Spotlight on Symposia,
From ONS 32nd Annual Congress, 22 (8), 17-18.
Given, B., Given, C., & McCorkle, R. (2002). Pain and fatigue management results of
a nursing randomized clinical trial. Oncology Nursing Forum, 29, 949-56.
Glaspy, J., Bukowski, R., & Steinberg, D. (1997). Impact of therapy with epoetin alfa
on clinical outcomes in patients with nonmyeloid malignancies during cancer
chemotherapy in community oncology practice. Journal of Clinical Oncology,
15, 1218-1234.
Glaus, A., Crow, R., & Hammond, S. (1996). A qualitative study to explore the concept
of fatigue of fatigue/tiredness in cancer patients and in healthy individuals.
Supportive Care Cancer, 4, 82.
Godino, C., Jodar, L., Duran, A., Martinez, I. & Schiaffino, A. (2006). Nursing education
as intervention to decrease fatigue perception in oncology patients. European
Journal of Oncology Nursing, 10 (2), 150-155.
Goldstein, D., Bennett, B., Friedlander, M., Davenport, T., Hickie, I., & Lloyd, A.
(2006). Fatigue states after cancer treatment occur both in association with,

and independent of, mood disorder: A longitudinal study. BMC Cancer, 6,
40.
Greenberg, D., Gray, J., & Mannix, C. (1993). Treatment-related fatigue and serum
interleukin-1 levels in patients during external beam irradiation for prostate
cancer. Journal of Pain and Symptom Management, 8 (4), 196-200.
Greenberg, D., Sawicka, J., Eisenthal, S., & Ross, D. (1992). Fatigue syndrome due to
localized radiation. Journal of Pain and Symptom Management, 8 (4), 196-200.
189

Grober, S. E. (2002). Resources for treatment of chemotherapy-related cognitive
difficulty. Cancer Practice, 10 (4), 216-218.
Groopman, J., & Itri, L. (1999). Chemotherapy-induced anemia in adults: Incidence
and treatment. Journal of National Cancer Institute, 92, 497.
Gutstein, H. (2001). The biologic basis of fatigue. Cancer, 92, 1678-83.
Hadorn, D., Baker, D., Hodges, J., & Hicks, N. (1996). Rating the quality of evidence for
clinical practice guidelines. Journal of Clinical Epidemiology, 49, 749-754.
Hakim, F., Copeda, R., & Kaimei, S. (1997). Constraints on CD4 recovery
postchemotherapy in adults: Thymic insufficiency and apoptotic decline of
expanded peripheral CD4 cells, Blood, 90, 3789-3798.
Hanna, L., Avila, P., Meteer, J., Nicholas, D., & Kaminsky, L. (2008). The effects of a
comprehensive exercise program on physical function, fatigue and mood in
patients with various types of cancer. Oncology Nursing Forum, 35 (3), 461-469.
Hartvig, P., Aulin, J., Hugerth, M., Wallenbery, S., & Wagenius, G. (2006). Journal of
Oncology Pharmacy, 12 (3), 155-164.
Hayes, J. (1991). Depression and chronic fatigue in cancer patients. Primary Care, 18,
327-339.
Heidegger, M. (1962). Being and Time. New York: Harper & Row.
Hickok, J., Morrow, G., Roscoe, J., Mustian, K., & Okunieff, P. (2005). Occurrence,
severity and longitudinal course of twelve common symptoms in 1129
consecutive patients during radiotherapy for cancer. Journal of Pain and
Symptom Management, 30 (5), 433-442.
Hofman, M., Ryan, J., Figueroa-Moseley, C., Jean-Pierre, P., & Morrow, G. (2007).
Cancer-related fatigue: The scale of the problem, Oncologist, 12, Suppl. 1, 4-10.
Hofman, M., Morrow, G., & Roscoe, J. (2004). Cancer patients‟ expectations of
190

experiencing treatment-related side effects: A University of Rochester Cancer
Center-Community Clinical Oncology Program of 938 patients from community
practice. Cancer, 101, 851-857.
Holland, J., Andersen, B., & Breitbart, W. (2007). NCCN Clinical Practice
Guidelines in Oncology. Distress management. Retrieved August 30, 2009 from
http://www.ncc.org/professionals/physician_gls/PDF/distress.pdf.
Holley, S. (2000). Evaluating patient distress from cancer-related fatigue: An instrument
development study. Oncology Nursing Forum, 27, 1425-1431.
Inui A. 1995. Cancer anorexia-cachexia syndrome: Are neuropeptides the key? Cancer
Research, 59, 4493-4501.
Irvine, D., Vincent, L., Graydon, J., Bubela, N., & Thompson, L. (1994). The prevalence
and correlation of fatigue in patients receiving treatment with chemotherapy and
radiotherapy. Cancer Nursing, 17, 367-378.
Jacobsen, P. (2004). Assessment of fatigue in cancer patients. Journal National Cancer
Institute Monograph, 32, 93-97.
Jacobsen, P., Hann, D., Azzarello, L., Horton, J., Balducci, L., & Lyman, G. (1999).
Symptom management of the patient receiving chemotherapy. Journal of Pain
and Symptom Management, 18, 233-242.
Jakobsson, S., Ekman, T., & Ahlberg, K. (2008). Components that influence assessment
and management of cancer-related symptoms: An interdisciplinary perspective.
Oncology Nursing Forum, 35 (4), 691-697.
Jansen, C., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). Potential
mechanisms for chemotherapy-induced impairments in cognitive function.
Oncology Nursing Forum, 32 (6), 1151-1163.

191

Jean-Pierre, P., Figueroa-Moseley, C., Kohli, S., Fiscella, K., Palesh, O., & Morrow, G.
(2007). The Oncologist, 12, 11-21.
Kangas, M., Bovbjerg, D., & Montgomery, G. (2008). Cancer-related fatigue: A
systematic and meta-analytic review of non-pharmacological therapies for cancer
patients. Psychology Bulletin, 134, 700-741.
Kim, S., Son, B., Hwang, S., Han, W., Yang, J., Lee, S., et al. (2008). Fatigue and
depression in disease-free breast cancer survivors: prevalence, correlates, and
association with quality of life. Journal of Pain Symptom Management, 35 (6),
644-655.
Kim, Y., Hickok, J., & Morrow, G. (2007). Fatigue and depression in cancer patients
undergoing chemotherapy: An Emotional Approach. Journal of Pain and
Symptom Management, 32, 311-321.
Kim, S., & Kim, H. (2005). Effects of a relaxation breathing exercise on fatigue in
hematopoietic stem cell transplantation patients. Journal of Clinical Nursing,
14 (1), 51-55.
Lai, J., Cella, D., & Dineen, K. (2005). An item bank was created to improve the
measurement of cancer-related fatigue. Journal of Clinical Epidemiology, 58,
190-197.
Lindqvist, O., Widmark, A., & Rasmussen, B. (2004). Meanings of the phenomenon of
fatigue as narrated by 4 patients with cancer in palliative care. Cancer Nursing,
27, 237-243.
Littlewood, T., Kallich, J., & San Miguel, J. (2006). Efficacy of darbopoetin alfa in
alleviating fatigue and the effect of fatigue on quality of life in anemic patients
with lymphoproliferative malignancies. Journal of Pain Symptom Management,
31, 17–325.
192

Littlewood, T., Bajetta, E., & Nortier, J. (2002). Effects of epoetin alfa on hematologic
parameters and quality of life in cancer patients receiving nonplatinum
chemotherapy: Results of a randomized, double-blind, placebo-controlled trial.
Journal of Clinical Oncology, 19, 2865-74.
Losito, J., Murphy, S., & Thomas M. (2006). The effects of group exercise on fatigue
and quality of life during cancer treatment. Oncology Nursing Forum, 33, 821825.
MacVicar, M., & Winningham, M. (1986). Promoting the functional capacity of cancer
patients. Cancer Bulletin, 38, 235-239.
Mao, J., Styles, T., Cheville, A., Wolf, J., Fernandes, S., & Farrar, J. (2009).
Acupuncture for nonpallitative radiation therapy-related fatigue: Feasibility study.
Journal of Social and Integrative Oncology, 7 (2), 52-58.
Maxwell, M. (1984). The AA experience: A close up view for professionals. New York:
McGraw-Hill.
McCann, K., & Boore, J. (2000). Fatigue in persons with renal failure who require
maintenance hemodialysis. Journal of Advanced Nursing, 2 (5), 1132-1142.
McDaniel, J., Musselman, D., & Porter, M. (1995). Depression in patients with cancer:
Diagnosis, biology, and treatment. Archives of General Psychiatry, 52, 89-99.
McDonald, M., Passki, S., Dugan, W., Rosenfeld, B., Tehobald, D., & Edgerton, S.
(1999). Nurses‟ recognition of depression in their patients with cancer. Oncology
Nursing Forum, 26, 593-599.
Meeske, K., Smith, A., & Alfano, C. (2007). Fatigue in breast cancer survivors two to
five years postdiagnosis: A HEAL study report. Qualitative Life Research,
16 (6):947–960.

193

Merleau-Ponty, M. (1962). The phenomenology of perception (C. Smith, trans.).
London: Routledge and Kegan Paul.
Messias, D., Yeager, K., Dibble, S., & Dodd, J. (1997). Patients‟ perspectives of fatigue
while undergoing chemotherapy. Oncology Nursing Forum, 24 (1), 43-48.
Meyer, C. (2000). Neurocognitive dysfunction in cancer patients. Oncology, 14(1), 7579.
Minton, O., & Stone, P. (2009). A systematic review of the scales used for the
measurement of cancer-related fatigue (CRF). Annals of Oncology, 20(1), 17-25.
Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. (2008). A systematic
review and meta-analysis of the pharmacological treatment of cancer-related
fatigue. Journal of Cancer Institute, 100, 1155-1166.
Mitchell, S., Beck, S., & Hood, L. (2007). Putting evidence into practice: EvidenceBased interventions for fatigue during and following cancer and its treatment.
Clinical Journal of Oncology Nursing, 11(1), 99-113.
Mock, V., Pickett, M., & Ropka, M. (2002). Fatigue and quality of life outcomes of
exercise during cancer treatment. Cancer Practice, 119-27.
Mock, V., McCorkle, R., Ropka, M., Pickett, M., & Poniatowski, B. (2002). Fatigue and
physical functioning during breast cancer treatment. Oncology Nursing Forum,
29, 338.
Mock, V. (2001). Fatigue management: Evidence and guidelines for practice. Cancer,
92 (6 suppl.), 1699-1707.
Mock, V., Atkinson, A., & Barsevick, A. (2000). National Comprehensive Cancer
Network: Oncology practice guidelines for cancer-related fatigue. Oncology, 14,
151-61.

194

Mock, V., Dow, K., & Meares C. (1997). Effects of exercise on fatigue, physical
functioning, and emotional distress during radiation therapy for breast cancer.
Oncology Nursing Forum, 24, 991-1000.
Montgomery, G., Kangas, M., David, D., Halilquist, M., Green, S., Boybjerg, D. et al.
(2009). Fatigue during breast cancer radiotherapy: An initial randomized study of
cognitive-behavioral therapy plus hypnosis. Health Psychology, 28 (3), 317-322.
Mormont, M., Waterhouse, J., & Bleuzen, P. (2000). Marked 24-hour rest/activity
rhythms are associated with better quality of life, better response, and longer
survival in patients with metastatic colorectal cancer and good performance
status. Clinical Cancer Research, 6, 3038–3045.
Morrow, G., Hickok, J., & Roscoe, J. (2003). Differential effects of paroxetine on
fatigue and depression: A randomized, double-blind trial from the University of
Rochester Cancer Center Community Clinical Oncology Program. Journal of
Clinical Oncology, 21(24), 4635-4641.
Morrow, G., Andrews, P., Hickok, J., Roscoe, J., & Matteson, S. (2002). Fatigue
associated with cancer and its treatment. Supportive Care Cancer, 10, 389-398.
Morrow, G., Hickok, J., & Raubertas, R. (2001). Effect of an SSRI antidepressant on
fatigue and depression in seven hundred thirty-eight cancer patients treated with
chemotherapy: A URCCCCOP Study. Proceedings of American Society of
Clinical Oncology, 20, 348a.
Mustain, K., Katula, J., & Zhao, H. (2007). A pilot study to assess the influence of Tai
Chi Chuan on functional capacity among breast cancer survivors. The Journal of
Supportive Oncology, 4 (3), 139-145.
Nail, L., & Winningham, M. (1995). Fatigue and weakness in cancer patients: The
symptoms experience. Seminars in Oncology Nursing, 11, 272-278.
195

Nail, L., Jones, L., Greene, D., Schipper, D., & Jensen, R. (1991). Use and perceived
efficacy of self-care activities in patients receiving chemotherapy. Oncology
Nursing Forum, 18 (5), 883-887.
NCCN, National Comprehensive Cancer Network: Practice guidelines. Cancer-related
fatigue panel 2009 Guidelines, V.1.2009. Retrieved September 3, 2009 from
http://www.nccn.org/professionals/ physician_gls/PDF/fatigue.pdf.
National Comprehensive Cancer Network: Practice guidelines. Cancer-related fatigue
panel 2007 Guidelines, V.1.2007. Retrieved January 14, 2008 from
http://www.nccn.org/professionals/ physician_gls/PDF/fatigue.pdf.
Olson, K. (2007). A new way of thinking about fatigue: A reconceptualization.
Oncology Nursing Forum, 34, 93-99.
ONS (Oncology Nursing Society) (2006). Putting Evidence Into Practice Into Practice:
Fatigue. Retrieved April 10, 2009 from http://www.ons.org/outcomes/
PEPcard/pd/FATIGUE-PEPCard.pdf.
Orre, I., Murison, R., & Dahl, A. (2009). Levels of circulating interleukin-1 receptor
antagonist and C-reactive protein in long-term survivors of testicular cancer with
chronic cancer-related fatigue. Brain Behavior and Immunology, 23(6), 868-874.
Osterborg, A., Brandberg, Y., & Molostova, V. (2002). Randomized double-blind,
placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in
hematologic malignancies. Journal of Clinical Oncology, 20, 2486-2494.
Osterlund, P. (2001). A phase I study of raifitrexed combined with carmofur versus 5FU in metastatic colon cancer. Oncology, 6(2), 113-119.
Page, M., Berger, A., & Johnson, L. (2007). Oncology Nursing Society‟s Putting
Evidence into Practice (PEP) card. Sleep-wake disturbances. Retrieved August

196

30, 2009 from http://www.ons.org/outcomes/PEPcard/pdf/SLEEP.PEPCard.pdf.
.
Page, M., Berger, A., & Johnson, L. (2006). Putting evidence into practice: Evidencebased interventions for sleep-wake disturbances. Clinical Journal of Oncology
Nursing, 10 (6), 753-767.
Pain, V., Randall, D., & Garlick, P. (1984). Protein synthesis in liver and skeletal muscle
of mice bearing an ascites tumor. Cancer Research, 44, 1054–1057.
Payne, J., Piper, B., Rabinowitz, I., & Zimmerman, M. (2006). Biomarkers, fatigue,
sleep, and depressive symptoms in women with breast cancer: A pilot study.
Oncology Nursing Forum, 33, 775–783.
Pearce, S., & Richardson, A. (1996). Fatigue in cancer: A phenomenological
perspective.
European Journal of Cancer Care, 5, 111-115.
Pinto, B., & Maruyam, N. (1999). Exercise in the rehabilitation of breast cancer
survivors. Psychooncology, 8, 191-206.
Piper, B., Borneman, T., & Sun, V. (2008). Cancer-related fatigue: Role of oncology
nurses in translating NCCN assessment guidelines into practice. Clinical Journal
of Oncology Nursing, suppl. 12 (5), 37-47.
Piper, B., Lindsey, A., & Dodd, M. (1987). Fatigue mechanisms in cancer patients:
Developing nursing theory. Oncology Nursing Forum, 14 (6), 17-23.
Pollio, H., Henley, T., & Thompson, C. (1997). The phenomenology of everyday life.
Cambridge, UK: Cambridge Press.
Porock, D., Kristjanson, L., Tinnelly, K., Duke, T., & Blight, J. (2000). An exercise
intervention for advanced cancer patients experiencing fatigue: A pilot study.
Journal of Palliative Care, 16, 30–36
197

Preti, H., Cabanillas, F., Talpz, M., Tucker, S., Seymour, J., & Kurzrock, R. (1997).
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma. Annals
of Internal Medicine, 127, 186-94.
Quesnel, C., Savard, J., Simard, S., Ivers, H., & Morin, C. (2003). Efficacy of cognitivebehavioral therapy for insomnia in women treated for nonmetastatic breast cancer.
Journal of Consultation and Clinical Psychology, 71, 189-200.
Quesada, J., & Talpaz, M. (1986). Clinical toxicity of interferon in cancer patients: A
review. Journal of Clinical Oncology, 4 (2), 234-243.
Ray, M.A. (1994). The richness of phenomenology: Philosophic, theoretic, and
methodological concerns. In J. M. Morse (Ed.), Critical issues in qualitative
research methods (pp. 117-133). Thousand Oaks, CA: Sage.
Ream, E., Richardson, A., & Alexander, D. (2006). Cancer nursing interventions for
fatigue during treatment for cancer. Cancer, 14, 116-127.
Ream, E., & Richardson, A. (2004). A critical appraisal of the factors associated with
fatigue. In M. Armes, M. Krishnasamy, & I. Higginson (Eds.). Cancer, 29–50.
Ream, E., Browne, N., & Glaus, A. (2003). Quality and efficacy of educational materials
on cancer-related fatigue: Views of patients from two European countries.
European Journal of Oncology Nursing, 7 (2), 99-109.
Ream, E., & Richardson, A. (1997). Fatigue in patients with cancer and chronic
obstructive airways disease: A phenomenological enquiry. International Journal,
34, 44-53.
Ream, E., & Richardson, A. (1996). Fatigue: A concept analysis. International Journal
of Nursing Studies, 33, 519-529.

198

Reuter, K., Classen, C., Roscoe, J., Morrow, G., Kirshner, J., Rosenbluth, R., … Spiegel,
D. (2006). Association of coping style, pain, age and depression with fatigue in
women with primary breast cancer. Psychooncology, 15 (9), 772-779.
Reuter, K., & Harter, M. (2004). The concepts of fatigue and depression in cancer.
European Journal of Cancer Care, 13, 127-134.
Rhoten, D. (1982). Fatigue and the postsurgical patient. In C. Norris (Ed.). Concept
clarification in nursing (pp. 277-300). Rockville, MD: Aspen.
Robbins, K., Kumar, P., Regine, W., Wong, F., Weir, A., Flick, P., … Niell, H. (1997).
Efficacy of targeted supradose cisplatin and concomitant radiation therapy for
advanced head and neck cancer: The Memphis experience. Internal Journal of
Radiation Oncology, Biology and Physics, 38, 263–271.
Roscoe, J., Matteson, S., & Mustain, K. (2005). Treatment of radiotherapy-induced
fatigue through a nonpharmacological approach. Integrative Cancer Therapy, 18,
23-28.
Roscoe, J., Hickok, J., & Roscoe, J. (2003). Effect of paroxetine hydrochloride (Paxil) on
fatigue and depression in breast cancer patients receiving chemotherapy. Breast
Cancer Research Treatment, 89, 243-249.
Ryden, M. (1977). Energy: A crucial consideration in the nursing process. Nursing
Forum, 16 (1), 71-82.
Santana, M., Au, H., Dharma-Wardene, M., Hewitt, J., Dupere, D., Hanson, J., … Feeny,
D. (2009). Health-related quality of life measures in routine clinical care: Can
FACT-fatigue help to assess the management of fatigue in cancer patients?
International Journal of Technology Assessment, 25 (1), 90-96.

199

Saykin, A., Ahles, T., & McDonald, B. (2003). Mechanisms of chemotherapy-induced
cognitive disorders: Neuropsychological, pathophysiological, and neuroimaging
perspectives. Seminars in Clinical Neuropsychiatry, 8 (4), 201-216.
Savard, J., Simard, S., Ivers, H, & Morin, C. (2005). Randomized study on the efficacy
of cognitive behavioral therapy for insomnia in women treated for nonmetastatic
breast cancer. Journal of Clinical Oncology, 23, 6083-6096.
Savard, J., & Morin, C. (2001). Insomnia in the context of cancer: A review of a
neglected problem. Journal of Clinical Oncology, 19, 895-908.
Schagen, S., Das, E., & van Dam, F. (2009). The influence of priming and pre-existing
knowledge of chemotherapy-associated cognitive complaints on the reporting of
such complaints in breast cancer patients. Psychooncology, 18 (6), 674-678.
Schneider, C., Hsieh, C., & Sprod, L. (2007). Effects of supervised exercise training on
cardiopulmonary function and fatigue in breast cancer survivors during and after
treatment. Cancer, 110, 918–925.
Schwartz, A., Thompson, J., & Masood, N. (2002). Interferon-induced fatigue in patients
with melanoma: A pilot study of exercise and methylphenidate. Oncology
Nursing Forum, 29, E85-90.
Schwartz, A. (1999). Fatigue mediates the effect of exercise on quality of life. Quality of
Life Research, 8, 529-38.
Schwartz, J., Jandorf, L., & Krupp, L. (1993). The measurement of fatigue: A new
instrument. Journal of Psychosomatic Research, 37, 753-762.
Servaes, P., Verhagen, C., & Bleijenberg, G. (2002). Fatigue in cancer patients during
and after treatment: Prevalence, correlated and interventions. European Journal
of Cancer, 38, 27-43.

200

Seymour, J., Talpz, M., Hagemeister, F., Cabanillas, F., & Kurzrock, R. (1997). Clinical
correlates of elevated serum levels of interleukin-6 in patients with untreated
Hodgkin‟s disease. American Journal of Medicine, 102, 21-28.
Silverman, D., Dy, C., & Castellon, S. (2007). Altered frontocortical, cerebellar, and
basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after
Chemotherapy. Breast Cancer Research and Treatment, 103 (3), 303-311.
Sloan, J., Cella, D., Frost, M., Guyatt, G., Sprangers, M., & Symonds, T. (2002).
Assessing clinical significance in measuring oncology patient quality of life:
Introduction to the symposium, content overview, and definition of terms. Mayo
Clinic Proceedings, 77 (4), 367-370.
Smets, E., Visser, M., & Garssen, B. (1996). Understanding the level of fatigue in cancer
patients undergoing radiotherapy. Journal of Psychosomatic Research, 45, 277293.
Smets, E., Garssen, B., & Bonke, B. (1995). The multidimensional fatigue inventory:
Psychometric qualities of an instrument to assess fatigue. Journal of
Psychosomatic Research, 39, 315-25.
Stark, D., Kiely, M. & Smith, A. (2002). Anxiety disorders in cancer patients: Their
nature, associations and relations to quality of life. Journal of Clinical Oncology,
20 (14), 3137-3148.
Stein, M. (1998). A multidimensional measure of fatigue for use with cancer patients.
Cancer Practice, 6, 143-145.
Stone, M. (2008). How common is fatigue in disease-free breast cancer survivors? A
systematic review of the literature. Breast Cancer Research Treatment, 112 (1),
5-113.

201

Sura, W., Murphy, S. & Gonzales, I. (2006). Level of fatigue in women receiving dosedense versus standard chemotherapy for breast cancer: A pilot study. Oncology
Nursing Forum, 33 (5), 1015-1021.
Svaninger, G., Lundberg, P., & Lundholm, K. (1983). Thyroid hormones and
experimental cancer cachexia. Journal of National Cancer Institute, 77, 555-561.
Syrop, J. (2008). Fatigue in people with cancer. Oncology, 22 (11), 41-42.
Tanaka, K., Akechi, T., & Okuyama, T. (2002). Impact of dyspnea, pain, and fatigue on
daily life activities in ambulatory patients with advanced lung cancer. Journal of
Pain and Symptom Management, 23 (5), 417-423.
Taylor, S., & Bogdan, R. (1984). Introduction to qualitative research: The search for
meanings. New York: John Wiley and Sons.
Thomas, S. (2004). Qualitative Nursing Research. Lecture given in Nursing 607,
University of Tennessee, Knoxville, Tennessee
Thomas, S., & Pollio, H. (2002). Listening to patients. New York: Springer Publishing
Company.
Tisdale, M. (1999). Wasting in cancer. The Journal of Nutrition, 129 (1), 243S-246S.
Tsang, K., Carlson, C., Crossover, L., & Olson, K. (2007). Pilot crossover trial of reiki
versus rest for treating cancer-related fatigue. Integrative Cancer Therapies, 6,
25-35.
Valle, R. S., King, M., & Halling, S. (1989.) An introduction to existentialphenomenological thought in psychology. In R. S. Valle & S. Halling (Eds).
Existential phenomenology perspectives in psychology, (pp. 3-16). New York:
Plenum Press.

202

Van der Pompe, G., & Antoni, M. (1996). Elevated basal cortisol levels and attenuated
ACTH and cortisol responses to behavioral challenges in females with metastatic
breast cancer. Psychoneuroendocrinology, 21, 361-374.
Visser, M., & Smets, E. (1998). Fatigue, depression and quality of life in cancer patients:
How are they related? Supportive Cancer Care, 6, 101-108.
Vistad, I., Fossa, S., Kristensen, G., & Dahl, A. (2007). Chronic fatigue and its correlates
in long-term survivors of cervical cancer treated with radiotherapy. British
Journal of Oncologic Gynecology, 114 (9), 1150-1158.
Vogelzang, N., Breitbart, W., & Cella, D. (1997). Patient, caregiver and oncologists
perceptions of cancer-related fatigue: Results of a tripart assessment survey.
Seminars in Oncology, 34, 4-12.
Von Ah, D., Kang, D., & Carpenter, J. (2008). Predictors of cancer-related fatigue in
women with breast cancer before, during, and after adjuvant therapy. Cancer
Nursing, 31 (2), 134-144.
Wefel, J., Lenzi, T., Theriault, R., Davis, R., & Myers, C. (2004). The cognitive sequalae
of standard-dose adjuvant chemotherapy in women with breast carcinoma:
Results of a prospective, randomized longitudinal trial. Cancer, 100 (11), 22922299.
Wetzler, M., Kurzrock, R., Estrov, Z., Kantarjian, H., Gissingler, M., & Underbrnk, M.
(1994). Altered levels of interleukin-1B and interleukin-1 receptor antagonist in
chronic leukemia. American Journal of Medicine, 102, 21-28.
Wielgus, K., Berger, A., & Hertzog, M. (2009.) Predictors of fatigue 30 days after
completing anthracycline plus taxane adjuvant chemotherapy for breast cancer.
Oncology Nursing Forum, 36 (1), 38-48.

203

Winningham, M., Ingwersen, K., Burke, M., & Wilkes, G. (2002). Oncology nursing
drug handbook. Boston: Jones & Bartlett Publishers.
Winningham, M., & Burke, M. (2000). Fatigue in cancer: A multidimensional approach.
Boston: Jones & Bartlett Publishers.
Winningham, M., Nail, L., Burke, M., Brophy, L., Cimprich, B., Jones, T., … Piper, B.
(1994). Fatigue and the cancer experience: The state of the knowledge.
Oncology Nursing Forum, 21, 23-36.
Winters-Stone, K., Bennett, J., Nail, L., & Schwartz, A. (2008). Strength, physical
activity, and age predict fatigue in older breast cancer survivors. Oncology
Nursing Forum, 35 (5), 815-821.
Yates, P., Aranda, S., Hargraves, M., Mirolo, B., Clavarino, A., & McLachlan, S. (2005).
Randomized controlled trial of an educational intervention for managing fatigue
in women receiving adjuvant chemotherapy for early-stage breast cancer. Journal
of Clinical Oncology, 23 (25), 6027-6036.
Yayuzsen, T., Davis, M., & Ranganathan, V. (2009). Cancer-related fatigue: Central of
peripheral? Journal of Pain and Symptom Management, 38 (4), 587-596.
Yoshikawa, E., Matsuoka, Y., & Inagaki, M. (2005). No adverse effects of adjuvant
chemotherapy on hippocampal volume in Japanese breast cancer survivors.
Breast Cancer Research and Treatment, 92 (1), 81-84.
Young-McCaughan, S., Dramiga, S., & Yoder, L. (2002). Physical and psychological
health outcomes in patients with cancer participating in a structured exercise
program. Oncology Nursing Forum, 29, 333.
Young-McCaughan, S., & Sexton, D. (1991). A retrospective investigation of the
relationship between aerobic exercise and quality of life in women with breast
cancer. Oncology Nursing Forum, 18, 751-757.
204

APPENDIX

205

Informed Consent Statement
Understanding the Meaning of Fatigue Experienced by the Breast Cancer Patient:
A Phenomenological Study

You are invited to participate in a research study. The purpose of this study is to
explore the experience of having cancer-related fatigue. If you agree to participate, an
experienced interviewer will conduct an audio taped interview with you that will last
approximately one hour in a place of your choice. You will be asked to share your lived
experience of being a cancer patient who is experiencing cancer-related fatigue. The
nature and direction of the interview will be determined by you and the investigator and
will unfold as the interview progresses. The interviewer may ask you to clarify or
elaborate on your comments. This interview will be audio taped so that the investigators
can use your exact words to understand your experience. These interviews will be
transcribed into written form for analysis by an interdisciplinary research group. You
will be asked to complete a demographic sheet indicating age, race, educational level, and
date of cancer diagnosis.

Your name will not appear on the tape or the transcript. Tapes, transcripts, and
consent forms will be kept in a separate locked file drawer in the Principle Investigator‟s
office. Tapes will be destroyed after the interview is transcribed. For further study,
transcripts will be archived in a locked drawer in the researcher‟s office.

206

In appreciation of your time and effort in participating, a handout on ways to
manage fatigue will be provided. Participating in this study is strictly voluntary. You
may contact the investigator following the interview and during the analysis to clarify the
interpretation of the experience. You may experience some fatigue as a result of the
length of the interview. Should you become tired during the interview, the interview can
be terminated and a follow-up interview can be completed at a time and location
convenient for you. You are free to choose not to participate in this study and you can
withdraw at any time, before, during, or after the interview. Should you feel sad or
anxious during the interview, you may request the interview to be terminated. Available
resources to assist you with the sadness or anxiety will be offered to you. Your audio
tape and/or transcript will be destroyed upon your request.

Any and all information will be kept in confidence. Neither your name nor any
identifying information will be used in any reports although your words may be used to
support the interpretation and analysis. Your transcribed words will not be traceable to
you in public reports or articles resulting from the study.
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Questions about this project can be directed to:

Lois Doane, MSN, RN, AOCN.
Sandra Thomas, PhD, RN.

(865) 384-8586

(865) 974-7581

University of Tennessee College of Nursing
1200 Volunteer Blvd.
Knoxville, TN. 37996-4180

I give permission to be interviewed.

____________________________________
Signature

_____________________
Date

I give permission for my transcribed interview to be archived for further study.

____________________________________
Signature

_____________________
Date
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Understanding the Meaning of Fatigue Experienced
by the Breast Cancer Patient

Confidentiality Pledge of Group Member

I, ______________________________________, a member of the Phenomenology
Research Group at the College of Nursing, University of Tennessee, pledge to maintain
confidentiality of this audio taped research interview following discussions of the
transcript in the research group. I will not discuss the contents of the transcripts outside
the research group.

Date: _____________________
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Understanding the Meaning of Fatigue Experienced
by the Breast Cancer Patient

Confidentiality Pledge of Transcriptionist

I, _______________________________________, as a transcriptionist for this study,
pledge to maintain confidentiality of this audio taped research interview during and
following transcription. I will not discuss the transcripts with anyone other than the
Principle Investigator and the faculty advisor.

Date: __________________

Signature: __________________________
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